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Abstract
Background: Neurofibromatosis type 1 (NF1) is a rare genetic disorder with
a long list of cognitive symptoms. One of the core difficulties in the cognitive
area is attention deficit, culminating frequently in the diagnosis of Attention
deficit hyperactivity disorder (ADHD). Given that each of the two diseases by
themselves are associated with impaired cognitive functioning, the comorbid-
ity of ADHD in NF1 may be a specific risk factor for major impairments in the
affected patients. The goal of this work was to identify characteristics of the
cognitive profile(s) of NF1 with and without ADHD and to distinguish atten-
tion dysfunctions in NF1 from those in neurotypical ADHD. Furthermore, this
work investigated the role of attention deficit in the intellectual development
of children with NF1.
Methods: 111 children with NF1 and/or ADHD (53 NF1ADHD, 28 NF1only, 30
ADHDonly), aged between 6 and 12 years, performed an extensive neuropsy-
chological test battery at three times within two years. Standardized assess-
ments regarding intelligence, memory, attention functions, executive functions,
and quality of life were performed in a time interval of 12 months.
Results: Firstly, the cognitive characteristics of children with NF1ADHD differ
markedly from those of children with NF1only. Comorbid ADHD in NF1 was
associated with lower intellectual ability, more attention problems, executive
dysfunctions, and lower quality of life. Additionally, certain attention dysfunc-
tions differed between NF1 and neurotypical ADHD. Secondly, attention func-
tions correlated with intellectual functioning in the short and long term and
predicted them in NF1. However, intellectual functioning in children with NF1
was not modified by changes in attention over the term of the research project.
Conclusions: [1] The NF1 patient group of this research project can be di-
vided into two distinct subgroups regarding their cognitive profile: one group
with almost unimpaired cognitive functioning (NF1only) and one group with af-
fected cognitive functioning (NF1ADHD). [2] Certain attention dysfunctions in
NF1 might rather be associated with the NF1-condition, than merely be the re-
sult of comorbid ADHD. [3] Attention functions are dimensionally and causally
linked to intellectual development in NF1.

Zusammenfassung
Hintergrund: Neurofibromatose Typ 1 (NF1) ist eine seltene genetische Er-
krankung, die mit einer Reihe an kognitiven Symptomen einhergeht. Zu den
häufigsten kognitiven Beeinträchtigungen zählen Aufmerksamkeitsprobleme
bis hin zur Diagnose einer Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung
(ADHS). Da sowohl NF1 als auch ADHS an sich mit beeinträchtigten kogniti-
ven Funktionen assoziiert sind, ist anzunehmen, dass eine komorbide ADHS
bei NF1 einen entscheidenden Risikofaktor für schwere kognitive Beeinträch-
tigungen darstellt. Ziel der vorliegenden Doktorarbeit war es, die kognitiven
Profile von NF1 mit und ohne ADHS zu charakterisieren und Unterschiede be-
züglich spezieller Aufmerksamkeitsdefizite zwischen ADHS bei NF1 und neu-
rotypischer ADHS herauszuarbeiten. Zudem wurde die Rolle von Aufmerk-
samkeitsproblemen in der intellektuellen Entwicklung von Kindern mit NF1
untersucht.
Methoden: 111 Kinder mit NF1 und/oder ADHD (53 NF1ADHD, 28 NF1only, 30
ADHDonly) im Alter von 6-12 Jahren wurden mit einer neuropsychologischen
Testbatterie untersucht. Zu drei Zeitpunkten innerhalb von 2 Jahren wurden
Untersuchungen bezüglich Intelligenz, Gedächtnis, Aufmerksamkeit, Exeku-
tivfunktionen und Lebensqualität durchgeführt.
Ergebnisse: NF1ADHD und NF1only unterschieden sich stark in ihrem kogni-
tiven Profil. Eine komorbide ADHS bei NF1 war mit niedrigeren intellektuel-
len Fähigkeiten, mehr Aufmerksamkeitsproblemen, exekutiven Dysfunktionen
und niedrigerer Lebensqualität verbunden. Zudem ergaben sich Unterschie-
de in bestimmten Aufmerksamkeitsdefiziten bei NF1 im Vergleich zu neuroty-
pischer ADHS. Aufmerksamkeitsfunktionen korrelierten kurz- und langfristig
mit intellektuellen Fähigkeiten und konnten diese bei NF1 vorhersagen.
Schlussfolgerung: [1] Es bestehen zwei voneinander abgrenzbare kognitive
Profile innerhalb der NF1-Population, mit einer nahezu unbeeinträchtigten
Gruppe (NF1only) und einer Gruppe (NF1ADHD) mit starken kognitiven Beein-
trächtigungen. [2] Bestimmte Aufmerksamkeitsdefizite scheinen eher mit NF1
an sich assoziiert zu sein als mit einer komorbiden ADHS. [3] Die Aufmerksam-
keit steht in einer dimensionalen und kausalen Verbindung zur intellektuellen
Entwicklung bei NF1.
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1. Theoretical Background
1.1. Neurofibromatosis Type 1
1.1.1. Disease Characterization and Pathophysiology
Neurofibromatosis type 1 (NF1), also called Recklinghausen’s disease, is an
autosomal dominant single-gene disorder, affecting skin and nervous system.
With an incidence rate of one in 2600 to 3000 individuals (Friedman, 1999; Lam-
mert, Friedman, Kluwe, & Mautner, 2005), NF1 is one of the most frequent
of rare genetic disorders. There are no known differences in the incidence of
NF1 regarding ethnic groups or gender (Friedman, 1999). Approximately half
of the cases of NF1 are caused by an inherited defect of the NF1-gene, while
the remainder is caused by de-novo mutations (Friedman, 1999). Characteris-
tic clinical features of NF1 include café-au-lait spots on skin, dermic neurofi-
broma and/or plexiform neurofibroma, freckling in the axillary or inguinal re-
gions, Lisch nodules, typical bone lesions, and a first degree relative with NF1
(National Institutes of Health, 1988). NF1 is diagnosed by clinical diagnostics of
observable symptoms and/or by molecular genetic tests. For the diagnosis of
NF1, the patient needs to present at least two of the clinical features mentioned
above. All diagnostic criteria and additional common clinical manifestations of
NF1 are listed in Table 1.1 and Table 1.2.
NF1 results from a heterozygous mutation in the NF1-gene and is located
on chromosome 17 (17q11.2). The NF1-gene encodes for the cytoplasmic pro-
tein Neurofibromin, which takes part in Ras GTPase activation. Ras GTPase
down-regulates the Ras (Rat sarcoma) protein family, which is involved in cel-
lular signal transduction associated with cell proliferation and differentiation.
Therefore, a lack of Neurofibromin leads to increased Ras GTPase and to de-
creased inhibitory control of cell growth, consequently increasing the risk for
tumorigenesis (Kehrer-Sawatzki & Mautner, 2009). Especially nerve cell and
1
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Table 1.1.
Diagnostic criteria for NF1 (National Institutes of Health, 1988)
Diagnostic criterion
1 Six or more café-au-lait skin macules over 5 mm in prepubertal individuals and
over 15 mm in postpubertal individuals
2 Two or more neurofibromas of any type or one plexiform neurofibroma
3 Axillary or inguinal freckling
4 Two or more Lisch nodules
5 Optic glioma
6 Bone lesion with sphenoid dysplasia or thinning of the long bone cortex with or
without pseudarthrosis
7 A first-degree relative (parent, sibling, or offspring) that meets NIH criteria
The diagnosis of NF1 requires at least two out of seven NIH criteria.
nerve sheath tumors are very common in NF1 and can lead to severe complica-
tions, if they occur in the central nervous system. Typically, tumors caused by
NF1 are benign, but there are special types of tumors that are tending to grow
malign. The most prominent malign tumor in NF1 is the Malignant Peripheral
Nerve Sheath Tumor (MPNST). The lifetime risk to develop a MPNST reaches
8 to 13% for patients with NF1 and most of these tumors are resistent against
chemo- or radiotherapy (Kehrer-Sawatzki & Mautner, 2009). Since there is no
causal treatment for NF1 so far, early diagnostics of symptoms and comorbidi-
ties, especially MPNSTs or other space-occupying tumors, are crucial for the
further course and potential cure.
Although NF1 manifests with complete penetrance, the clinical severity and
phenotype of the disorder are highly variable, indicating that other factors than
the mutation of the gene alone add to the specific clinical phenotype (Kehrer-
Sawatzki & Mautner, 2009). However, until now it remains unclear which fac-
tors contribute.
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Table 1.2.
Frequency and age of onset of major clinical manifestations of neurofibromatosis 1 (Ferner et al., 2007).
Clinical manifestation Frequency (%) Age of onset
Café au lait patches >99 Birth to 12 years
Skin-fold freckling 85 3 years to adoles-
cence
Lisch nodules 90–95 >3 years
Cutaneous neurofibromas >99 >7 years (usually late
adolescence)
Plexiform neurofibromas 30 (visible) –
50 (on imaging)
Birth to 18 years
Disfiguring facial plexiform
neurofibromas
3–5 Birth to 5 years
Malignant peripheral nerve
sheath tumor
2–5
(8–13% lifetime risk)
5–75 years
Scoliosis 10 Birth to 18 years
Scoliosis requiring surgery 5 Birth to 18 years
Pseudarthrosis of tibia 2 Birth to 3 years
Renal artery stenosis 2 Lifelong
Phaeochromocytoma 2 >10 years
Severe cognitive impairment
(IQ <70)
4–8 Birth
Learning problems 30–60 Birth
Epilepsy 6–7 Lifelong
Optic pathway glioma 15 (only 5% symptomatic) Birth to 7 years
(up to 30 years)
Cerebral gliomas 2–3 Lifelong
Sphenoid wing dysplasia <1 Congenital
Aqueduct stenosis 1.5 Lifelong
Reproduced from Guidelines for the Diagnosis and Management of Individuals with Neurofibromatosis 1, Journal of
Medical Genetics, Ferner et al., Volume 44, Issue 2, 2007 with permission from BMJ Publishing Group Ltd.
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1.1.2. Structural Brain Abnormalities in NF1
The widespread spectrum and the variability in presence and severity of cog-
nitive impairments suggest that more than just one factor is responsible for the
genesis of the cognitive profile of NF1 (Diggs-Andrews et al., 2012). Aside from
underlying molecular features (Diggs-Andrews et al., 2012), structural abnor-
malities of the brain are discussed as causal factors (De Winter, Moore, Slopis,
Ater, & Copeland, 1999; Schrimsher, Billingsley, Slopis, & Moore, 2003).
Patients with NF1 present a long list of structural brain abnormalities such
as symptomatic and asymptomatic opticus glioma (Kehrer-Sawatzki & Maut-
ner, 2009), brain tumors, macrocephaly with higher volumes of white matter
(Payne, Moharir, Webster, & North, 2010), enlargement of the corpus callo-
sum (Cutting, Cooper, et al., 2002; Kayl, Moore, Slopis, Jackson, & Leeds, 2000;
Payne et al., 2010), or unidentified bright objects (UBO, also: T2 weighed MRI
hyperintensities) (Payne, Barton, Shores, & North, 2013). However, cognitive
deficits were observed in NF1 even in the absence of tumors or macrocephaly
(Ferner, Hughes, & Weinman, 1996), and data on the association between UBOs
and cognitive deficits remains inconclusive (Cutting et al., 2000; Hyman et al.,
2003; Hyman, Gill, Shores, Steinberg, & North, 2007). General cognitive impair-
ment has consistently been associated with UBOs in NF1, and in a longitudinal
design, Payne et al. (2013) found functional improvement of cognitive deficits,
when UBOs dissolved over the years. In contrast, the cognitive profile of pa-
tients without UBOs was stable, albeit impaired (Payne et al., 2013).
Functional MRI studies discovered abnormal network structures in the brain
of NF1 patients with reduced long-range anterior-posterior connectivity that
correlated with intelligence and internalizing symptoms (Tomson et al., 2015).
In task-based fMRI studies with visuo-spatial and spatial working memory
tasks, researchers found a general pattern of increased short-range and de-
creased long-range connectivity and reduced activation in frontal regions (Bill-
ingsley et al., 2004; Shilyansky, Lee, & Silva, 2010).
1.1.3. Molecular Abnormalities in NF1
Animal research on molecular abnormalities in NF1 reveals that the deficiency
of neurofibromin caused by mutations in the NF1 gene not only leads to in-
creased tumor genesis, as mentioned above, but also seems to be involved in
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different cognitive impairments. Neurofibromin is expressed in all organ sys-
tems of the body, but plays a particularly important role in the nervous system
(Gutmann, Geist, Wright, & Snider, 1995). It acts as an inhibitor in the Ras sig-
naling pathway. Overly active Ras signaling can provoke an abnormally high
GABA-release, which consecutively leads to increased GABA-mediated inhi-
bition, decreased cell growth, and reduced synaptic plasticity (see Figure 1.1)
(Ismail, Fatemi, & Johnston, 2017; Oliveira & Yasuda, 2014; Diggs-Andrews &
Gutmann, 2013; Costa & Silva, 2002). Animal models of NF1 suggest abnormal
Ras-dependent functioning of the prefrontal cortex, striatum and hippocam-
pus, leading to deficits in attention, memory and visuo-spatial learning (Costa
et al., 2002).
inactive 
RAS-GDP
Neurofibromin 
deficiency
active !
RAS-GTP
deactivation by 
Neurofibromin
increased GABAA-
mediated inhibition
suppression of 
hippocampal 
longterm potentiation
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GABAA-release
hyperactivation of 
RAS-pathway
cognitive dysfunction
reduced 
synaptic 
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molecular 
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Figure 1.1. Neurofibromin deficiency leads to reduced synaptic plasticity and is associated with
cognitive dysfunction in NF1.
Pathological Ras-pathway activity seems to be linked to cognitive dysfunc-
tion in patients with NF1. Research on influencing synaptic plasticity through
medication suggests that the HMG-CoA reductase inhibitors simvastatin and
lovastatin have the potential to directly affect the Ras signaling pathway (Krab,
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de Goede-Bolder, et al., 2008; Li et al., 2005). Therefore, it was hypothesized that
treatment with simvastatin or lovastatin would influence GABA-mediated in-
tracortical inhibition and would lead to an amelioration of cognitive functions
in NF1. Krab, de Goede-Bolder, et al. (2008) conducted a major study, during
which a 12-week simvastatin treatment was tested against placebo in children
with NF1. Against their expectations, the authors did not observe a significant
difference between the simvastatin and placebo groups on cognitive functions
after the treatment. In contrast, a study investigating the effect of lovastatin in
adult patients revealed that a 4-day treatment with 200 mg lovastatin signif-
icantly decreased intracortical inhibition and significantly increased synaptic
plasticity and phasic alertness (Mainberger et al., 2013). However, another lo-
vastatin study conducted by Payne et al. (2016) could not confirm the positive
effect of lovastatin on cognitive functions. After 16 weeks of treatment with lo-
vastatin (40 mg/day), no improvement of visuo-spatial learning and attention
could be found in children with NF1 (Payne et al., 2016).
Additional to Ras-dependent signaling alterations, more recent studies sug-
gest that neurofibromin deficiencies lead to reduced dopamine signaling, which
may be responsible for impairments in learning and memory (Diggs-Andrews
et al., 2012; Wolman et al., 2014), and even more so for attention problems
in NF1 (Diggs-Andrews & Gutmann, 2013). In a mouse model, Brown and
colleagues could trace back attention defects in NF1-mutant mice to reduced
dopamine levels and reduced postsynaptic dopamine signaling in the striatum.
Striatal dopamine levels could be normalized by dopamine-elevating drugs
(e.g. methylphenidate), accompanied by an amelioration of attention perfor-
mance (Brown et al., 2010).
1.1.4. Neuropsychological and Developmental Difficulties
Besides a wide range of physical complications (Friedman & Birch, 1997), NF1
is considered to cause a variety of cognitive dysfunctions (Hyman, Shores, &
North, 2005; North, Joy, Yuille, Cocks, & Hutchins, 1995). The vast majority of
NF1 patients experiences moderate to severe impairment in at least one area of
cognitive functioning (North, Hyman, & Barton, 2002). Figure 1.2 illustrates the
profile of NF1 and includes the most prominent impairments, without claiming
to be a complete list of the symptoms.
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Figure 1.2. Physical and cognitive profile of NF1.
Intelligence
Mean intelligence quotients of patients with NF1 have been repeatedly located
in the lower normal range (Ferner et al., 1996; North et al., 2002) and NF1 pa-
tients are reported to score significantly lower in intelligence tests than healthy
(sibling-) controls (Hachon, Iannuzzi, & Chaix, 2011; Hyman et al., 2005). Hy-
man, Arthur, and North (2006) found in their study that 10% of children with
NF1 fall over two standard deviations below and 20% fall between one to two
standard deviations below their healthy siblings with their general intellectual
ability. Karmiloff-Smith (2008) strongly believes that genetic mutations tend
to affect low-level cognitive processes that will have diverse, cascading effects
on different domains as development proceeds over time. In view of this as-
sumption, it seems reasonable that the NF1-gene mutation should lead to a
high number of patients with severe cognitive dysfunction and mental retar-
dation. However, the prevalence of mental retardation seems to be just slightly
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increased in NF1 (about 4-8%), which distinguishes NF1 from other genetic dis-
orders like Fragile-X-Syndrome (Brewer, Moore, & Hiscock, 1997).
The intelligence profile of NF1 patients measured with the Wechsler Intelli-
gence Scale for Children (WISC-IV) often presents with strengths in verbal com-
prehension, but weaknesses in visuo-spatial abilities, working memory and
processing speed (Lidzba, Granström, Lindenau, & Mautner, 2012; Potvin, Hardy,
& Walsh, 2015).
Learning disabilities
In the context of NF1 research, a distinction is made between specific and gen-
eral learning disabilities. Specific learning disabilities are defined as poor per-
formance in one or more specific didactic domain with an intelligence score
in the normal range, whereas general learning disabilities are defined as poor
performance in one or more specific didactic domain with an intelligence score
below 85. According to a study by Hyman et al. (2006), about 30 to 60% of NF1
patients exhibit specific and general learning disabilities. Other authors found
an even higher prevalence. Krab, Aarsen, et al. (2008) found a prevalence of
specific and general learning disabilities of 39% in the NF1 patient group. Only
22% of their patients had no learning disability and only 10% of the children
with NF1 had no problems in any aspect of school functioning. In the study by
Krab, Aarsen, et al. (2008), impairment in school functioning was assessed in 4
domains of school performance (technical and comprehensive reading, spelling
and mathematics) and in 6 domains of cognitive skills (intelligence, memory,
language, visual-spatial skills, executive skills and attention). Children with
NF1 showed impairment in all 4 domains of school performance and in all
cognitive skills. Academic underachievement in children with NF1 has also
been reported by Pride, Payne, and North (2012), who assessed intelligence,
academic achievement, attention functions and executive functions. The NF1
group performed significantly poorer than the healthy control group on the
majority of academic and cognitive measures, but especially attention prob-
lems and executive dysfunctions seemed to undermine academic achievement
in children with NF1 (Pride et al., 2012).
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Attention and executive dysfunctions
About 30-50% of NF1 patients manifest attention problems (Hyman et al., 2005;
Templer, Titus, & Gutmann, 2012) and an even higher number of patients dis-
play executive dysfunctions (Payne, Hyman, Shores, & North, 2011). A study
by Mautner and colleagues revealed that 73% of children with NF1 had at least
light attention problems and 33% of them presented very serious attention dys-
functions (Mautner et al., 2010).
Executive functions play a central role when it comes to learning processes
and they are important for the handling of many everyday situations. Prob-
lems with executive functions have been identified in patients with NF1 inde-
pendently from IQ (Galasso et al., 2014; Plasschaert et al., 2016) and could be
observed by professionals in laboratory test situations as well as in daily living
by parents and teachers (Casnar & Klein-Tasman, 2017; Payne et al., 2011). Ex-
ecutive dysfunctions were found in the NF1 population concerning cognitive
flexibility (Zöller, Rembeck, & Bäckman, 1997; Roy et al., 2014), response inhibi-
tion (Payne et al., 2011), working memory (Payne, Arnold, Pride, & North, 2012;
Casnar & Klein-Tasman, 2017), planning (Roy et al., 2010; Galasso et al., 2014;
Gilboa, Rosenblum, Fattal-Valevski, Toledano-Alhadef, & Josman, 2014), orga-
nization (Payne et al., 2011), and processing speed (Lidzba et al., 2012; Potvin et
al., 2015). Difficulties in executive skills can continue into adulthood in patients
with NF1 (Zöller et al., 1997) and are suggested to be related to academic under-
achievement (Gilboa et al., 2014; Janke et al., 2014). Whether and to what extent
executive dysfunctions in NF1 depend on the occurrence of a comorbid Atten-
tion Deficit Hyperactivity Disorder (ADHD) is disputed so far (Potvin et al.,
2015; Payne et al., 2012; Roy et al., 2010). However, in a small study by our own
research group, we found that children with NF1 plus comorbid ADHD were
affected in executive functioning compared to population norms, while chil-
dren with NF1 without comorbid ADHD showed no dysfunctions (Denkinger
et al., 2018).
Visuo-spatial disabilities
Visuo-spatial disabilities are consistently reported in parients with NF1 (Zöller
et al., 1997; Krab, de Goede-Bolder, et al., 2008; Schrimsher et al., 2003). Schrim-
sher et al. (2003) could predict the NF1 diagnostic status against healthy con-
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trols in up to 90% of NF1 patients with a combination of visual-spatial/motor
tasks. The most robust indicator of NF1 was an impairment in the Judgement
of Line Orientation Test. Payne et al. (2013) found significantly poorer visuo-
spatial learning in children with NF1 compared to healthy controls using the
Paired Associates Learning (PAL) task from the Cambridge Neuropsychologi-
cal Test Automated Battery (CANTAB).
Memory problems
Problems with short-term, long-term and working memory were found for
both the verbal/auditive domain and the visual-spatial domain (Descheemaek-
er, Plasschaert, Frijns, & Legius, 2013; Krab, de Goede-Bolder, et al., 2008; Payne
et al., 2012; Billingsley, Slopis, Swank, Jackson, & Moore, 2003; Hofman, Har-
ris, Bryan, & Denckla, 1994). Descheemaeker and colleagues investigated adult
NF1 patients and compared their performance in auditory short- and long-term
memory (task: Auditory Verbal Learning Test) as well as visual-spatial short-
and long-term memory (task: Complex Figure of Rey) to matched controls.
NF1 patients showed impairment in all tested memory domains and scored
significantly below the control group (Descheemaeker et al., 2013). In children
with NF1, Payne and colleagues demonstrated severe dysfunctions in visual-
spatial short-term memory (task: PAL, CANTAB) and in working memory
(task: working memory index, WISC-IV) even after controlling for confounders
like full-scale IQ, sustained attention and visuo-spatial disabilities (Payne et al.,
2012). In contrast to these findings stands a study by Hyman et al. (2005), who
assessed verbal learning and verbal delayed memory (task: California Verbal
Learning Test for Children) as well as visual learning and visual delayed mem-
ory (task: Continuos Visual Memory Test) and found no memory impairment
in any modality in children with NF1, compared to healthy sibling-controls.
Comparing standard scores, they even found stronger memory skills than gen-
eral intellectual functioning in their patient group. The authors explained their
unusual findings with the application of a standardized verbal memory test,
the abstract nature of the visual task and the inclusion of a control for percep-
tual discrimination difficulties.
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Impaired language acquisition and language skills
Language impairments are also very common among patients with NF1 (Ali-
vuotila et al., 2010; Brei, Klein-Tasman, Schwarz, & Casnar, 2014). Alivoutila
and colleagues investigated speech characteristics in children and adolescents
as well as adult patients with NF1. They found deviations in phonation and ar-
ticulation in 94% of the patients compared to 50% in healthy controls. The most
typical speech issue among patients with NF1 was difficulty to regulate pitch,
resulting in monotone speech, and nasal voice. Also very common were flu-
ency problems including slurred speech, labored or sloppy articulation, dele-
tion and reduction of sounds and syllables. The authors believe that these
issues can have great negative social consequences. Brei et al. (2014) found
difficulties in core language skills in more than one third of preschool-aged
NF1 patients. Areas of particular difficulties were Receptive Language (33.3%),
Language Structure (28.6%) and Expressive Language (28.6%), all measured
with the Clinical Evaluation of Language Fundamentals – Preschool 2 (CELF-
P2; Wiig et al. 2004). These lab-measured difficulties also seemed to relate to
everyday communication and social interaction (Brei et al., 2014).
Emotional and social difficulties
Many patients with NF1 demonstrate emotional and social difficulties, which
include challenges in forming friendships, rejection by their peers or teasing,
poorer social skills in general, and both internalizing and externalizing prob-
lems (Barton & North, 2004; Huijbregts & de Sonneville, 2011). Social cogni-
tion, such as understanding paradoxical sarcasm or the capacity to recognize
emotion seems to be significantly impaired in adult NF1 patients compared to
healthy controls and these deficits were associated with decreased grey matter
volume in the right superior temporal gyrus in a study by Pride et al. (2014).
Also, children with NF1 exhibited problems in functional communication as
well as weaker adaptive behavior compared to same-aged peers (Klein-Tasman
et al., 2014, 2013). It is suggested that general cognitive disabilities like diffi-
culties in processing speed, cognitive control and social information process-
ing account for emotional problems in patients with NF1, because adaptive
functioning in complex social situations seems to require good communication
between many cognitive operations (Huijbregts & de Sonneville, 2011). Fur-
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thermore, there is an increased incidence of autistic traits in patients with NF1
(Plasschaert et al., 2015). Walsh et al. (2013) found a clinically relevant symp-
tomatology for Autism Spectrum Disorder (ASD) in about 40% of children with
NF1. Garg and colleagues found an even higher prevalence of ASD symptoma-
tology in the Social Responsiveness Scale (SRS): 29.4% of children with NF1
exhibited symptoms in the severe clinical range and a further 26.6% exhibited
symptoms in the mild to moderate range (Garg et al., 2013).
Quality of Life
Like in other chronic diseases, research consistently reports lower global Qual-
ity of Life (QoL) in children and adolescents with NF1 compared to healthy
children (Vranceanu, Merker, Park, & Plotkin, 2015; Garwood et al., 2012; Krab
et al., 2009). For example, Cipolletta, Spina, and Spoto (2018) found that chil-
dren with NF1 rated their QoL in the Pediatric Quality of Life Inventory as
significantly lower than healthy controls on all scales (physical health, emo-
tional state, social life, school activities, and global score), while parents rated
their children’s QoL as significantly poorer on only two of the four subscales
(emotional state and social life) and on the global score. In general, however,
QoL in NF1 is rated as poorer in parent proxy-reports than in children’s reports
(Vranceanu et al., 2015).
Some authors started the attempt to identify factors that influence QoL in
NF1. According to these authors, the familial type of NF1, parental educa-
tion, and good family relationships/cohesion should have a positive effect on
QoL (Vranceanu et al., 2015; Oostenbrink et al., 2007; Graf, Landolt, Mori,
& Boltshauser, 2006), while male sex, perceived disease severity, presence of
plexiform neurofibromas, more disease complications, greater pain interfer-
ence, orthopedic problems, socioemotional problems, cognitive dysfunctions,
and learning disabilities were negatively correlated with QoL (Vranceanu et al.,
2015; Wolters et al., 2015; Wolkenstein et al., 2009; Oostenbrink et al., 2007; Graf
et al., 2006). Disease visibility was not associated with QoL in parent proxy-
reports, but it was a significant negative predictor for QoL by child report
(Vranceanu et al., 2015). Pain alone has no influence on QoL in NF1 (Vranceanu
et al., 2015), but when pain is combined with complications it impacts QoL.
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Motor dysfunction
Motor dysfunction is a common comorbidity of very different neuro-develop-
mental disorders, including NF1. Impairments in patients with NF1 affect gross
motor function, including hypotonia and hampered motor coordination, gait,
balance as well as fine motor function (Haas-Lude et al., 2018; Johnson et al.,
2010; Krab, de Goede-Bolder, et al., 2008) and muscle strength (Stevenson et
al., 2012; Souza, Passos, Guedes, Rezende, & Rodrigues, 2009). The large num-
ber of prescriptions for physiotherapy or occupational therapy in children with
NF1 is an indicator for the great burden that these motor deficits mean to NF1
patients (Krab, de Goede-Bolder, et al., 2008).
1.2. NF1 and Attention Deficit Hyperactivity
Disorder
It is well known that, regarding their cognitive profile, patients with NF1 do
not represent a homogeneous group (Kayl & Moore, 2000). There seem to be
some combinations of cognitive dysfunctions which have more impact than
others. Especially Attention Deficit Hyperactivity Disorder (ADHD) appears
to increase the risk for a number of cognitive comorbidities (Pride et al., 2012;
Lidzba et al., 2012; Koth, Cutting, & Denckla, 2000; Hyman et al., 2006). Lidzba
et al. (2012) and colleagues as well as other authors (Koth et al., 2000) found that
patients with NF1 and additional attention deficit score significantly lower in
intelligence tests and have more specific learning disabilities than children with
NF1 without clinically relevant attention problems (Hyman et al., 2006). In ad-
dition to unspecific attention problems, up to 50% of all NF1 patients present
ADHD-like symptoms to an extent that they fulfill the diagnostic criteria for
ADHD (Hyman et al., 2005; Kayl & Moore, 2000; Koth et al., 2000; Maut-
ner, Kluwe, Thakker, & Leark, 2002) according to the Diagnostic and Statistical
Manual of Mental Disorders - 4th edition, Text Revision (DSM-IV-TR) (American
Psychiatric Association, 2000). The prevalence of ADHD is about ten times
higher in the NF1 patient group than in the general population (Mautner et al.,
2002), where ADHD is already the most prevalent psychiatric disorder in child-
hood, affecting 3-5% of all children (American Psychiatric Association, 2000).
With the introduction of the Diagnostic and Statistical Manual of Mental Dis-
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orders - 5th edition (DSM-5), it must be assumed that the prevalence of ADHD
in the general population is even increasing, since the diagnostic criteria have
been extended (American Psychiatric Association, 2013).
1.2.1. General Characteristics of ADHD – Disease
Characterization and Comorbidities
ADHD in general is characterized by a plurality of symptoms in the categories
inattention, hyperactivity, disruptive behavior and impulsivity, all being de-
velopmentally inappropriate for the child’s age (American Psychiatric Associ-
ation, 2000). Children with ADHD often have trouble to act appropriate to the
situation and attract negative attention. Because they have basic problems to
regulate their behavior, they are often regarded as “agitators”, defiant or lazy.
Negative social interactions with family members, friends and teachers, as well
as academic difficulties lead to decreased self-esteem, lower life satisfaction,
and a variety of psychiatric comorbidities (Becker, Roessner, Breuer, Dopfner,
& Rothenberger, 2011).
In Germany, ADHD is diagnosed according to the diagnostic criteria of the
International Classification of Diseases - 10th edition (ICD-10) (World Health
Organization, 2004), whereas in international research contexts, ADHD is usu-
ally diagnosed with the diagnostic criteria of the DSM-IV-TR (American Psy-
chiatric Association, 2000) or since May 2013 the DSM-5 (American Psychi-
atric Association, 2013). In this thesis, we used the diagnostic criteria of the
DSM-IV-TR. All clinical symptoms are listed in Table 1.3. In the DSM-IV-TR,
three main subtypes of ADHD are classified: the inattentive subtype, the com-
bined subtype and the hyperactive-impulsive subtype. Children have to present
at least six symptoms of the categories inattention and/or hyperactivity/im-
pulsivity to fulfill the diagnostic criteria. Symptoms have to be observed in
different situations of daily life and have to be stable over at least six months.
According to the DSM-IV-TR, symptoms have to be present prior to seven years
of age, which was changed to twelve years of age in the DSM-5.
The gender distribution of ADHD in childhood is uneven with approximately
three affected boys to one affected girl (Cuffe, Moore, & McKeown, 2005; Dul-
can, 1997). One reason for the higher prevalence among boys could be that
they more often annoy by externalizing behavior problems and therefore get
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Table 1.3.
Diagnostic criteria for ADHD as described in the DSM-IV-TR (American Psychiatric Association,
2000)
A. Either 1 or 2:
1. Symptoms of Inattention:
Six (or more) of the following symptoms of inattention have persisted for at least 6
months to a degree that is maladaptive and inconsistent with developmental level.
a often fails to give close attention to details or makes careless mistakes in
schoolwork, work, or other activities
b often has difficulty sustaining attention in tasks or play activities
c often does not seem to listen when spoken to directly
d often does not follow through on instructions and fails to finish school work,
chores, or duties in the workplace (not due to oppositional behaviour or failure
to understand instructions)
e often has difficulty organizing tasks and activities
f often avoids, dislikes, or is reluctant to engage in tasks that require sustained
mental effort (such as school work or homework)
g often loses things necessary for tasks and activities (toys, school assignments,
pencils, books, or tools)
h is often easily distracted by extraneous stimuli
i is often forgetful in daily activities
2. Symptoms of Hyperactivity and Impulsivity:
Six (or more) of the following symptoms of hyperactivity-impulsivity have per-
sisted for at least 6 months to a degree that is maladaptive and inconsistent with
developmental level.
Hyperactivity:
a often fidgets with hands or feet or squirms in seat
b often leaves seat in classroom or in other situations in which remaining seated
is expected
c often runs or climbs excessively in situations in which it is inappropriate
(in adolescents or adults, may be limited to subjective feeling of restlessness)
d often difficulty playing or engaging in leisure activities quietly
e often “on the go” or often acts as if “driven by motor”
f often talks excessively
Impulsivity:
g often blurts out answers before questions have been completed
h often has difficulty awaiting turn
i often interrupts or intrudes on others (eg., butts into conversations or games)
B. Some hyperactive-impulsive or inattentive symptoms that caused impairment
were present before 7 years of age
C. Some impairment from the symptoms is present in two or more settings
(eg., at school [or work] and at home)
D. There must be clear evidence of clinically significant impairment in social, aca-
demic, or occupational functioning
E. The symptoms do not occur exclusively during the course of a Pervasive Devel-
opmental Disorder, Schizophrenia, or other Psychotic Disorder and are not better
accounted for by another mental disorder (eg., Mood Disorder, Anxiety Disorder,
Dissociative Disorders, or a Personality Disorder)
15
Chapter 1. Theoretical Background
diagnosed more often, while girls with ADHD rather tend to develop the more
unremarkable inattentive subtype of ADHD and more often exhibit depressive
symptoms (Biederman et al., 2002; Muller et al., 2011). Patients with the inat-
tentive subtype of ADHD often attract attention very late, because they do not
exhibit as many behavior problems in situations of daily living and can some-
times compensate their deficits with their intellectual abilities.
The course and severity of clinical symptoms of ADHD vary over time and
the smooth transitions between normative behavior and clinically relevant prob-
lem behavior sometimes complicate diagnostics. The diagnosis of a clinically
relevant disease often depends on the extent of developmental risks that are
caused by the symptoms and the clinically relevant psychosocial impairment
(Banaschewski & Dopfner, 2014).
At the end of the last century, it was believed that ADHD was a children’s
disease, which would disappear in the course of adolescence, but current stud-
ies provide increasing evidence for its continuation into adulthood for between
15% to 65% of affected individuals (Faraone, Biederman, & Mick, 2006). Muller
et al. (2011) found that 4 to 6% of patients with childhood ADHD still experi-
ence serious ADHD-symptoms in adulthood. The prevalence of ADHD in the
general adult population is 2.5% (Katzman, Bilkey, Chokka, Fallu, & Klassen,
2017). However, it is possible to reduce ADHD symptomatology by learning
strategies to cope with these deficits.
Patients with ADHD are at a high risk for additional psychiatric comorbidi-
ties. Jensen and colleagues found that 70% of children with ADHD aged be-
tween 7 and 9 years had at least one additional psychiatric disorder (P. S. Jensen
et al., 2001). Very common are oppositional defiant disorder (40%), conduct dis-
order (14%), anxiety (33.5%), tics (11%), mood disorders like depression (3.8%)
and specific learning disorders (Muller et al., 2011). Also very common in pa-
tients with ADHD are traits and symptoms of ASD with 15-25% (Kotte et al.,
2013; Antshel, Zhang-James, Wagner, Ledesma, & Faraone, 2016). Since clini-
cians are permitted to make an ASD diagnosis in the context of ADHD, 12.4% of
ADHD patients have an ASD diagnosis (C. M. Jensen & Steinhausen, 2015). In
earlier versions of the DSM, this was not acceptable, but with the introduction
of the DSM-5 it is allowed (Antshel et al., 2016).
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1.2.2. Etiology of ADHD with and without NF1
Although the definition of ADHD without NF1 (ADHDonly) is based on be-
havior, it is increasingly recognized that the neurocognitive components of
ADHDonly, which are based on impairments of the central nervous system,
can not be ignored (American Psychiatric Association, 2013). There is increas-
ing evidence, that ADHDonly might be a result of a disturbed self-regulation
with a high involvement of executive dysfunctions (e.g. dysfunctions in the
areas cognitive control, impulse control and working memory) (Barkley, 1997;
Gawrilow, Schmitt, & Rauch, 2010). Additionally, ADHDonly is associated with
a disturbance of the reward system, which interferes with the ability to be
self-motivating (Gawrilow et al., 2010). Some authors are also convinced that
ADHDonly is a result of disturbances in neuronal control circuits (Biederman
& Faraone, 2005; Cortese, 2012b). Biederman and Faraone (2005) hypothesized
that the polygenetic factors provoke abnormalities in brain structures and a
dysregulation of neurotransmitters (dopamine and noradrenalin) in the basal
ganglia. While noradrenalin is known to be important for attentional processes,
dopamine influences impulse/drive and motivation.
In the etiology of ADHDonly, genetic factors seem to explain a high percent-
age (up to 80%) of phenotype variance (Burt, 2009; Thapar, Cooper, Eyre, &
Langley, 2013), but the pathophysiology is a very complex pattern of gene
to gene, to environment, to epigenetic interactions (Thapar et al., 2013; Ba-
naschewski & Dopfner, 2014). Twin and family studies indicate that the hered-
ity of ADHDonly adds up to 70-80% (Biederman & Faraone, 2005; Cortese,
2012a). Environmental factors that seem to have a great influence on the mani-
festation of ADHDonly are prenatal exposure to harmful substances like alcohol
(Pagnin, Zamboni Grecco, & Furtado, 2018) or nicotine (Schwenke et al., 2018),
as well as infections and complications during pregnancy (Millichap, 2008).
Also, the exposure to environmental containments like lead or polychlorinated
biphenyl (PCB) during childhood seems to be associated with an increased in-
cidence of ADHDonly (Eubig, Aguiar, & Schantz, 2010). Furthermore, negative
social constructions and dysfunctional family systems can aggravate symptoms
of ADHDonly. Disturbed behavior of a child provokes negative reactions, which
leads to an increase of disturbed behavior and to more negative reactions, cre-
ating a vicious circle (American Psychiatric Association, 2013; Gawrilow et al.,
2010).
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Although the etiology of ADHD symptoms in NF1 (NF1ADHD) still remains
unclear (Payne et al., 2010), at least genetic factors are likely to differ from those
in ADHDonly: The incidence of attention problems is far higher in NF1 patients
than in their healthy siblings or parents (Koth et al., 2000), and the typical gen-
der ratio of three boys to one girl in ADHDonly seems to face a balanced gender
ratio in the NF1 population (Hyman et al., 2005).
A closer look at the underlying neural mechanisms reveals both, similarities
and differences between NF1ADHD and ADHDonly: According to current hy-
potheses, disturbances in the catecholaminergic metabolism in fronto-striatal
brain structures play a role in the genesis of both ADHDonly and NF1ADHD
(Diggs-Andrews & Gutmann, 2013; Brown et al., 2010; Cantwell, 1996). But ad-
ditionally, ADHDonly has been associated with a reduction of brain volume, es-
pecially in the left-sided prefrontal cortex (Cantwell, 1996), anomalies in white
matter microstructure in the fronto-striatal system (Cantwell, 1996; Frodl &
Skokauskas, 2012), anomalous hemispheric asymmetries (Silk et al., 2016), and
structural changes in limbic regions such as the amygdala (Frodl & Skokauskas,
2012). Up to date, there is no evidence for such alterations in NF1ADHD.
In NF1, attention deficit could be traced back to reduced dopamine levels
in the striatum in a mouse model (Brown et al., 2010). Brown and colleagues
observed an altered dopaminergic metabolism in the striatum and showed a
normalization of reduced striatal levels of dopamine by methylphenidate, ac-
companied by an improvement of attention performance (Brown et al., 2010).
So far, there are still many uncertainties regarding the etiology of ADHD in
patients with NF1, but given the high incidence, it does not seem to be an inde-
pendent comorbidity.
1.2.3. ADHD and Cognitive Development of Children with
and without NF1
Intelligence and learning disabilities
Cognitive deficits and secondary impairments of NF1ADHD resemble those of
ADHDonly. Similar to patients with ADHDonly, NF1 patients with ADHD score
significantly lower in intelligence tests than healthy (sibling-) controls (Bieder-
man et al., 2009; Frazier, Demaree, & Youngstrom, 2004; Pride et al., 2012),
and show lower IQ scores than NF1 patients without ADHD (NF1only) (Koth et
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al., 2000; Lidzba et al., 2012; Pride et al., 2012). For ADHDonly, meta-analyses
found significantly lower overall cognitive abilities and lower levels of overall
achievement compared to healthy controls (Frazier et al., 2004; Frazier, Young-
strom, Glutting, & Watkins, 2007). Learning disabilities, repeated grades and
placement in special classes were observed more often in children with ADHDonly
than in healthy children (Biederman et al., 2009). In NF1, patients with NF1ADHD
also display more specific learning disabilities and academic underachieve-
ment than patients with NF1only (Hachon et al., 2011; Payne et al., 2012).
The course and profile of cognitive impairments in ADHDonly appears sta-
ble over childhood into young adulthood. Ameliorations of ADHD symptoms
are not necessarily accompanied by cognitive improvements (Biederman et al.,
2009). Similarly, the developmental course of cognitive impairments in NF1
seems stable (Cutting, Huang, et al., 2002; Pavol et al., 2006), mediated, how-
ever, by the presence or absence of T2 signal hyperintensities on MRI (Payne et
al., 2013).
Attention
Attention functions are basic cognitive properties, which are necessary for al-
most every intellectual and practical activity. Since attention functions are in-
volved in manifold processes like perception, memory, action planning and
performance, problem-solving, spatial orientation and other, it is difficult to
differentiate between attention functions and other cognitive functions at a con-
ceptual and also at a functional level (Sturm, George, von Giesen, & Hilde-
brandt, 2012). According to (neuro-)psychological attention theories, at least
five attentional components can be distinguished: [1] alertness, [2] sustained
attention and vigilance, [3] spatial orientation of the attentional focus, [4] selec-
tive attention, and [5] shared/divided attention, attentional flexibility (Sturm,
Herrmann, & Münte, 2009). Some authors propose that there are two basic di-
mensions of attention: intensity and selectivity of attention (Van Zomeren &
Brouwer, 1994). While intensity describes the ability to activate and sustain
attention, selectivity refers to the ability to select and prioritize certain stimuli
(selective and shared/divided attention) (Van Zomeren & Brouwer, 1994). Spa-
tial orientation of the attentional focus would be a separate dimension outside
this taxonomy of attention.
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In children with ADHDonly and NF1ADHD, dysfunctions have been found in
almost every component of attention. On functional test measures of attention
variables (e.g. Test of Variables of Attention, (Greenberg, Kindschi, Dupuy, &
Hughes, 2013)), children with ADHDonly tend to perform worse on impulse
control (Commission Errors) than on sustained attention (Omission Errors).
However, Mautner et al. (2002) found with the same test that children with
ADHDonly displayed more deficits in sustained attention. Additionally, they
performed subnormal on response time and response time variability (reflect-
ing distractibility). Children with NF1ADHD seemed especially impaired in im-
pulse control in the study by Mautner et al. (2002), but they also performed
subnormal on response time and response time variability. Lion-Francois et
al. (2017) found in a sustained attention task that children with NF1ADHD were
impaired in the areas of intensive, selective, and executive attention, while chil-
dren with ADHDonly were only impaired in response time.
Regarding the distribution of ADHD subtypes, some authors found that chil-
dren with NF1ADHD– like children with ADHDonly– most frequently present
the combined subtype, whereas the hyperactive/impulsive subtype is very rare
in NF1 (Pride et al., 2012).
Executive functions
The generic term executive functions refers to a family of top-down neurocog-
nitive processes that enable humans to successfully master in novel environ-
ments as well as familiar settings by constant evaluation, adjustment of reac-
tions, regulation of emotions, and control of outcomes (Baddeley, 2002). They
are responsible for purposeful, goal-directed behavior (Anderson, 2002). Gen-
erally, executive functions develop from the age of about 2.5 years and do not
reach their maturation until the early adulthood (Kubesch & Walk, 2009). The
neuroanatomical correlates of executive functions are complex and widespread
networks of frontal and superior parietal structures that develop in a difficult
and lengthy process (Makris et al., 2007).
The definition of executive functions varies depending on the scientific per-
spective. One of the oldest descriptions of executive functions is Baddeley’s
model of working memory (Baddeley, 1988), which characterizes the “central
executive” as a component of working memory. In this model, the “central ex-
ecutive” is responsible for the incorporation of the information from all other
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components of the working memory (the phonological loop, the visuo-spatial
sketchpad, the episodic buffer, and the long-term memory).
More recent models suggest that executive functions are a rather indepen-
dent cognitive element, which includes working memory processes, but refers
also to other multifaceted and clearly delimitable subcomponents (Miyake et
al., 2000; Smith & Jonides, 1999). A well-accepted current model of executive
functions was defined by Smith and Jonides (1999) and includes the subcom-
ponents task management, attention and inhibition, planning, monitoring, and
coding. In this model, attentional processes are incorporated under the um-
brella term of executive functions. According to current research, attentional
processes are closely linked to other components of executive functions and
have to be taken into account when it comes to executive processes.
Cognitive Flexibility
divided attention
working memory
conceptual transfer
feedback utilisation
Goal Setting
initiative
conceptial reasoning
planning
strategic organisation
Attentional Control
selective attention
self-regulation
self-monitoring
inhibition
Information
Processing
efficiency
fluency
speed of processing
Figure 1.3. Proposed model of executive function (adapted from Anderson, 2002).
The present thesis takes the model of Anderson (2002) as a basis (see Fig-
ure 1.3). The authors proposed a model of executive functions with four dis-
tinct domains ([1] attentional control, [2] information processing, [3] cognitive
flexibility, and [4] goal setting), which are considered discrete functions that are
likely to be related to specific frontal systems. In this model, attentional con-
trol plays the leading role and influences all other executive domains, while the
other three domains are inter-related and inter-dependent. Attentional control
is responsible for selective and prolonged attentional processes, as well as for
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the regulation and monitoring of actions, and thus for tactic and goal-directed
behavior. Impairments in the domain of attentional control are likely to lead
to impulsivity, lack of self-control, and problems with planning and organizing
(Anderson, 2002).
Therefore, it is not surprising that executive dysfunctions seem to be a hall-
mark of ADHD. Executive dysfunctions have been well described for both,
ADHDonly and ADHD in NF1 (Potvin et al., 2015; Pride et al., 2012; Doyle,
2006; Biederman et al., 2004). Some authors even consider executive dysfunc-
tions as the source of ADHD symptoms (Barkley, 1997), but more recent re-
search results indicate that they are only a part but not the source of all ADHD
symptoms (Willcutt, Doyle, Nigg, Faraone, & Pennington, 2005).
In ADHDonly, executive dysfunctions emerge independently from intelligence,
age, sex, socio-economic status or ethnicity (Doyle, 2006) and even indepen-
dently from the subtype of ADHD (Willcutt et al., 2005). Similarly to NF1,
studies indicate that executive dysfunctions continue into adulthood in patients
with ADHDonly (Doyle, 2006).
In both patient groups, executive dysfunctions include deficits in inhibition,
sustained attention, working memory and verbal fluency (Payne et al., 2012;
Hervey, Epstein, & Curry, 2004). Especially working memory deficits are well
described in both populations. In ADHDonly, poor performances in verbal
and spatial domains of working memory are repeatedly reported for school-
aged children (Martinussen & Tannock, 2006) and visuospatial working mem-
ory deficits were found even in preschool children with ADHD symptoms (Re,
De Franchis, & Cornoldi, 2010). Furthermore, working memory deficits were
rather linked to the inattention symptom dimension than to the hyperactive-
impulsive symptom dimension (Martinussen & Tannock, 2006). In NF1, spa-
tial working memory deficits were found independently of ADHD symptoms
(Payne et al., 2012), but there are also studies showing that deficits in other
working memory tasks (e.g. Digit Span and Letter-Number Sequencing of the
WISC-IV) and problems with working memory skills in daily living (assessed
with parent and teacher questionnaires) are more pronounced in NF1ADHD than
in NF1only (Potvin et al., 2015; Pride et al., 2012). Also, verbal cognitive fluency
seems to be affected in children with NF1ADHD, but not in children with NF1only
(Denkinger et al., 2018). Regarding impulse control, Mautner et al. (2002) found
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that NF1 patients with ADHD reacted significantly more impulsively than pa-
tients with NF1only, who did not differ from healthy controls.
Academic career
Both functional domains, attention and executive functions, are essential for
other cognitive processes, and specifically for learning. Consequently, under-
achievement (i.e., academic performance below expectations according to intel-
ligence) is common both in ADHDonly and in NF1 (Ek, Westerlund, Holmberg,
& Fernell, 2011). Given their long-term personal and economic consequences,
more knowledge on the causes and potential remedy of attention and academic
problems in patients with NF1 is of high clinical relevance.
Emotional profile
A study comparing the emotional profile of NF1 and ADHDonly found close re-
semblance between patients with NF1ADHD and patients with ADHDonly, who
both presented significantly lower life satisfaction, more excitability, aggres-
siveness, stress/tension, somatic distress and more emotional instability than
patients with pure NF1 (Mautner, Granström, & Leark, 2015).
Quality of Life
According to the WHO QoL is defined as the individual’s perception of their
position in life in the context of the culture and value systems in which they live
and in relation to their goals, expectations, standards and concerns (WHOQOL
Group, 1995).
Like in NF1 (as described above), available studies consistently report that
children with ADHDonly experience impaired QoL (Danckaerts et al., 2010;
D. Coghill & Hodgkins, 2016; Marques et al., 2013; Thaulow & Jozefiak, 2012;
Jafari, Ghanizadeh, Akhondzadeh, & Mohammadi, 2011; Pongwilairat, Lou-
threnoo, Charnsil, & Witoonchart, 2005). Lee et al. (2016) found that parents
of children with ADHDonly and children themselves rate their QoL lower than
that of healthy controls regarding the domains physical functioning (moderate
effect) and psychosocial functioning (strong effect). D. Coghill and Hodgkins
(2016) found a significant correlation between symptom severity of ADHDonly
and QoL for parent/carer ratings and child ratings in questionnaires, with more
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ADHD symptoms being associated with poorer QoL. However, the authors
also believe that ADHD medication may help to improve health-related QoL in
patients with ADHDonly (D. R. Coghill, Banaschewski, Soutullo, Cottingham,
& Zuddas, 2017). Like in NF1, children with ADHDonly tend to rate their QoL
higher than parents in proxy-reports (Galloway & Newman, 2017).
1.2.4. Treatment Effects of Methylphenidate
In terms of therapeutic interventions in ADHD, the combination of behavioral
psychotherapy and medication is the gold standard (American Academy of
Pediatrics, 2001). For medication, Methylphenidate (MPH) or atomoxetin are
recommended, with MPH affecting the metabolism of dopamine and atomox-
etin that of noradrenalin. The positive therapeutic effects of methylphenidate
on the core symptoms of ADHD such as inattention, hyperactivity and impul-
sivity have repeatedly been confirmed (MTA Cooperative Group, 2004). Con-
cerning the therapy of ADHD in NF1, pharmaceutical interventions with MPH
have been shown to have similar positive effects on the core symptoms as in
ADHDonly (Lion-Francois et al., 2014; Mautner et al., 2002), although it remains
unclear how attention system dysfunction in human NF1 patients is actually
linked to the dopaminergic system.
Additionally to positive effects of MPH on attention performance, it has a sig-
nificantly positive effect on executive functioning (Barnett et al., 2001). Given
the improvement of attention performance and executive functioning in chil-
dren with ADHD being treated with MPH, one would expect a consecutive im-
provement of intellectual performance in the short term and academic achieve-
ment in the long term. Researchers suppose that ADHD leads – among others
– to an inaccurate test-taking behavior, which might interfere with the perfor-
mance on an intelligence test and therefore might underestimate a child’s true
ability when a test is administered to a child with ADHD, which is not taking
stimulant medication.
However, in ADHDonly, the reported effects of treatment with MPH on intel-
lectual performance are rather insignificant (Pietrzak, Mollica, Maruff, & Sny-
der, 2006). Several studies showed that medical treatment was accompanied by
a significant, but small, increase of IQ scores (about 2–6 IQ points) in ADHDonly
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(Tsai et al., 2013; Gimpel et al., 2005; Thurber & Walker, 1983; Kavale, 1982).
Thus, the effect is of little clinical relevance.
In contrast, in patients with NF1, an analysis of retrospective data provides
evidence for more significantly positive effects of MPH on general cognition
(Lidzba, Granström, Leark, Krägeloh-Mann, & Mautner, 2014; Brown et al.,
2010). Children with NF1 and ADHD that were medicated, improved in full-
scale IQ by an average of 18 IQ points over several years. This large positive
effect might be highly relevant for the academic career of the affected children,
but due to the range of limitations inherent in retrospective data analyses, an
interpretation of these results has to be done with caution.
1.3. Scope and Hypotheses
Data on the influence of ADHD on cognitive abilities and long-term cogni-
tive development in NF1 is extremely scarce. Therefore, the first goal of the
present thesis was to compare neuropsychological characteristics of NF1ADHD
and NF1only with the purpose to gain information about the cognitive pro-
file(s) of NF1, and to compare the attention profiles of NF1ADHD and ADHDonly
(Study 1). The second goal was to compare the intellectual development of chil-
dren with NF1ADHD and NF1only over a prolonged time period, as well as to
investigate treatment effects of methylphenidate on intellectual development
in patients with NF1ADHD (Study 2).
1.3.1. Study 1: Analysis of Cognitive Characteristics of NF1
with and without ADHD
Up to now, in the relevant literature, patients with NF1 were considered to be
generally impaired in manifold cognitive domains, including global intellectual
functioning, short- and long-term memory, attention functions and executive
functions. However, recent studies indicate that some combinations of cogni-
tive dysfunctions in NF1 have more impact than others. Especially attention
deficit and ADHD seem to raise the risk for a number of cognitive comorbidi-
ties.
So far, very few studies investigated cognitive aspects of NF1 considering
the effect of presence or absence of ADHD. However, a retrospective study by
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Lidzba et al. (2012) reveals negative effects of ADHD-symptoms on intelligence
test performance, with differences in full-scale IQ up to one standard deviation
between children with NF1ADHD and NF1only. These findings are corroborated
by a retrospective study by Potvin et al. (2015), who also found significant dif-
ferences between patients with NF1ADHD and NF1only regarding intelligence,
and additionally, regarding executive functions and memory skills. Further-
more, Mautner et al. (2002) found decreased attention functions in NF1ADHD
compared to NF1only.
The purpose of Study 1 was to expand the knowledge about the role of
ADHD in NF1. Therefore, the cognitive profiles of NF1ADHD and NF1only were
compared, which should help to extract NF1-typical cognitive characteristics
and to differentiate between NF1-caused and ADHD-caused cognitive impair-
ments. Additionally, a comparison of children with NF1ADHD and ADHDonly
was designed to define differences between these types of attention disorders,
since an independent comorbidity of ADHD in NF1 seems unlikely. Further-
more, an analysis of quality of life was included, which should provide infor-
mation about frequent secondary problems in NF1 and ADHD.
Five hypotheses were formulated for Study 1 and tested in a cross sectional
comparison:
[H1] Intellectual ability:
ADHD is associated with reduced intellectual ability in NF1, as it is in children
without NF1. NF1 per se is not generally associated with reduced intellectual
ability.
[H2] Memory skills:
ADHD is associated with reduced memory skills in NF1, as it is in children
without NF1.
[H3] Attention functions:
NF1 per se – as well as ADHD per se – is associated with reduced attention
functions. NF1ADHD and ADHDonly is associated with significantly more se-
vere attention dysfunction than NF1only, but NF1only is not spared in attention
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functions. Additionally, NF1ADHD and ADHDonly differ significantly in their
attention profiles.
[H4] Executive functions:
ADHD is associated with reduced executive functioning in NF1, as it is in chil-
dren without NF1. NF1 per se is not associated with reduced executive func-
tioning.
[H5] Quality of life:
NF1 and ADHD as chronic diseases lead to impaired QoL.
1.3.2. Study 2: Longitudinal Analysis of Attentional and
Intellectual Development in NF1
The aim of Study 2 was to investigate the long-term cognitive development of
children with NF1. The intention was to clarify if an amelioration of attention
functions is accompanied by an improvement of intellectual functioning in the
long term.
This assumption may at first seem odd, because the course and profile of cog-
nitive impairment in ADHDonly appear stable over childhood into young adult-
hood and ameliorations of ADHD-symptom severity was not or in a rather
small extent correlated with cognitive improvement (Hellwig-Brida, Daseking,
Keller, Petermann, & Goldbeck, 2011; Biederman et al., 2009; D. R. Coghill,
Rhodes, & Matthews, 2007; Gimpel et al., 2005). Similarly, the developmental
course of cognitive impairments in NF1 seems stable (Pavol et al., 2006; Hyman
et al., 2003; Cutting, Huang, et al., 2002), mediated, however, by the presence
or absence of T2 signal hyperintensities on MRI (Payne et al., 2013). However,
there is first tentative evidence for positive effects of ADHD treatment with
methylphenidate on attention, and even more so on intellectual functioning in
NF1ADHD (Lidzba et al., 2012). Potentially due to an inherently decreased learn-
ing capacity, patients with NF1 might, in terms of intellectual development,
profit more from successful ADHD interventions than patients with ADHDonly.
Since the study by Lidzba et al. (2012) was conducted with retrospective
data and the conclusions drawn from such data analyses have to be considered
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with caution, Study 2 was designed to investigate prospectively the effects of
an amelioration of attention functions on intellectual development in children
with NF1ADHD. Three hypotheses were formulated for a study with a longitu-
dinal design:
[H1] Attention performance is a predictor for intellectual development
Attention dysfunction is significantly related to reduced intellectual function-
ing in the short and long term. Attentional functioning is a predictor for intel-
lectual functioning.
[H2] Improvement of intellectual functioning
An amelioration of attention functions is accompanied by a significant improve-
ment in intellectual functioning over a two-year-period. The expected effect is
specific for children with NF1 and does not, or in a significantly smaller extent
occur in children with ADHDonly.
[H3] Treatment effects
An intervention with methylphenidate is accompanied by a stronger improve-
ment in intellectual functioning than other or no interventions (e.g. psychother-
apy, occupational therapy) in patients with NF1ADHD.
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2.1. Study Design
2.1.1. Study Design and Framework
The present research project was conducted in a cooperation between the Uni-
versity Children’s Hospital Tübingen (Dept. Pediatric Neurology) and the Uni-
versity Medical Center Hamburg-Eppendorf (Dept. Neurology, Neurofibro-
matosis Outpatient Unit). Since NF1 is a rare genetic disorder, the cooperation
between the two largest German centers specialized in NF1 was necessary to
recruit the number of patients needed for this project. 126 participants were
consecutively recruited for this project from May 2013 until January 2016 and
111 participants were enrolled after checking for the inclusion and exclusion
criteria. The total duration of the project mounts up to four and a half years,
from May 1st, 2013 until December 31th, 2017.
Two studies were conducted in the context of this research project. In Study
1, patient characteristics were compared in a cross-sectional design. Study 2
includes data of the development of specific patient characteristics in a longi-
tudinal design. To collect the longitudinal data, three assessments were per-
formed with each participant within two years (see Figure 2.1). Between each
assessment lay 12 months (+/- 2 month). The relatively long time period of 12
month between two assessments was chosen to avoid order effects (e.g. due to
learning effects, practice effects, boredom).
2.1.2. Recruitment
Participants for the NF1 groups were consecutively recruited in the context of
hospital service at the University Children’s Hospital Tübingen (Dept. Pe-
diatric Neurology) and the University Medical Center Hamburg-Eppendorf
(Dept. Neurology, Neurofibromatosis Outpatient Unit). For the ADHD group,
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T1 neuropediatric and neuropsychological assessment
6 months
12 months
24 months
questionnaire control
T2 neuropsychological assessment
T3 neuropsychological assessment
Figure 2.1. Study process.
participants were recruited exclusively at the University Hospital Tübingen
(Dept. Pediatric Neurology, Dept. Child and Adolescent Psychiatry and Psy-
chotherapy). Additional participants were recruited by advertisements in jour-
nals of NF1 and ADHD lay groups. Study participation was voluntary and was
rewarded with a detailed test report (with therapeutic recommendations) for
each assessment. Patients’ assent and written informed consent of their care-
givers were obtained prior to the investigations according to the 1964 Declara-
tion of Helsinki and the approval of the local ethics committee (655/2012BO1).
2.1.3. Inclusion and Exclusion Criteria
Inclusion criteria comprised fulfillment of the diagnostic criteria of NF1 and/or
ADHD, age between 6 and 12 years at the time of the enrollment, and an intel-
ligence score between 70 and 115. Since existing literature shows that patients
with NF1 as well as patients with ADHD tend to score below the average in
intelligence tests, we recruited patients within the normal and low borderline
range of intelligence, so that the sample would be representative for NF1 and
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ADHD regarding intelligence. The age range of 6-12 years was chosen, because
children of this age have a high potential for learning and cognitive develop-
ment. Typical psychiatric comorbidities of NF1 and ADHD were allowed, in-
cluding specific developmental disorders of speech and language, specific de-
velopmental disorders of scholastic skills, specific developmental disorder of
motor function, conduct disorders and emotional disorders with onset specific
to childhood.
Before the enrollment in this study, all participants passed through a neuro-
pediatric examination to identify potential exclusion criteria, which included
neurological diseases with intracranial manifestations like symptomatic optic
nerve gliomas or brain tumor, traumatic brain injury, ischemia or hemorrhage.
Additionally, participants were excluded for suspected or proven genetic syn-
dromes other than NF1, explaining ADHD symptoms (e.g. Fragile-X), and for
any form of epilepsy, very preterm birth (< 32 week of gestation; < 1500 gram)
or severe psychiatric disorders (e.g. autistic disorders).
2.1.4. Study Population
Three groups of patients were included in the studies of the present thesis.
The particular group of interest consisted of patients with NF1 plus ADHD
(NF1ADHD-group). Additionally, two control groups were recruited: one group
with patients with NF1only (NF1only-group) and another group with patients
with ADHDonly (ADHDonly-group). All together, 126 participants were re-
cruited (see Figure 2.2). After checking for inclusion and exclusion criteria,
111 participants were enrolled in Study 1 and 66 participants were enrolled in
Study 2. The differing number of participants in Study 1 and Study 2 is due
to drop-outs during the course of the longterm study and the matched group
design of Study 2. All participants suffering from NF1 fulfilled the diagnostic
criteria for NF1 according to the National Institute of Health Consensus De-
velopment Conference statement (National Institutes of Health, 1988). All pa-
tients with ADHD fulfilled the diagnostic criteria according to the DSM-IV-TR
(American Psychiatric Association, 2000)1. All participants were either native
speaker of the German language or spoke German as their second language at
1In the present research project, the diagnostic criteria of the DSM-IV-TR were used to di-
agnose ADHD, since the DSM-5 was not published yet by the time the research project
started (the DSM-5 was published on May 18th, 2013 and this research project started on
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an adequate level. Further demographic data about the study populations is
described in the following chapters about Study 1 and Study 2.
Total: 126
Inclusions: 111
NF1ADHD
T1: 53
T2 : 39 
T3: 29 
NF1only
T1: 28 
T2: 21 
T3: 19 
ADHDonly
T1: 30 
T2: 24 
T3: 20 
Exclusions: 15
Figure 2.2. Number of patients that were recruited and enrolled.
2.2. Methods and Material
2.2.1. Neuropediatric Examination
In a neuropediatric examination, participants were checked for somatic exclu-
sion criteria, for undetected NF1 in the ADHDonly-group, and were neurolog-
ically characterized. NF1 patients were assessed regarding their type of NF1
(familial type versus spontaneous mutation).
May 1st, 2013). Additionally, important diagnostic tools used in this project (e.g. Disyps-KJ,
Conners-3) are based on the criteria of the DSM-IV-TR.
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2.2.2. Interviews and Questionnaires for Patient
Characterization
Information about (socio-)demographic data, comorbid disorders, medication,
and therapeutic interventions prior to the assessment were collected in a stan-
dardized interview and by means of a questionnaire (Soziodemographische Daten).
Some of the (socio-)demographic data were used to calculate the Socio-Economic
Status (SES) of the participant, which was measured with the Winkler-Index
(Winkler & Stolzenberg, 2009). The Winkler-Index takes into account the par-
ents’ educational achievement, their professional position and the family in-
come.
Additionally, a clinical interview on the basis of the DSM-IV-TR-based Dia-
gnostik-System für psychische Störungen im Kindes- und Jugendalter (Disyps-KJ)
(Döpfner & Lehmkuhl, 1998) was conducted by a psychologist with the parents
or caregivers of the participants, to confirm or reject the ADHD diagnosis, to
investigate common comorbid disorders (e.g. Conduct disorders) and to collect
data for patient characterizations.
Problem behavior was assessed with the German version of the Child Behav-
ior Checklist (CBCL) (school-age version: CBCL6/18), which is a standardized
parent questionnaire for children between 6 and 18 years. It consists of 118
items and provides scores for internalizing and externalizing problem areas,
containing the subscales Anxious/Depressed, Withdrawn/Depressed, Somatic
Complaints, Social Problems, Thought Problems, Attention Problems, Rule-
Breaking Behavior, and Aggressive Behavior (Arbeitsgruppe Deutsche Child
Behavior Checklist, 1998).
2.2.3. Neuropsychological Assessments and Behavior Rating
Scales
Intelligence
Intelligence was assessed with the German version of the Wechsler Intelligence
Scale for Children IV (WISC-IV) (Petermann & Petermann, 2008), which is a stan-
dardized test to measure the general intellectual ability of children between 6.0
and 16.11 years. It generates a score for full-scale IQ and provides four primary
index scores that describe the intellectual ability in separate cognitive domains
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(Verbal Comprehension Index, Perceptual Reasoning Index, Working Memory
Index, and Processing Speed Index). Overall, full-scale IQ is derived from 10
primary subtests. The index Verbal Comprehension is measured with the three
subtests Similarities (verbal concept formation, reasoning), Vocabulary (word
knowledge, verbal concept formation), and Comprehension (verbal reasoning
and conceptualization, evaluation and use of past experience, practical knowl-
edge and judgement). For the Perceptual Reasoning Index, three subtests are
conducted as well: Block Design (ability to analyze and synthesize abstract
visual stimuli), Picture Concepts (abstract categorical reasoning ability), and
Matrix Reasoning (perceptual organization, classification and spatial ability,
simultaneous processing, knowledge of part-whole relationships). The index
Working Memory is assessed with the two subtests Digit Span (short-term au-
ditory memory, memory span, mental manipulation, cognitive flexibility, en-
coding, attention) and Letter-Number Sequencing (short-term auditory mem-
ory, memory span, mental manipulation, sequential processing, attention). The
index Processing Speed is measured with the subtests Coding (psycho-motor
speed, visual-motor coordination, visual scanning, short-term visual memory)
and Symbol Search (visual-motor coordination, visual scanning, visual discrim-
ination, short-term visual memory) (Wechsler, 2003).
Memory
Memory functions were assessed with the Verbaler Lern- und Merkfähigkeitstest
(VLMT) (Helmstaedter, Lendt, & Lux, 2001). The VLMT is a German auditory
verbal learning and memory test, which measures short-term and medium-
term memory function as well as learning capacity. The VLMT measures Im-
mediate Recall of a list of words (short-term memory), Delayed Recall of the
same list of words after 30 minutes (medium-term memory) and Recognition
of the learned words in a larger list of words. Additionally, it measures the loss
of learned information resulting from an interference list (distraction).
Attention
Attention functions were measured with the visual condition of the eighth ver-
sion of the Test of Variables of Attention R© (T.O.V.A.) (Greenberg et al., 2013).
The T.O.V.A. is a computer-based continuous performance test, which takes
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about 21 minutes and measures Variability of Response Time (consistency), Re-
sponse Time, Commission Errors (impulsivity), and Omission Errors (inatten-
tion). Additionally, it provides an Attention Performance Index (API), post-
commission response times, and multiple or anticipatory responses, as well
as an ADHD score, which is a comparison to an age/gender specific ADHD
group. The T.O.V.A. uses simple visual geometric stimuli (to minimize the ef-
fects of cultural differences and learning problems) and presents them with
a mid-range interstimulus interval of two seconds. Stimuli are presented for
exactly 100 milliseconds. The test holds two conditions: a low frequency con-
dition, where the target is presented very infrequently (3.5 times less than the
distractor) and a stimulating condition, where the target is presented very fre-
quently (3.5 times more often than the distractor). In the low frequency condi-
tion, people with attention problems and ADHD are expected to make an inap-
propriately high number of omission errors, while in the stimulating condition,
they are expected to make inappropriately many commission errors. Addition-
ally, ADHD-patients are expected to show slower overall response times and a
higher variability of response times (Greenberg et al., 2013).
Functional aspects of attention were measured with the German edition of
the long version of the Conners Rating Scales: Conners Skalen zu Aufmerksamkeit
und Verhalten - 3 R© (Conners-3) (Lidzba, Christiansen, & Drechsler, 2013). The
Conners-3 are standardized parent and teacher questionnaires for the charac-
terization of children between 6 and 18 years of age with respect to severity of
attention problems, executive functions and comorbidities. The Conners-3 par-
ent version contain 107 items and six main scales: Inattention, Hyperactivity/-
Impulsivity, Learning Problems, Executive Functioning, Defiance/Aggression
and Peer Relations. They also provide a Global Index as a measure of general
psychopathology and an ADHD Index, which serves as screening instrument
and indicates if further assessment of ADHD is required.
Executive functions
Executive functions were assessed with the index Working Memory of the WISC-
IV, the scale Commission Errors of the T.O.V.A., and the German version of
the Behavior Rating Inventory of Executive Function R© (BRIEF) (Drechsler & Stein-
hausen, 2013).
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The BRIEF is a standardized parent and teacher questionnaire to assess func-
tional aspects of executive dysfunction in situations of daily living in children
between 6 and 16 years. The BRIEF includes 86 items that load on eight non-
overlapping clinical subscales, which can be divided into two broader indices
(Behavioral Regulation, Metacognition). It also generates a Global Executive
Composite score that takes all subscales into account. The index Behavioral
Regulation is derived from the three scales Inhibit, Shift and Emotional Con-
trol. The index Metacognition contains the five scales Initiate, Working Mem-
ory, Plan/Organize, Organization of Materials, and Monitor, which can be fur-
ther divided into Monitoring of Task Performance and Self Monitoring. The
broad overview and the detailed differentiation of executive dysfunctions that
the BRIEF provides, make it a very useful tool to identify subjects with ADHD
(especially with the metacognition scales) and even to distinguish between
different subtypes of ADHD (mainly with the behavioral regulation scales)
(Drechsler & Steinhausen, 2013).
Quality of Life
Information about quality of life was collected with the standardized parent
questionnaire Fragebogen zur Erfassung der gesundheitsbezogenen Lebensqualität
bei Kindern (Kiddo-Kindl) for children between 7 and 14 years (Ravens-Sieberer
& Bullinger, 2000). It contains 24 items, which relate to six dimensions: Phys-
ical well-being, Mental well-being, Self-Esteem, Family, Friends, and School.
For children with chronic diseases, there is an additional scale with six items
regarding quality of life in respect to the disease (Disease Modul).
2.2.4. Procedure
ADHD was diagnosed by a neuropediatrician, a child and adolescent psychi-
atrist or a child and adolescent psychotherapist. At the baseline examination,
ADHD diagnosis was confirmed or discarded on the basis of a standardized
parent interview and the clinical impression. Every of the three assessments
took about three to four hours and started with the learning trials of the VLMT,
followed by the T.O.V.A. and the delayed recall of the VLMT. Subsequently,
the WISC-IV was performed. At the same time as the child performed the
tests, parents were interviewed and completed the questionnaires. The Disease
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Modul of the Kiddo-Kindl was only applied to parents of children with NF1,
not to parents of children with ADHDonly. After the assessment, parents were
informed about the test results and counseled about therapy options. Teacher
questionnaires (Conners-3 and BRIEF) were sent by mail. Every patient got a
detailed test report about all results after each assessment.
Table 2.1 provides an overview about the assessment plan of the research
project.
2.3. Statistical Analyses
Data was analyzed using the 23rd version of the IBM Statistical Package for So-
cial Science (SPSS). As independent variable and between subject factor for the
analyses of both studies served the group allocation of the patients (NF1ADHD-
group, NF1only-group and ADHDonly-group). The level of significance was a
priori set at p < .05 for all tests and adjusted by Bonferroni corrections in the
case of multiple comparisons. Equality of variances for the groups was as-
sessed for each dependent variable via Levene’s test. Normality of distribution
was analyzed by using the Shapiro-Wilk-test.
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Table 2.1.
Assessment Plan
Neuropediatric, psychiatric, and neuropsychological assessment 
Assessment T1a T1.1b T2c T3c 
Time in months 0 +6 +12 +24 
Standardised confirmation of diagnosis and patient 
characterisation     
Neuropediatric examination to check for neurological exclusion 
criteria and to check for undetected NF1 in the ADHD 
group. 
X    
Clinical Interview: confirm ADHD diagnosis and screen for 
common comorbidities. 
• Disyps-KJ; DSM-IV-based parent interview for 
assessing mental disorders in children and 
adolescents 
 
 
X 
 
   
Behavior Rating Scales: standardized parent and teacher 
questionnaires for patient characterization with respect to 
attention, executive functions, and comorbidities. 
• Child Behavior Checklist (CBCL) 
 
 
 
X 
 
 
 
X 
 
 
 
X 
 
 
 
X 
• Conners Skalen zu Aufmerksamkeit und Verhalten 
(Conners 3) X X X X 
• Behavior Rating Inventory for Executive Functions 
(BRIEF) X X X X 
Environmental factors     
Parent questionnaires to assess: 
• Socio-demographic background of the families 
 
X 
 
X 
 
X 
 
X 
• Interventions X X X X 
• Disease-related quality of life assessment in children 
(Kiddo-Kindl) X X X X 
Neuropsychological assessment     
A 3-hour neuropsychological assessment, performed by a 
qualified psychologist using standardized tests: 
• Wechsler Intelligence Scale for Children (WISC-IV) 
 
 
X 
 
 
 
X 
 
 
X 
• Test for Variables of Attention (T.O.V.A.) X  X X 
• Verbaler Lern- und Merkfähigkeitstest (VLMT) X  X X 
aBaseline examination  bQuestionnaire follow-up cFollow-ups after 12 and 24 month 
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3. Study 1: Analysis of Cognitive
Characteristics of NF1 with and
without ADHD
3.1. Scope and Hypotheses
In the first study, we tested five hypotheses about children with NF1 with and
without ADHD in a cross-sectional design. Children with ADHDonly served as
control-group. Aim of Study 1 was to compare several cognitive functions of
children with NF1 with and without ADHD and to reveal a cognitive profile,
which is characteristic for NF1. Secondarily, we attempted to differentiate be-
tween characteristics of ADHD in NF1 and of ADHDonly. Additionally, quality
of life of these patients was investigated (see H5).
[H1] Intellectual ability:
ADHD is associated with reduced intellectual ability in NF1, as it is in children
without NF1. NF1 per se is not generally associated with reduced intellectual
ability.
Predictions:
(a) Children with NF1ADHD and children with ADHDonly perform signifi-
cantly below the population norms on measures of intellectual ability, while
children with NF1only perform similar to the population norms.
(b) Children with NF1ADHD score significantly lower on measures of intellec-
tual ability than children with NF1only or ADHDonly, because the combination
of the diseases NF1 and ADHD leads to more crucial deficits in intellectual
abilities.
39
Chapter 3. Study 1: Analysis of Cognitive Characteristics of NF1 with and without ADHD
[H2] Memory skills
ADHD is associated with reduced memory skills in NF1, as it is in children
without NF1.
Predictions
(a) Children with NF1ADHD and children with ADHDonly perform signifi-
cantly worse than children with NF1only on all measures of verbal memory
skills, because inattention and distractibility negatively influence memory skills.
[H3] Attention functions:
NF1 per se – as well as ADHD per se – is associated with reduced attention
functions. NF1ADHD and ADHDonly is associated with significantly more se-
vere attention dysfunction than NF1only, but NF1only is not spared in attention
functions. Additionally, NF1ADHD and ADHDonly differ significantly in their
attention profiles.
Predictions:
(a) All children with NF1 and children with ADHD perform significantly
below the population norms on one or more measures of attention functions.
(b) Children with NF1ADHD and children with ADHDonly perform signifi-
cantly worse than children with NF1only on all attention measures.
(c) Children with NF1ADHD show significantly more impulsive reactions and
less impairment in sustained attention than children with ADHDonly, based on
the results of Mautner and colleagues (Mautner et al., 2002).
[H4] Executive functions:
ADHD is associated with reduced executive functioning in NF1, as it is in chil-
dren without NF1. NF1 per se is not associated with reduced executive func-
tioning.
Predictions
(a) Children with NF1ADHD and children with ADHDonly perform signifi-
cantly below the population norms on measures of executive functions, since
executive dysfunction is a hallmark of ADHD. Children with NF1only perform
similar to the population norms on measures of executive functions.
(b) Children with NF1ADHD and children with ADHDonly perform signifi-
cantly worse than children with NF1only on all executive measures.
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[H5] Quality of Life:
NF1 and ADHD as chronic diseases lead to impaired QoL.
Predictions
(a) All study participants show reduced QoL compared to population norms.
(b) Children with NF1ADHD show a significantly lower QoL than children
with NF1only or ADHDonly.
3.2. Data Analyses and Results of Study 1
As described in the Methods’ chapter, data was analyzed with the 23rd version
of the IBM Statistical Package for Social Science (SPSS). Study 1 had a cross-
sectional design, which means that data of the first assessment point of the re-
search project was analyzed. Although the conditions of equality of variances
and of normality of distribution were not met for all variables (see Appendix,
Table A.1, Table A.2, Table A.3, and Table A.4), univariate analyses of covari-
ance (ANCOVAs) and multivariate analyses of (co-)variance (MAN(C)OVAs)
were conducted nevertheless, because ANCOVAs and MAN(C)OVAs are con-
sidered to be very robust against violations of these conditions (Bortz, 2010;
Levy, 1980). Furthermore, there are no nonparametric alternatives for ANCO-
VAs or MAN(C)OVAs. For other group comparisons, nonparametric tests were
conducted, if equality of variances or normality of distribution were not ful-
filled.
For most of the assessments, there was no missing data. However, there was
missing data for the VLMT in 1 participant. Also, there was missing data for
calculating the SES in 8 participants, and for the analyses of the questionnaires
Conners-3 (parent evaluation: 3; teacher evaluation: 21), BRIEF (parent evalu-
ation: 25; teacher evaluation: 42), CBCL (4 participants) and Kiddo-Kindl (18
participants). Reasons for the missing data were that some participants were
unable to perform certain assessments, or parents did not fill in the question-
naires neatly, or the questionnaires BRIEF and Kiddo-Kindl were at first not
provided in the Neurofibromatosis Outpatient Unit in Hamburg. Additionally,
parents did not always agree to contact teachers or teachers did not agree to
complete the questionnaires. If data was missing in a certain analysis, all data
of the corresponding participant was excluded in the analysis.
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3.2.1. Choice of covariates
Since a random assignment of participants to groups was not possible in the
present study design, age, sex distribution, SES, and full-scale IQ were consid-
ered as relevant demographic variables that could possibly have a meaningful
or confounding influence on the results. These variables were tested for signif-
icant group differences with the intent to discuss them as covariates for further
analyses.
Age was excluded as a potential covariate, because there were no signifi-
cant group differences regarding age in our sample (F(2, 111) = 1.454; p =
.238; η2 = .036). Supplementally, all tests and questionnaires used in this study
were standardized for age.
Furthermore, there were no significant group differences regarding SES (F(2,
103) = 1.876; p = .159; η2 = .194). Therefore, SES was not treated as covariate
in any of the analyses.
Sex distribution and full-scale IQ differed significantly between the groups
(sex distribution: χ2(1, N = 111) = 7.296, p = .024; full-scale IQ: F(2, 111) =
13.029; p < .001; η2 = .194).
Regarding sex distribution, it has to be considered that samples of patients
with ADHD naturally have an uneven ratio between boys and girls, which is
about 3 boys to 1 girl (Cuffe et al., 2005). Therefore, sex is an inherent differenti-
ation of samples with ADHD and other samples and not a variable that differs
because of chance or choise. As Miller and Chapman (2001) described in their
article Misunderstanding Analysis of Covariance: “if a variable” – like sex distribu-
tion in our case – “is systematically related to the defining characteristic of the
groups, removing variance associated with this variable could systematically
alter the apparent nature of and the relationships between the groups.” There-
fore, sex should not be a covariate, if an ADHD patient group is compared to a
healthy control group. In the present study, however, an ADHD group is com-
pared to two other patient groups, of which the sex distribution and the extent
of ADHD-associated characteristics are unknown so far. While the 3:1 ratio of
boys to girls is met with 22 boys to 8 girls in the ADHDonly-group, there is only
a trend to more boys (33) than girls (20) in the NF1ADHD-group; whereas the
sex distribution in the NF1only-group is reversed with more girls (17) than boys
(11). To minimize the bias that could possibly be associated with an uneven
sex distribution between the groups (e.g. that boys exhibit more externalizing
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problem behavior, agitation or impulsivity), sex was treated as a covariate for
the analyses of test scales and parameters. For the analyses of the question-
naire data, sex was no covariate, because all questionnaires used in Study 1
were standardized for sex.
Full-scale IQ was chosen as a covariate for all analyses of test scales and pa-
rameters, as well as the questionnaire data. General intellectual ability is well
known to be a moderator/mediator for the performance in other cognitive do-
mains and group differences in any of these specific domains could simply be
due to differences in general intellectual ability. Since the relation between in-
telligence and other cognitive abilities is of no theoretical interest in terms of
our analyses for Study 1, we expect the use of full-scale IQ as a covariate to
clarify the relation between our independent and dependent variables.
3.2.2. Group Characteristics of the Study Population
Data analyses
Demographic data for group characterization was analyzed with chi-square
tests for sex, ADHD subtype, NF1 subtype, and therapeutic interventions, or
a two-tailed Univariate Analysis of Variance (ANOVA) for SES. For age, the
condition of equality of variances (Levene’s test) was not fulfilled. As an al-
ternative, the nonparametric Kruskal Wallis test was conducted. Severity of
ADHD symptomatology was analyzed with a Multivariate Analysis of Vari-
ance (MANOVA) for the two subscales ADHD-index and Global-index of the
Conners-3 parent evaluation. Group differences of severity of problem be-
havior were analyzed with an ANOVA for the total score of the CBCL and
MANOVAs for the subscales.
Results
Altogether, 111 participants were enrolled in Study 1. Fifty-three participants
were allocated to the group with NF1ADHD. Twenty participants were female
(37.7%) and 33 participants were male (62.3%). The mean age in this group was
8.873 years (SD: 1.692) and 25 participants (47.2%) had the familial type of NF1.
Twenty participants (37.7%) in this group were suffering from the Inattentive
Type and 33 participants (62.3%) from the Combined Type of ADHD. Eight
participants (15.1%) were receiving stimulant medication for the treatment of
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ADHD prior to the beginning of and during the study, and seven of these par-
ticipants (13.2%) were receiving MPH.
For the NF1only-group, 28 participants were enrolled, with 17 female partici-
pants (60.7%) and 11 male participants (39.3%) The mean age in this group was
8.360 years (SD: 1.352) and 19 participants (67.9%) were suffering from a spo-
radic mutation of the NF1-gene, while 9 participants (32.1%) had the familial
type of NF1.
In the ADHDonly-group, 8 participants (26.7%) were female and 22 partic-
ipants (73.3%) were male. The mean age of this group was 8.958 years (SD:
1.124). In this patient group, 14 participants (46.7%) fulfilled the criteria for the
Inattentive Type and 16 participants (53.3) for the Combined Type of ADHD.
Stimulant medication was taken by 2 participants (6.7%) of this group prior to
and during the study. Both were treated with MPH.
There were no significant differences between the groups regarding age (F(2,
111) = 1.454; p = .238; η2 = .036) or SES (F(2, 103) = 1.876; p = .159; η2p =
.194). The SES was in the middle range for all three groups (Winkler-index:
mean = 12.11, SD: 4.395). Sex, however, differed significantly between the
groups (χ2(1, N = 111) = 7.296, p = .024). ADHD subtype and subtype of
NF1 did not differ significantly between the two ADHD groups or rather the
two NF1 groups (ADHD subtype: χ2(1, N = 83) = 0.632, p = .490, NF1 sub-
type χ2(1, N = 81) = 1.699, p = .240).
Data from parent questionnaires confirmed that our patient groups differed
significantly with respect to observed symptoms of ADHD, distinguishing the
NF1only-group from both ADHD groups (ADHD-index: F(2, 107) = 29.231; p <
.001; η2 = .360). Regarding the two ADHD groups, there were significant main
effects of the independent variable Group on the ADHD-index (F(2, 81) =
4.484; p = .037; η2 = .054) and the Global-index (F(2, 81) = 5.038; p = .028; η2 =
.060) of the Conners-3, with the ADHDonly-group being rated as significantly
more impaired. Mean values of all Conners-3 subscales (parent and teacher
evaluation) are listed in Table A.6.
Table 3.1 summarizes data of explorative analyses for group characteriza-
tions (e.g. number of participants suffering from previous language disorders,
different learning disabilities, depression or anxiety, as well as number of par-
ticipants receiving any kind of therapy during the study).
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Table 3.1.
Demographic data and group characteristics for Study 1
Mean (SD), number or percent per group p
NF1ADHD NF1only ADHDonly values
Number of participants 53 28 30 -
Sex (female/male) 20/33 17/11 8/22 .024* b
Age 8.873 (1.692) 8.360 (1.352) 8.958 (1.124) .238 a
SES (Winkler-Index) 12.02 (4.906) 13.38 (4.215) 11.13 (3.461) .159 a
familial/sporadic NF1 25/28 9/19 - .240 b
ADHD/ADD 33/20 - 16/14 .490 b
Previous language disorders 24.4% (14) 14.3% (4) 23.3% (7) .415 b
Learning Disabilities 16.9% (9) 3.6% (1) 3.3% (1) .108 b
Dyslexia 15% (8) 3.6% (1) 20.0% (6) .188 b
Dyscalculia 9.4% (5) 0% (0) 10.0% (3) .519 b
Depression 0% (0) 0% (0) 3.3% (1) .538 b
Anxiety disorders 1.9% (1) 3.6% (1) 3.3% (1) .457 b
Oppositional defiant disorder 7.6% (4) 0% (0) 10.0% (3) .325 b
Conduct disorder 3.8%(2) 0% (0) 6.7% (2) .325 b
Occupational therapy 24.5% (13) 17.9% (5) 33.3% (10) .708 b
Speech language therapy 17.0% (9) 17.9% (5) 10.0% (3) .333 b
Psychotherapy 3.8% (2) 0% (0) 13.3% (4) .143 b
Educational support 34.0% (18) 21.4% (6) 50.0% (15) .250 b
Other therapies/support 22.6% (12) 17.9% (5) 23.3% (7) .826 b
Methylphenidate 13.2% (7) 0% (0) 6.7% (2) .094 b
a = ANOVA
b = Pearson Chi-Square
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Data of the CBCL revealed significantly more problem behavior for both
of the ADHD groups compared to the NF1only-group (F(2, 107) = 9.785; p <
.001; η2 = .158; NF1only-group vs. NF1ADHD-group: p < .001; NF1only-group
vs. ADHDonly-group: p = .003). For the scales Internalizing and Externalizing
problem behavior, there was a significant group difference for the multivari-
ate test (Pillai′s Trace, V = 0.162; F(4, 107) = 4.596; p = .001; η2 = .081), but
only externalizing problem behavior differed significantly between the groups
(F(2, 107) = 9.693; p < .001; η2 = .157). Planned pairwise comparisons showed
that the NF1only-group was rated as significantly lower on externalizing prob-
lem behavior than both of the ADHD groups (NF1only-group vs. NF1ADHD-
group: p = .001; NF1only-group vs. ADHDonly-group: p < .001). The MANOVA
for the subscales of the CBCL showed a significant main effect of Group (Pillai′s
Trace, V = 0.525; F(16, 107) = 4.357; p < .001; η2 = .262), with significantly less
problem behavior in the NF1only-group on the subscales Social Problems, At-
tention Problems, Rule-Breaking Behavior, and Aggressive Behavior than in
both of the ADHD groups (results of the CBCL analyses are listed in Table 3.2
and mean values of the CBCL are listed shown in Table A.10.).
Table 3.2.
Results of separate univariate analyses and planned pairwise comparisons of the CBCL
CBCL N df F-value sig. partial
η2
post hoc compar-
isons
Total score 107 2 9.785 .000*** .158 A>B***, C>B**
Externalizing 107 2 9.693 .000*** .157 A>B**, C>B***
Internalizing 107 2 1.961 .146 .036 -
Anxious/Depressed 107 2 1.031 .360 .019 -
Withdrawn/Depressed 107 2 4.586 .012 .081 -
Somatic Complaints 107 2 .296 .744 .006 -
Social Problems 107 2 12.655 .000*** .196 A>B***, C>B*
Thought Problems 107 2 .644 .527 .012 -
Attention Problems 107 2 19.260 .000*** .270 A>B***, C>B***
Rule-Breaking Behavior 107 2 8.162 .001** .136 A>B**, C>B**
Aggressive Behavior 107 2 9.886 .000*** .160 A>B***, C>B***
Significance levels: for the total score: *** < .001, ** < .01, * < .05, for the scales Internalizing and Externalizing problem
behavior: *** < .0005, ** < .005, * < .025, for the subscales: *** < .000125, ** < .00125, * < .00625.
A = NF1ADHD-group, B = NF1only-group, C = ADHDonly-group
“>” means “higher score/more problems” (e.g. A>B* = Group A has significantly higher mean scores and more prob-
lems in this area than group B.)
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3.2.3. [H1] Intellectual Ability
Data analyses
For the analyses of intellectual ability, the full-scale IQ of the WISC-IV and all
indices of the WISC-IV (Verbal Comprehension, Perceptual Reasoning, Work-
ing Memory, and Processing Speed) served as dependent variables. The calcu-
lations were conducted with IQ-scores. For the comparison of the performance
of the two ADHD groups with the normative sample, observed frequencies
of subnormal performance were compared to the expected frequency from the
normative sample (15.8%) by Pearson’s nonparametric chi-square test. Full-
scale IQ was compared between the three experimental groups via a Univariate
Analysis of Covariance (ANCOVA) and the indices of the WISC-IV where com-
pared with a Multivariate Analysis of Covariance (MANCOVA). Sex served as
a covariate for these analyses. The level of significance for univariate analyses
of the WISC-IV indices was set at p < .0125, because of the Bonferroni correc-
tion. For the index Perceptual Reasoning, Levene’s test was significant, but the
MANCOVA was conducted nevertheless for the reasons described above.
Results
The nonparametric chi-square tests for the comparison of the patient groups
with the normative sample showed significantly more frequent subnormal per-
formances in the NF1ADHD-group for full-scale IQ, Perceptual Reasoning, Work-
ing Memory, and Processing Speed. For the ADHDonly-group and the NF1only-
group, there were no significant differences to the normative sample in the fre-
quency of subnormal performances on any of the indices of the WISC-IV. Test
statistic of the nonparametric chi-square tests is listed in Table 3.3.
The ANCOVA for the comparison of the performance of the three experimen-
tal groups revealed significant group differences on full-scale IQ (F(2, 111) =
12.147; p < .001; η2 = .185). Planned post hoc comparisons showed significant
differences between the groups, pointing out that the NF1ADHD-group scored
significantly lower in the intelligence test than the NF1only-group (p < .001)
and the ADHDonly-group (p = .044). Between the NF1only-group and the
ADHDonly-group, there were no significant differences. The covariate sex had
no significant effect on the dependent variable.
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Table 3.3.
Results of the nonparametric chi-square tests for the WISC-IV
WISC-IV scale Group N subnormal df chi- Asymp.
performance square Sig.
Full-scale IQ NF1ADHD 53 30.2% 1 8.092 .004**
ADHDonly 30 20.0% 1 0.377 .539
NF1only 28 3.6% 1 3.183 .074
Verbal Compehension NF1ADHD 53 13.2% 1 0.287 .592
ADHDonly 30 6.7% 1 1.913 .167
NF1only 28 0% 1 - -
Perceptual Reasoning NF1ADHD 53 26.4% 1 4.382 .036*
ADHDonly 30 23.3% 1 1.240 .266
NF1only 28 0% 1 - -
Working Memory NF1ADHD 53 47.2% 1 38.755 .000***
ADHDonly 30 10.0% 1 0.781 .377
NF1only 28 10.7% 1 0.563 .453
Processing Speed NF1ADHD 53 37.7% 1 18.898 .000***
ADHDonly 30 23.3% 1 1.240 .266
NF1only 28 7.1% 1 1.606 .205
*** < .001, ** < .01, * < .05
In the NF1only-group, there were no subnormal performances for Verbal Comprehension or Perceptual Reasoning,
therefore no test statistic could be calculated with SPSS.
On the multivariate test for the WISC-IV indices, the covariate sex was signif-
icantly related to the outcome variables (F(4, 111) = 3.351; p = .013; η2p = .114).
Separate univariate ANCOVAs revealed a significant influence of sex on Pro-
cessing Speed (F(1, 111) = 6.993; p = .009; η2p = .061), with girls clearly per-
forming faster than boys in both ADHD groups. After correcting for the ef-
fect of the covariate, the significant effect of Group on the multivariate test re-
mained (Pillai′s Trace, V = 0.212, F(8, 111) = 3.109; p = .002; η2 = .106). Sep-
arate univariate ANCOVAs revealed significant main effects of Group on all
WISC-IV indices: Verbal Comprehension (F(2, 111) = 5.739; p = .004; η2p =
.097), Perceptual Reasoning(F(2, 111) = 5.178; p = .007; η2p = .088), Work-
ing Memory (F(2, 111) = 7.817; p = .001; η2p = .127), and Processing Speed
(F(2, 111) = 5.543; p = .005; η2p = .094). Mean scores of the WISC-IV are pic-
tured in Figure 3.1 and listed in Table A.5.
Planned post hoc comparisons showed that the NF1ADHD-group scored sig-
nificantly lower than the NF1only-group on all four indices of the WISC-IV (Ver-
bal Comprehension p = .003; Perceptual Reasoning p = .005; Working Mem-
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Figure 3.1. Mean values of the WISC-IV for all three patient groups. Significant group differ-
ences emerged between the NF1only-group and the NF1ADHD-group on full-scale IQ
and on all four indices of the WISC-IV, as well as between the ADHDonly-group and
the NF1ADHD-group on full-scale IQ and the index Working Memory. Error bars
show the standard error (SE) of the mean.
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ory p = .002; Processing Speed p = .004). Compared to the ADHDonly-group,
the NF1ADHD-group scored significantly lower on the index Working Memory
(p = .016), but not on the other indices. Between the NF1only-group and the
ADHDonly-group there were no significant differences. Figure 3.2 illustrates
the intellectual profile of the three patient groups.
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Figure 3.2. Intellectual profiles of the patient groups by mean values for the four indices of the
WISC-IV. The figure demonstrates that patients of the NF1ADHD-group are clearly
restricted in their performance on all four indices compared to the other two groups.
3.2.4. [H2] Memory Skills
Data analyses
To explore the second hypothesis about memory skills, the main scales of the
VLMT (Immediate Recall, Delayed Recall and Recognition) were compared
with a MANCOVA. All scores of the VLMT were T-scores. Full-scale IQ and
sex served as covariates for this analysis. The level of significance for separate
univariate analyses was set at p < .017, because of the Bonferroni correction.
Data was missing in one participant (NF1ADHD-group) for the scale Recogni-
tion. This participant was excluded in the whole analysis.
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Results
There were no effects of the covariates on the dependent variables and there
was no significant main effect of Group in the multivariate test. Patient groups
did not differ in their performance on any of the three scales of the VLMT (Im-
mediate Recall, Delayed Recall and Recognition). The performance of all three
experimental groups lay in the normal range for all scales. Mean values of the
VLMT are illustrated in Figure 3.3 and listed in Table A.5.
35
40
45
50
55
60
Immediate Recall Delayed Recall Recognition
T-
sc
or
es
NF1only
NF1ADHD
ADHDonly
0
Figure 3.3. Mean values of the VLMT for all three patient groups. There were no significant
differences between the groups. Error bars show the standard error (SE) of the mean.
3.2.5. [H3] Attention functions
Data analyses
To test the third hypothesis, the performances of all three experimental groups
on the four parameters of the T.O.V.A. (Variability of Response Time, Response
Time, Commission Errors and Omission Errors) were compared with the nor-
mative sample. Observed frequencies of subnormal performance were com-
pared to the expected frequency from the normative sample (15.8%) by Pear-
son’s nonparametric chi-square test.
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For group comparisons, the main parameter of the T.O.V.A., the API, and
all four sub-parameters (Variability of Response Time, Response Time, Com-
mission Errors and Omission Errors) were tested for group differences with an
ANCOVA or a MANCOVA, with full-scale IQ and sex as covariates.
Additionally, the extent of functional attention problems (Conners-3 sub-
scales Inattention and Hyperactivity/Impulsivity, parent and teacher evalua-
tion) was analyzed with MANCOVAs, with full-scale IQ as covariate. All scores
of the T.O.V.A. are IQ-scores, while all scores of the Conners-3 are T-scores. The
level of significance for separate univariate analyses of the four sub-parameters
of the T.O.V.A. was set at p < .0125 and for univariate analyses of the Conners-3
subscales set at p < .025, because of Bonferroni corrections.
For the analyses of functional measures of attention functions, data of 3 par-
ent evaluations (2 NF1only-group, 1 NF1ADHD-group) and 21 teacher evalua-
tions (6 NF1only-group, 12 NF1ADHD-group, 3 ADHDonly-group) of the Conners-
3 was missing. Analyses were therefore conducted with data of 108 participants
for the parent evaluations and 90 participants for the teacher evaluations.
Results
The results of the nonparametric chi-square tests revealed significantly increased
numbers of subnormal performances in the NF1ADHD-group on all four sub-
parameters of the T.O.V.A. and in the ADHDonly-group on Variability of Re-
sponse Time, Response Time, and Omission Errors (see Table 3.4). For the
NF1only-group, the frequency of subnormal performances was only significantly
increased on the parameter Omission Errors. Test statistic of the nonparametric
chi-square tests is listed in Table 3.4.
The ANCOVA revealed a significant influence of the covariate full-scale IQ
on the analysis (F(4, 111) = 13.525; p < .001; η2p = .113), while the covariate sex
had no influence. After accounting for the effect of the covariate full-scale IQ,
a significant main effect of Group on the API remained (F(2, 111) = 7.586; p =
.049; η2p = .055). Planned pairwise comparisons showed a significant difference
between the NF1only-group and the ADHDonly-group (p = .043), but no differ-
ences between the NF1ADHD-group and one of the other groups. Mean values
of the API of the T.O.V.A. are illustrated in Figure 3.4 and listed in Table A.5.
Regarding the multivariate test on the four T.O.V.A. sub-parameters, the in-
dependent variable group had no significant effect on the outcome variables
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Table 3.4.
Results of the nonparametric chi-square tests for the parameters of the T.O.V.A.
T.O.V.A. Parameter Group N subnormal df chi- Asymp.
performance square Sig.
Variability of Response
Time
NF1ADHD 53 58.5% 1 71.897 .000***
ADHDonly 30 40.0% 1 13.031 .000***
NF1only 28 17.9% 1 0.080 .777
Response Time NF1ADHD 53 39.6% 1 22.305 .000***
ADHDonly 30 40.0% 1 13.031 .000***
NF1only 28 21.4% 1 0.640 .424
Commission Errors NF1ADHD 53 26.4% 1 4.382 .036*
ADHDonly 30 26.7% 1 2.601 .107
NF1only 28 17.9% 1 0.080 .777
Omission Errors NF1ADHD 53 62.3% 1 85.202 .000***
ADHDonly 30 33.3% 1 6.819 .009**
NF1only 28 32.1% 1 5.524 .019*
*** < .001, ** < .01, * < .05
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Figure 3.4. Mean values of the API for all three patient groups. Scores below zero indicate the
likelihood of ADHD. The NF1only-group differed significantly from the ADHDonly-
group on the API score. Error bars show the standard error (SE) of the mean.
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(for mean values see Figure 3.5 and Table A.5). Though, the covariates, full-
scale IQ and sex, were significantly related to the outcome variables (full-scale
IQ: F(4, 111) = 5.294; p = .001; η2p = .171), sex: (F(4, 111) = 8.741; p < .001; η2p =
.253), with a positive correlation between higher intelligence scores and better
scores on the sub-parameters Variability of Response Time, Response Time, and
Omission Errors of the T.O.V.A. (for all groups). Also, girls performed clearly
worse than boys regarding Omission Errors in all three experimental groups.
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Figure 3.5. Mean values of the T.O.V.A. sub-parameters for all three patient groups. There were
no significant differences between the patient groups. TOVA scores are conform
with IQ scores, mean = 100, standard deviation = 15. Error bars show the standard
error (SE) of the mean.
The MANCOVA for the Conners-3 subscales showed no significant effect of
the covariate full-scale IQ on the multivariate tests of the parent or the teacher
evaluation. For the independent variable, the multivariate tests showed signif-
icant relationships between group and the outcome variables (parent evalua-
tion: Pillai′s Trace, V = 0.401, F(4, 111) = 13.052; p < .001; η2 = .201; teacher
evaluation: Pillai′s Trace, V = 0.226, F(8, 111) = 5.471; p < .001; η2 = .113).
On separate univariate analyses, significant main effects of Group were found
on both Conners-3 subscales Inattention and Hyperactivity/Impulsivity in the
parent evaluation, as well as the teacher evaluation (see Table 3.5). Planned
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pairwise comparisons revealed significantly better evaluations for the NF1only-
group on Inattention and Hyperactivity/Impulsivity (parent and teacher eval-
uation) than for both of the ADHD groups (see Table 3.5). However, there were
no significant differences between the two ADHD-groups. Mean values are
illustrated in Figure 3.6) and listed in Table A.6.
Table 3.5.
Results of separate univariate analyses and planned pairwise comparisons of the Conners-3 parent and
teacher evaluation
N df F-value sig. partial post hoc
η2 comparisons
parent evaluation
Inattention 108 2 32.442 .000*** .384 A>B***, C>B***
Hyperactivity/Impulsivity 108 2 13.464 .000*** .206 A>B***, C>B***
teacher evaluation
Inattention 90 2 9.937 .000*** .188 A>B***, C>B**
Hyperactivity/Impulsivity 90 2 9.084 .000*** .174 A>B***, C>B**
*** < .0005, ** < .005, * < .025
A = NF1ADHD-group, B = NF1only-group, C = ADHDonly-group
“>” means “higher score/more problems” (e.g. A>B* = Group A has significantly higher mean scores and more prob-
lems in this area than group B.)
35
40
45
50
55
60
65
70
75
Inattention parents Inattention teachers Hyperactivity/Impulsivity 
parents
Hyperactivity/Impulsivity 
teachers
T-
sc
or
es
NF1only
NF1ADHD
ADHDonly
0
Figure 3.6. Mean values of the Conners-3 subscales Inattention and Hyperactivity/Impulsivity
(parent and teacher evaluation) for the three patient groups. Significant differences
emerged between the NF1only-group and both ADHD groups. Error bars show the
standard error (SE) of the mean.
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3.2.6. [H4] Executive Functions
Data analyses
The forth hypothesis about executive functions was tested with nonparamet-
ric chi-square tests for the comparison of the performances of the experimental
groups with the normative sample. Observed frequencies of subnormal perfor-
mance were compared to the expected frequency from the normative sample
(15.8%) by Pearson’s nonparametric chi-square test. Dependent variables were
the index Working Memory of the WISC-IV, the parameter Commission Errors
of the T.O.V.A. and the main scale of the questionnaire BRIEF (Global Executive
Composite score, parent and teacher evaluation).
Group comparisons of the experimental groups were conducted with uni-
variate ANCOVAs for Working Memory and Commission Errors. Full-scale IQ
and sex served as covariates in the analysis of Commission Errors. In the anal-
ysis of Working Memory, only sex, but not full-scale IQ was a covariate, due to
high intercorrelation of the subscales with the main scale of the WISC-IV. The
Global Executive Composite score of the BRIEF (parent and teacher evaluation)
was compared via ANCOVAs, with full-scale IQ as covariate.
For the two broader indices and the subscales of the BRIEF, MANCOVAs
were conducted for the parent and the teacher evaluation. Full-scale IQ served
as a covariate in these analyses. The level of significance was Bonferroni ad-
justed for separate univariate analyses of the outcome variables and therefore
set at p < .025 for the two broader indices (Behavioral Regulation Index and
Metacognitive Index) and at p < .005 for the subscales. Although Levene’s test
of equality of variances was significant for several subscales, the MANCOVAs
were conducted nevertheless, because of the reasons described above.
Data of 25 participants (18 NF1ADHD-group, 7 NF1only-group) was missing
for the BRIEF parent evaluation and of 42 participants (26 NF1ADHD-group,
14 NF1only-group, 3 ADHDonly-group) for the BRIEF teacher evaluation. Par-
ticipants with missing data were completely excluded from the analyses. In
the analysis of the parent evaluation 86 participants, and in the analysis of the
teacher evaluation 68 participants were included.
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Results
The nonparametric chi-square tests for the comparison of the NF1ADHD-group,
the ADHDonly-group, and the NF1only-group with the normative sample re-
vealed significant main effects on Working Memory, Commission Errors and
the Global Executive Composite (GEC) score of the BRIEF (parent and teacher
evaluation) for the NF1ADHD-group, which means that children with NF1ADHD
performed significantly more frequent in the subnormal range than healthy
children. For the ADHDonly-group, there was a significant main effect on the
GEC score of the BRIEF (parent and teacher evaluation), but no effects on Work-
ing Memory or Commission Errors (see Table 3.6). The NF1only-group did not
differ from the normative sample on any of the measures regarding the fre-
quencies of subnormal performance.
Table 3.6.
Results of the nonparametric chi-square tests for executive measures
Dependent variable Group N subnormal df chi- Asymp.
performance square Sig.
Working Memory NF1ADHD 53 47.2% 1 38.755 .000***
ADHDonly 30 10.0% 1 0.781 .377
NF1only 28 10.7% 1 0.563 .453
Commission Errors NF1ADHD 53 26.4% 1 4.382 .036*
ADHDonly 30 26.7% 1 2.601 .107
NF1only 28 17.9% 1 0.080 .777
GEC parent evaluation NF1ADHD 35 51.4% 1 33.039 .000***
ADHDonly 30 66.7% 1 57.821 .000***
NF1only 21 0% - - -
GEC teacher evaluation NF1ADHD 27 63.0% 1 44.723 .000***
ADHDonly 27 51.9% 1 26.098 .000***
NF1only 14 0% - - -
*** < .001, ** < .01, * < .05
Expected percentage of subnormal performances in the normative sample: 15.8% In the NF1only-group, there were
no subnormal performances for Verbal Comprehension or Perceptual Reasoning, therefore no test statistic could be
calculated with SPSS.
The comparisons of the three experimental groups showed no significant
group differences for Commission Errors, but significant main effects of Group
on Working Memory (F(2, 111) = 7.817; p = .001; η2p = .127) and the GEC
scores of the parent and teacher evaluations in the BRIEF (see Tables 3.7 and
3.8). The covariates had no effect on Working Memory and the GEC score of
the parent evaluation. For the teacher evaluation, there was a significant influ-
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ence of full-scale IQ on the dependent variable (F(1, 68) = 4.134; p = .046; η2p =
.061), but the main effect of Group remained after accounting for the effect of
the covariate. Planned pairwise comparisons revealed that the NF1only-group
scored significantly better than the NF1ADHD-group on the measures Working
Memory (p = .002), GEC – parent evaluation (p < .001), and GEC – teacher
evaluation (p < .001). Also, the NF1only-group scored significantly better than
the ADHDonly-group on the GEC scores of the parent and teacher evaluation
(parent evaluation: p < .001; teacher evaluation: p < .001). Furthermore,
there was a significant group difference between the NF1ADHD-group and the
ADHDonly-group on Working Memory (p = .016), with the ADHDonly-group
performing better than the NF1ADHD-group, but not on the GEC scores. For the
mean values see Figure 3.7 and Figure 3.8.
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Figure 3.7. Mean values for Working Memory (WISC-IV) and Commission Errors (T.O.V.A.)
for all three patient groups. Significant group differences emerged for Working
Memory between the NF1only-group and the NF1ADHD-group as well as between
the ADHDonly-group and the NF1ADHD-group. TOVA scores are conform with IQ
scores, mean = 100, standard deviation = 15. Error bars show the standard error (SE)
of the mean.
The MANCOVAs of the the two broader indices of the BRIEF (Behavioral
Regulation Index and Metacognition Index) showed significant main effects
of the independent variable group in the parent evaluation (Pillai′s Trace, V =
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0.330, F(4, 86) = 8.095; p < .001; η2p = .165) and the teacher evaluation (Pillai′s
Trace, V = 0.286, F(4, 68) = 5.345; p = .001; η2p = .143). Significantly better
ratings were found for the NF1only-group than for the NF1ADHD-group or the
ADHDonly-group on both indices in the parent and teacher evaluation (see Ta-
ble 3.7 and 3.8). The covariate full-scale IQ had no effect in the multivariate
tests.
Table 3.7.
Results of the BRIEF parent evaluation
N df F-value sig. partial post hoc
η2 comparisons
Global Executive Compos-
ite
86 2 17.000 .000*** .293 A>B***, C>B***
Behavioral Regulation In-
dex
86 2 6.575 .002** .138 A>B*, C>B**
Metacognition Index 86 2 19.564 .000*** .323 A>B***, C>B***
Inhibit 86 2 7.274 .001* .151 A>B**, C>B**
Shift 86 2 4.218 .018 .093 -
Emotional Control 86 2 3.590 .032 .081 -
Initiate 86 2 8.177 .001* .166 A>B*, C>B***
Working Memory 86 2 25.322 .000*** .382 A>B***, C>B***
Plan/Organize 86 2 15.927 .000*** .280 A>B***, C>B***
Organization of Materials 86 2 4.528 .014 .099 -
Monitor 86 2 16.143 .000*** .283 A>B***, C>B***
Monitoring of Task Perfor-
mance
86 2 8.398 .000*** .170 A>B**, C>B**
Self Monitoring 86 2 11.390 .000*** .217 A>B***, C>B***
For the Global Executive Composite: *** < .001, ** < .01, * < .05
For the Behavioral Regulation Index and the Metacognition Index: *** < .0005, ** < .005, * < .025
For the subscales: *** < .0001, ** < .001, * < .005
A = NF1ADHD-group, B = NF1only-group, C = ADHDonly-group
“>” means “higher score/more problems” (e.g. A>B* = Group A has significantly higher mean scores and more prob-
lems in this area than group B.)
The analysis of the subscales of the BRIEF parent evaluation revealed no ef-
fect of the covariate, but a significant effect of the independent variable Group
(Pillai′s Trace, V = 0.550, F(20, 86) = 2.809; p < .001; η2p = .275). Separate
ANCOVAs showed significant group differences for the subscale Inhibit of the
Behavioral Regulation Index and the subscales Initiate, Working Memory, Plan
/Organize, Monitor, Monitoring of Task Performance, and Self Monitoring of
the Metacognition Index (see Table 3.7). The NF1only-group was rated as sig-
nificantly better than the NF1ADHD-group or the ADHDonly-group on all sub-
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scales mentioned above, while there were no significant differences between
the NF1ADHD-group and the ADHDonly-group (for means see Figure 3.8).
For the teacher evaluation, there was no significant effect of the covariate
full-scale IQ on the multivariate test, but for the independent variable group
(Pillai′s Trace, V = 0.537, F(20, 68) = 2.056; p = .010; η2p = .269). Significant
group differences were found for the subscales Inhibit, Initiate, Working Mem-
ory, Plan /Organize, and Monitoring of Task Performance (see Table 3.8). Again,
planned pairwise comparisons revealed that the NF1only-group was rated as
significantly better than the NF1ADHD-group or the ADHDonly-group on all
subscales mentioned above, while there were no significant differences between
the NF1ADHD-group and the ADHDonly-group (for means see Figure 3.8). All
mean values of the BRIEF scales and subscales are listed in Table A.7 and Ta-
ble A.8.
Table 3.8.
Results of the BRIEF teacher evaluation
N df F-value sig. partial post hoc
η2 comparisons
Global Executive Compos-
ite
68 2 10.993 .000*** .256 A>B***, C>B***
Behavioral Regulation In-
dex
68 2 5.216 .008* .140 A>B*, C>B*
Metacognition Index 68 2 12.562 .000*** .282 A>B***, C>B***
Inhibit 68 2 8.394 .001* .208 A>B**, C>B**
Shift 68 2 1.294 .281 .039 -
Emotional Control 68 2 1.147 .324 .035 -
Initiate 68 2 9.967 .000*** .238 A>B***, C>B**
Working Memory 68 2 6.175 .004* .162 A>B**, C>B**
Plan/Organize 68 2 8.102 .001* .202 A>B**, C>B**
Organization of Materials 68 2 3.470 .037 .098 -
Monitor 68 2 6.338 .003* .165 A>B**, C>B**
Monitoring of Task Perfor-
mance
68 2 6.941 .002* .178 A>B**, C>B**
Self Monitoring 68 2 3.327 .042 .094 -
For the Global Executive Composite: *** < .001, ** < .01, * < .05
For the Behavioral Regulation Index and the Metacognition Index: *** < .0005, ** < .005, * < .025
For the subscales: *** < .0001, ** < .001, * < .005
A = NF1ADHD-group, B = NF1only-group, C = ADHDonly-group
“>” means “higher score/more problems” (e.g. A>B* = Group A has significantly higher mean scores and more prob-
lems in this area than group B.)
60
3.2. Data Analyses and Results of Study 1
35
40
45
50
55
60
65
70
75
GEC BRI MCI
T-
sc
or
es
Parent Evaluation
35
40
45
50
55
60
65
70
75
GEC BRI MCI
T-
sc
or
es
Teacher Evaluation
0 0
35
40
45
50
55
60
65
70
75
T-
sc
or
es
35
40
45
50
55
60
65
70
75
T-
sc
or
es
00
NF1only
NF1ADHD
ADHDonly
Figure 3.8. Mean values of the BRIEF scales and subscales for the three patient groups. Signif-
icant group differences emerged for every scale and almost every subscale between
the NF1only-group and the other two groups, see Tables 3.7 and 3.8. Error bars show
the standard error (SE) of the mean.
Abbreviations: GEC = Global Executive Composite, BRI = Behavioral Regulation In-
dex, MCI = Metacognition Index, EC = Emotional Control, WM = Working Memory,
P/O = Plan/Organize, OM = Organization of Materials, TP = Monitoring of Task
Performance, SM = Self Monitoring.
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3.2.7. [H5] Quality of Life
Data analyses
QoL of each patient group was compared to population norms by Pearson’s
nonparametric chi-square test. Observed frequencies of subnormal scores were
compared to the expected frequency from the population norms (15.8%). De-
pendent variables were the main scale and all subscales of the questionnaire
Kiddo-Kindl.
QoL was also compared between the experimental groups with an ANCOVA
for the total score and a MANCOVA for the subscales of the Kiddo-Kindl,
with full-scale IQ as covariate. Data of 97 participants (45 NF1ADHD-group, 22
NF1only-group, 30 ADHDonly-group) could be analyzed. Levene’s test of equal-
ity of variances was significant for the subscales Self-Esteem and Family, but
the MANCOVA was conducted nevertheless, for the reasons described above.
Results
Most of the mean values of the Kiddo-Kindl lay in the normal range for all three
experimental groups (see Figure 3.9 and Table A.9).
The nonparametric chi-square tests for the comparison of the experimental
groups with the population norms revealed significant main effects for the
NF1ADHD-group on the total score of the Kiddo-Kindl and on the subscales
Self-Esteem, Family, Friends, and Chronic disease. However, very important
and surprising is that parents rated their children not only as subnormal on the
subscales Family and Friends, but also as supernormal on the subscales Self-
Esteem and Chronic disease. For the NF1only-group, only the subscale Friends
showed a significant main effect, with significantly more ratings in the subnor-
mal range than expected by the population norms. For the ADHDonly-group,
there were significant main effects on the total score of the Kiddo-Kindl and
on the subscales Mental well-being, Family, and Friends. All significant effects
for the ADHDonly-group arose from significantly more subnormal ratings (not
supernormal ratings) (see Table 3.9).
For the group comparison, the ANCOVA revealed a significant main effect
of Group on the total score of the Kiddo-Kindl (F(2, 97) = 3.738; p = .027; η2p =
.074), while the covariate had no effect on the dependent variable. Post hoc
comparisons revealed that the NF1only-group was rated as significantly better
62
3.2. Data Analyses and Results of Study 1
Table 3.9.
Results of the nonparametric chi-square tests for Quality of Life
Dependent variable Group N subnormal df chi- Asymp.
scores square Sig.
Total score NF1ADHD 45 28.9% 1 5.678 .017*
NF1only 22 9.1% 1 .763 .382
ADHDonly 30 43.3% 1 16.884 .000***
Physical well-being NF1ADHD 45 24.4% 1 2.457 .117
NF1only 22 13.6% 1 .084 .772
ADHDonly 30 13.3% 1 .148 .701
Mental well-being NF1ADHD 45 22.2% 1 1.345 .246
NF1only 22 13.6% 1 .084 .772
ADHDonly 30 33.3% 1 6.819 .009**
Self-Esteem NF1ADHD 45 4.4% 1 4.416 .036*
NF1only 22 0.0% - - -
ADHDonly 30 6.7% 1 1.913 .167
Family NF1ADHD 45 35.5% 1 13.001 .000***
NF1only 22 4.5% 1 2.121 .145
ADHDonly 30 33.3% 1 6.819 .009**
Friends NF1ADHD 45 51.1% 1 41.723 .000***
NF1only 22 36.4% 1 6.890 .009**
ADHDonly 30 50.0% 1 26.088 .000***
School NF1ADHD 45 17.8% 1 .119 .730
NF1only 22 9.1% 1 .763 .382
ADHDonly 30 26.7% 1 2.601 .107
Chronic disease NF1ADHD 45 2.2% 1 6.296 .012*
NF1only 22 4.5% 1 2.121 .145
ADHDonly 30 0.0% - - -
*** < .001, ** < .01, * < .05
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Figure 3.9. Mean values of the Kiddo-Kindl in z-scores for all three patient groups. The normal
range of z-scores reaches from -1 to +1. Error bars show the standard error (SE) of
the mean.
in quality of life than the ADHDonly-group (p = .029). Between the NF1ADHD-
group and the other two groups, there was no significant difference (NF1ADHD-
group vs. NF1only-group: p = .078; NF1ADHD-group vs. ADHDonly-group:
p = 1.000). However, the MANCOVA for the subscales of the Kiddo-Kindl
showed no significant group effect for the multivariate test. Also, there was no
effect of the covariate full-scale IQ.
3.3. Discussion of Study 1
The aim of Study 1 was to identify the cognitive characteristics of NF1 with
and without ADHD, and to distinguish between ADHD in NF1 and ADHDonly.
The results yield a mixed picture, but mostly corroborate the hypotheses. The
main finding is that the NF1 group of this study can be divided in two distinct
subgroups at the level of neurocognitive characteristics: children with NF1only
and children with NF1ADHD. An ADHD diagnosis seems to make a marked
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difference in the cognitive profile of patients with NF1. The key results are
briefly discussed below.
3.3.1. Intellectual Ability
Consistent with previous findings (Lidzba et al., 2012; Potvin et al., 2015) and
as predicted by hypothesis 1, there was no reduction or impairment of intel-
lectual functioning in children with NF1only as a group. They scored close to
the intelligence mean score of 100 on all indices of the WISC-IV. In compari-
son, children with NF1ADHD showed reduced intellectual functioning on most
indices of the intelligence test and had the lowest IQ scores of all three patient
groups. Even though mean scores of all intelligence indices lay still within nor-
mal limits, the NF1ADHD-group differed significantly from the NF1only-group
in all areas of intellectual ability, as Figure 3.2 shows.
Intellectual ability in NF1only
The result of spared intellectual functioning in NF1 contradicts the consistent
finding of earlier NF1 research (Hyman et al., 2005; North et al., 2002; Ferner
et al., 1996). A lot of previous studies reported a generalized downward shift
of IQ in NF1, but the authors of most of these studies treated the population as
one homogeneous group and did not consider ADHD as a crucial factor for the
intellectual outcome and therefore did not split their NF1 patient groups into
subgroups. Two more recent studies, which analyzed retrospectively clinical
patient data, show that NF1 patients without the additional cognitive burden
of ADHD perform close to the average on intelligence tests (Lidzba et al., 2012;
Potvin et al., 2015). The results of Study 1 confirm those results and indicate
that ADHD is a specific risk factor for reduced intellectual abilities in NF1.
Effects of ADHD on intellectual ability in NF1
Regarding our predictions, hypothesis 1(a) was partly confirmed: children with
NF1ADHD show reduced intellectual abilities compared to the normative sam-
ple, except for Verbal Comprehension. However, children with ADHDonly did
not show lowered intellectual abilities compared to the normative sample, which
contradicts our expectations and earlier research results (Frazier et al., 2004).
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Hypothesis 1 (b) could be partly confirmed, as well. Regarding full-scale IQ,
the NF1ADHD-group performed below the NF1only-group and the ADHDonly-
group, but the picture of the indices of the intelligence test is more diverse.
While the NF1ADHD-group performed significantly worse than the NF1only-
group on all indices, they only differed from the ADHDonly-group on Working
Memory. Working Memory had the lowest scores of all indices of the WISC-IV
in all three patient groups, but the performance was far more decreased in the
NF1ADHD-group than in the other two groups.
Intellectual profile of NF1
Similar to previous research (Potvin et al., 2015), our results show an uneven
profile of intellectual abilities in children with NF1. Both NF1 groups showed
a pattern of better verbal than visual-spatial skills and processing speed, and
the most intense weakness in working memory. For children with NF1ADHD,
this intellectual profile equates exactly the profile which was found by Potvin
and colleagues. For children with NF1only, they found a slightly different pro-
file with the most pronounced weakness in processing speed rather than in
working memory. However, the results of the present study indicate that mi-
nor working memory problems might be associated with the NF1 condition,
and are exacerbated by additional ADHD symptoms. In our sample, 10.7% of
the NF1only-group compared to 47.2% of the NF1ADHD-group presented scores
below the normal range on the index Working Memory. Considering that only
10.0% of the ADHDonly-group performed subnormally regarding working mem-
ory skills, it seems that the cognitive burden of the NF1ADHD-group in working
memory is more than a simple summation of the negative effects of NF1 and
ADHD symptoms. Additionally, it is surprising that the NF1only-group and
the ADHDonly-group showed so few subnormal performances, because the ex-
pected number of the population norms would have been 15.8%.
3.3.2. Memory Skills
In contrast to previous findings in NF1 research (Descheemaeker et al., 2013;
Billingsley et al., 2003; Ferner et al., 1996), there were no verbal learning or
memory deficits in any of our patient groups, independently from gender, age,
ADHD or NF1. However, not all former studies used a standardized test,
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which limits their informative value. In the present study, all groups displayed
scores within the normal range for Immediate and Delayed Recall, as well as
for Recognition in the VLMT, as Figure 3.3 illustrates. Furthermore, children
with NF1ADHD and children with ADHDonly did not differ from children with
NF1only. Therefore, hypothesis 2 has to be rejected.
Spared verbal (and visual) memory skills in children with NF1 were found
before in a study, where a standardized verbal learning test similar to the VLMT
was used (Hyman et al., 2005). Comparing standard scores, they even found
stronger memory skills than general intellectual skills in children with NF1.
3.3.3. Attention Functions
Hypothesis 3 (a) could be confirmed. The results of the attention measures
show that the two ADHD groups presented reduced scores on nearly all pa-
rameters of the T.O.V.A. compared to the normative sample. Children with
NF1only presented reduced scores on Omission Errors (reflecting inattention/-
sustained attention). These results corroborate earlier findings of subclinical at-
tention problems – especially regarding sustained attention – in children with
NF1 without an ADHD diagnosis (Pride et al., 2012).
Hypothesis 3 (b) was partly confirmed: Children with ADHD– irrespective of
NF1– were evaluated as significantly worse on hyperactivity/impulsivity and
inattention than children with NF1only in the questionnaires. Children with
ADHDonly also performed below children with NF1only on the main parameter
of the T.O.V.A., the API, but there were no differences on the sub-parameters of
the T.O.V.A.. Also, the two NF1 groups differed neither on the API nor on the
sub-parameters of the T.O.V.A.
Regarding hypothesis 3 (c), there were no significant quantitative differences
in the attention functions of children with NF1ADHD and with ADHDonly, nei-
ther in the attention test nor in the parent or teacher evaluations. Therefore,
hypothesis 3 (c) has to be rejected.
Attention profiles of NF1ADHD and ADHDonly
At first glance, the pattern of functional attention dysfunction in NF1ADHD
seems to mimic that of ADHDonly with mild hyperactivity/impulsivity (in the
questionnaires) and moderate inattention (in the T.O.V.A. and the question-
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naires). However, a closer look into the data reveals a more detailed picture:
While the ADHDonly-group showed the lowest mean values on the T.O.V.A.
sub-parameters Variability of Response Time and Response Time itself, the
NF1ADHD-group showed a more pronounced reduction of the mean score for
Omission Errors (see Figure 3.5).
Furthermore, the frequencies of subnormal performances showed that chil-
dren with NF1ADHD were more affected regarding attention dysfunction than
children with ADHDonly. Nearly twice as many children with NF1ADHD (62.3%)
than children with ADHDonly (33.3%) showed subnormal performances on Omis-
sion Errors. Also, Response Time Variability was more often reduced in NF1ADHD
(58.5%) than in ADHDonly (40.0%). Finally, even though the ADHDonly-group
performed much worse on Response Time regarding mean scores (ADHDonly-
group: M = 84.28, NF1ADHD-group: M = 91.27), the frequencies of subnor-
mal performances showed nearly no difference between the two ADHD groups
(ADHDonly-group: 40.0%, NF1ADHD-group: 39.6%), which indicates that chil-
dren with ADHDonly are not more often affected in response time than children
with NF1ADHD, but if so, they are more severely affected and perform much
slower.
Overall, the above mentioned differences in the attention domain lead to the
assumption that the attention profile of NF1ADHD differs from that of ADHDonly.
Children with with NF1ADHD seem to be especially affected regarding inatten-
tion, while children with ADHDonly seem to have more serious problems with
response times. These results are partly in line with the findings of a recent
study, where children with ADHDonly showed inferior response times to chil-
dren with NF1ADHD in a sustained attention task (Lion-Francois et al., 2017).
Additionally, the authors found that children with NF1ADHD showed lower
overall performances in the areas of intensive, selective, and executive atten-
tion. The authors took these performance differences as evidence for the as-
sumption that the two conditions ADHDonly and NF1ADHD are fundamentally
different from each other and concluded that the condition NF1ADHD is not
only the sum of NF1 and ADHD, and that ADHD symptomatology does not
contribute to all attentional deficits in NF1 (Lion-Francois et al., 2017).
Our results are also confirmed by other studies showing that symptoms of
inattention are more prevalent in NF1 than other attention problems (Pride
et al., 2012) and they support the idea that certain deficits are rather associ-
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ated with NF1 than merely the result of a comorbid ADHD symptomatology
(Galasso et al., 2014; Huijbregts, 2012).
Subclinical attention problems in NF1
The concept of attention problems in NF1, which are independent from an
ADHD diagnosis, is corroborated by further results of Study 1: The frequencies
of subnormal performances on all four parameters of the T.O.V.A. were higher
than the expected values for the normal (healthy) population (max. 15.8%, if
one takes percentile rank as a basis) for all of our patient groups. This is not sur-
prising for children suffering from ADHD, but it is unexpected for the NF1only-
group. Even if there is still a marked difference between NF1 patients with and
without an additional ADHD diagnosis, the number of below average perfor-
mances in the NF1only-group is high, especially in the areas of distractibility
(Variability of Response Times) and inattention (Omission Errors). Subclini-
cal attention problems seem to be prevalent among children with NF1only and
might be an inherent cognitive feature of the NF1 condition. Some authors as-
sume that the downstream effects of the unique etiology underlying ADHD
in NF1 result in a relatively homogeneous and “inattentive” phenotype (Pride
et al., 2012). Affected inattention/sustained attention in children with NF1only
was found before (Pride et al., 2012), but affected performances in other areas
of attention function are an unexpected and novel finding that requires further
investigation.
3.3.4. Executive Functions
Conform to hypothesis 4, both ADHD groups showed reduced executive func-
tions, while children with NF1only were not impaired in any area of executive
functions. These results confirm the assumption that executive dysfunctions
are rather associated with ADHD than with NF1 per se.
Hypothesis 4 (a) was mostly confirmed: children with NF1ADHD showed sig-
nificantly reduced executive functions compared to the normative sample on
the test measures (Working Memory; Commission Errors) and showed signifi-
cant impairment in the parent and teacher questionnaires (GEC of the BRIEF).
Children with ADHDonly, however, had significant impairment only in the par-
ent and teacher questionnaires.
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Hypothesis 4 (b) was also confirmed in most parts: children with NF1ADHD
scored significantly below children with NF1only on most executive test mea-
sures and most questionnaire scales. Also, the ADHDonly-group was rated as
significantly worse than the NF1only-group on most scales of the parent and
teacher questionnaires.
Questionnaire data
Regarding the results of the BRIEF, the parent and teacher evaluations show
pronounced differences between the NF1only-group and the two ADHD groups
on the GEC and the two broader indices Behavioral Regulation Index and Me-
tacognition Index, as Figure 3.8 illustrates. These results suggest that executive
dysfunctions in situations of daily living are not associated with the NF1 con-
dition itself, but are a hallmark of ADHD. The results of the present study
support the findings of Pride et al. (2012), who also found that children with
NF1only were rated as significantly better by parents and teachers in the BRIEF
than children with NF1ADHD. The results of the comparison of the GEC scores
(BRIEF) of the NF1ADHD-group and the ADHDonly-group with the normative
sample shows significantly more subnormal performances for both groups.
These results are in line with our expectations and indicate a high prevalence
of executive dysfunctions, since the GEC score is composed of eight different
subscales and presents a comprehensive overview of executive dysfunction in
situations of daily living. Concerning the subscales of the BRIEF, children with
NF1ADHD and ADHDonly were rated as impaired and as significantly worse
than the NF1only-group in most areas. The results indicate that children with
NF1ADHD and ADHDonly are similarly impaired in executive functions regard-
ing situations at home and situations at school. Additionally, the parent and
teacher evaluations the two ADHD groups are conform with each other except
for the subscale Self-Monitoring, where parents rated the NF1ADHD-group and
the ADHDonly-group as impaired, but teachers did not. This high concordance
of parent and teacher evaluations corroborates the validity of the present data
and cannot be taken for granted. In previous studies, parent ratings have sug-
gested significantly more impairment than teacher ratings (Payne et al., 2011;
Dilts et al., 1996).
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Test measures
The comparison between our ADHD groups revealed only minor differences
for working memory (WISC-IV). Children with NF1ADHD performed signifi-
cantly worse than children with ADHDonly, and the ADHDonly-group did not
differ from the normative sample. These results resemble those of Potvin and
colleagues (Potvin et al., 2015). They compared index scores of the WISC-IV
and found that children with NF1ADHD scored significantly worse on work-
ing memory than children with ADHDonly or NF1only, even though all pa-
tient groups scored significantly below the average of the population norms
in the study of Potvin et al. (2015). Payne et al. (2012) also found children with
NF1ADHD to have impairment in working memory and to differ significantly
from healthy children. Pride et al. (2012), however, found no significant group
differences for performance based tests of executive function, including work-
ing memory (WISC-III:Freedom From Distractibility).
In contrast to the data of Potvin et al. (2015), the NF1only-group in the present
study did not show significant impairment of working memory skills, neither
in the neuropsychological test nor in the questionnaires (see Figure 3.7 and Fig-
ure 3.8). These results confirm our hypothesis that executive dysfunction is a
hallmark of ADHD and not of NF1 per se.
The results for the NF1ADHD-group on impulse control partly confirm and
partly contradict earlier studies. In the present study, children with NF1ADHD
showed more frequently impairment in impulse control, than healthy children,
as found by Mautner et al. (2002) and Payne et al. (2012), too. However, Payne
et al. (2012) also found that children with NF1only performed worse than healthy
children, which cannot be affirmed by the present results.
For the ADHDonly-group, the lack of significant differences between our pa-
tients and the normative sample in the results of the neuropsychological tests
(working memory and impulse control) is particularly surprising, since exec-
utive dysfunctions in the working memory area are well documented for pa-
tients with ADHDonly (Martinussen, Hayden, Hogg-Johnson, & Tannock, 2005;
Martinussen & Tannock, 2006; Potvin et al., 2015). For impulse control, the
study situation is not entirely clear, with both, impaired (Willcutt et al., 2005;
Losier, McGrath, & Klein, 1996) and unimpaired findings (McGee, Clark, &
Symons, 2000). However, the results of the present study do not necessar-
ily mean that there are no working memory impairments or impulse control
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deficits in the present ADHDonly-group. The results of the neuropsychologi-
cal tests are contrary to the results of the external assessments. In the ques-
tionnaires, the ADHDonly-group was explicitly rated as impaired in working
memory and impulse control (BRIEF subscales: Inhibit and Working Memory).
Discrepancies between different measuring types
Discrepancies between test measures and external assessments are not new in
research on attention functions and executive functions. It is well known that
the setting of a neuropsychological test holds different demands for a subject
than a situation of daily living, were more distraction is around. Neuropsycho-
logical tests are normally conducted in an artificial laboratory situation, where
it is quiet and distractions are reduced to a minimum. The assessment of skills
in such a controlled situation is, however, only a snapshot and correlates only
to a limited extend with the abilities in daily living. Studies with different mea-
suring types for ADHD symptoms and executive dysfunctions found substan-
tial discrepancies between neuropsychological tests and functional measures,
indicating that functional ratings of ADHD symptoms have higher ecological
validity and are superior to neuropsychological tests in predicting deficits in
daily living (Barkley & Murphy, 2010; Barkley & Fischer, 2011; Pride et al.,
2012). Barkley and Fischer (2011) found that children with ADHD present far
more problems with executive dysfunctions in daily living than the results of
neuropsychological tests revealed. Another study also found only a low level
of correlation between commission errors in the T.O.V.A. and parents’ evalua-
tions of impulse control in the questionnaire BRIEF (Bodnar, Prahme, Cutting,
Denckla, & Mahone, 2007). Therefore, the parent and teacher evaluations of the
present study might probably be more meaningful than the test measures in
terms of working memory impairments and impulsivity.
Another possible explanation for discrepancies is that different instruments
are tapping different functions, each with certain underlying neuroanatomical
structures (Stuss and Alexander (2000), as cited in Payne et al. (2011)). Recent
research classified executive functions into “cold” functions – associated with
the dorsolateral prefrontal cortex – and “hot” functions – primarily associated
with the ventromedial or orbitofrontal prefrontal cortex. While the cold execu-
tive functions are described as more “cognitive” in nature (including working
memory, attention, and organization skills), the hot executive functions are as-
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sociated with impulse control, response inhibition, and social cognition (Chan,
Shum, Toulopoulou, and Chen (2008); Grafman and Litvan (1999), as cited in
Payne et al. (2011)). Payne et al. (2011) assume that external assessments such
as questionnaires rather record hot executive functions, because they assess ob-
servable behavior, while test measures rather record cold executive functions,
because they are more demanding in terms of cognitive skills. In any case,
the authors conclude that both types of measures have the capacity to detect
meaningful impairments and therefore should be included in neuropsycholog-
ical evaluations (Payne et al., 2011).
3.3.5. Quality of Life
Hypothesis 5 about children with NF1 and/or ADHD (as chronic diseases) suf-
fering from reduced QoL was partly confirmed.
Hypothesis 5 (a) was confirmed in most parts. Both ADHD groups showed
reduced QoL on the total score of the Kiddo-Kindl and two respectively three
out of seven subscales. Children with NF1ADHD showed reduced QoL regard-
ing familial aspects (frequency of being uneasy/comfortable at home, conflicts
with one’s parents) and building/maintaining friendships, while children with
ADHDonly showed reduced QoL regarding mental well-being (frequency of
having fun, being lethargic, feeling lonely, and feeling anxious/unconfident),
familial aspects, and building/maintaining friendships. Children with NF1only,
however, only showed reduced QoL in the area “Friends” (building/maintain-
ing friendships).
Hypothesis 5 (b) has to be rejected. Not children with NF1ADHD, but children
with ADHDonly had the lowest QoL scores and the highest number of impaired
areas. Additionally, they were rated with significantly poorer global QoL than
children with NF1only. These results indicate that it is not NF1 per se or the
cumulation of the two chronic diseases NF1 and ADHD that severely reduces
QoL, but, ADHD itself is the crucial factor.
QoL in NF1
The results of the present study partly contradict findings of previous research,
which consistently reported lower global QoL in children and adolescents with
NF1 compared to healthy children or population norms (Vranceanu et al., 2015;
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Cipolletta et al., 2018; Garwood et al., 2012; Krab et al., 2009; Wolkenstein et al.,
2009; Oostenbrink et al., 2007; Graf et al., 2006). In contrast, our results show
that the differentiation between children with NF1only and NF1ADHD is again
very important. Children with NF1only had no globally decreased QoL in the
present study and seemed to be affected in only one area of the questionnaire
(subscale Friends). Literature on QoL in NF1 reports that protective factors
might be higher parental education, the familial type of NF1, and good family
relationships (Graf et al., 2006; Oostenbrink et al., 2007). Negative predictors for
QoL, on the other side, include problems with emotional functioning, cognitive
functioning, and learning disabilities, socioemotional problems, perceived dis-
ease severity by parents, and teacher reported behavioral problems, as well as
male sex and physical complaints like orthopedic problems, presence of plexi-
form neurofibromas, more disease complications, and greater pain interference
(Vranceanu et al., 2015; Wolters et al., 2015; Wolkenstein et al., 2009; Oosten-
brink et al., 2007; Graf et al., 2006).
In the present NF1only-group, there were less children with the familial type
of NF1 (about 1/3) than in the NF1ADHD-group (about 1/2), which could have
a negative effect on their QoL. However, the SES (which is composed of the
scores for parents’ educational achievement, parents’ professional position, and
family income) was higher, but not significantly so, in the present NF1only-
group than in the NF1ADHD-group or the ADHDonly-group. Additionally, the
NF1only-group was spared in almost every domain of cognitive functioning and
presented very view learning disabilities, thus they profit from a combination
of many protective factors proposed by other authors (Vranceanu et al., 2015;
Wolters et al., 2015; Wolkenstein et al., 2009; Oostenbrink et al., 2007; Graf et al.,
2006).
Compared to the NF1only-group, the NF1ADHD-group of the present study
was rated with poorer global QoL and with lower QoL regarding family and
friends (see Figure 3.9), and they presented several of the risk factors named
above.
QoL in ADHDonly
Regarding ADHD without NF1, the results of the present study corroborate
previous findings of decreased global QoL in children with this disease (Dan-
ckaerts et al., 2010; D. Coghill & Hodgkins, 2016; Marques et al., 2013; Thaulow
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& Jozefiak, 2012; Jafari et al., 2011; Pongwilairat et al., 2005). The ADHDonly-
group was especially rated as impaired regarding the global score and mental
well-beeing, family and friends. For the domain of physical functioning, the
present study found no impairment for children with ADHDonly compared to
the population norm, but other studies also found merely a moderate effect of
ADHD on this domain of QoL in parent proxy-reports (Lee et al., 2016). For the
domains emotional, social and School functioning, Lee et al. (2016) reported
strong effects of ADHD symptoms on QoL, which is confirmed by the present
results except for the domain School functioning (see Figure 3.9).
Effects of ADHD on QoL in NF1
A comparison between the NF1ADHD-group and the ADHDonly-group shows
that the children of these patient groups were rated similarly regarding their
QoL, even if the severity of impairments in QoL was more pronounced in
ADHDonly. The results support and extend the findings of Mautner et al. (2015),
who investigated the effect of ADHD on life satisfaction and personality in
adults with NF1. The authors found that ADHD in NF1 had a statistically sig-
nificant negative impact on overall life satisfaction and especially affected gen-
eral health, self-satisfaction, sexuality, and family/friends. Additionally, the
results of Mautner et al. (2015) show that adults with ADHDonly had the lowest
scores regarding overall life satisfaction compared to patients with NF1ADHD
and NF1only, which is conform with the present results.
One surprising finding of Study 1 is that parents of children with NF1ADHD
rated QoL on the subscales Self-Esteem and Chronic Disease of the Kiddo-Kindl
as supernormal. The subscale Self-Esteem consists of four items about the sense
of well-being and satisfaction about oneself, while the Disease Modul includes
items about worries in daily living concerning the disease. The results indicate
that NF1 as a chronic disease has only little impact on situations of daily living
for the affected children and adolescents in the age-group studied – at least in
the perception of their parents.
3.3.6. Conclusion of Study 1
The results of Study 1 indicate that there are – at least – two distinct profiles of
NF1 with one group being far more affected than the other.
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The cognitive profile of children with NF1ADHD is characterized by reduced
intellectual abilities (in the lower normal range), minor to moderate attention
problems with general attention problems (subnormal scores on the API of
the T.O.V.A.), distractibility (reduced scores on Variability of Response Time)
and moderate inattention (reduced scores on Omission Errors). Executive dys-
functions were affected regarding working memory, impulsivity (Commission
Errors, T.O.V.A.), and functional aspects of executive functions in situations
of daily living (inhibition, initiative, working memory, planning/organizing,
monitoring of task performance and self monitoring). Additionally, quality of
life seems to be moderately reduced with respect to familial aspects and build-
ing/maintaining friendships. Verbal memory skills are spared in NF1ADHD.
The cognitive profile of children with NF1only reveals almost entirely unim-
paired cognitive functions. Children with NF1only were found to have normal
intellectual abilities, unimpaired verbal memory skills, and unimpaired execu-
tive functions. Regarding attention functions, they showed no problems with
hyperactivity or impulsivity, but mild problems with inattention, which was
expected. Quality of life was mostly unimpaired except for building/maintain-
ing friendships.
Regarding attention characteristics of ADHD in NF1 and of ADHDonly, the
results of Study 1 show that there are differences in certain attention dysfunc-
tions of children with NF1ADHD and children with ADHDonly. The NF1ADHD-
group was far more affected regarding inattention (T.O.V.A. Omission Errors),
while the ADHDonly-group showed markedly slower response times (T.O.V.A.
Response Time). These results indicate that attention deficit in NF1 is rather
associated with the NF1-condition than merely due to a comorbid ADHD di-
agnosis.
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4.1. Scope and Hypotheses
Study 2 examines attention performance as a possible predictor for intellectual
development in NF1 in a longitudinal design. The aim was to gain knowledge
about the complex interaction between attentional and intellectual abilities and
the specificity of attention deficit in NF1. Three patient groups (NF1ADHD-
group, NF1only-group, and ADHDonly-group) were investigated to answer the
question of the course and development of intellectual functions in NF1, de-
pendent and independent from attention dysfunctions and an amelioration of
them.
Since an improvement of intellectual abilities as a possible consequence of an
amelioration of attention functions will be the result of a cumulative effect, it
can only become obvious after a relatively long observation time. In the present
study, the time interval between the examinations was 12 months. Shorter in-
tervals would have carried the risk of improved test performances because of
retest effects. The longest interval between the first and the third examination
added up to 24 months.
Three hypotheses were formulated and tested:
[H1] Attention performance is a predictor for intellectual development
Attention dysfunction is significantly related to reduced intellectual function-
ing in the short and long term. Attentional functioning is a predictor for intel-
lectual functioning.
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Predictions:
(a) Children with NF1ADHD and with ADHDonly perform significantly worse
on measures of intellectual functioning than children with NF1only at all three
assessment points.
(b) Attention performance at the first assessment point predicts intellectual
performances at all three assessment points.
[H2] Improvement of intellectual functioning
An amelioration of attention functions is accompanied by a significant improve-
ment in intellectual functioning over a two-year-period. The expected effect is
specific for children with NF1 and does not, or in a significantly smaller extent
occur in children with ADHDonly.
Predictions:
(a) Children with NF1ADHD with improvement in attention functions per-
form significantly better in measures of intellectual functioning at the third as-
sessment point.
(b) Children with ADHDonly show no significant improvement in intellectual
functioning at the third assessment point, even if they improved in attention
functions.
(c) Children with NF1only show no modification of their intellectual function-
ing.
[H3] Treatment effects of MPH in NF1
An intervention with methylphenidate is accompanied by a stronger improve-
ment in intellectual functioning than other or no interventions (e.g. psychother-
apy, occupational therapy) in patients with NF1ADHD.
Predictions:
(a) Patients with NF1ADHD, who were treated with MPH, show a significantly
stronger improvement in intellectual functioning after a two-year-period com-
pared to patients with NF1ADHD, who were treated with other interventions or
who received no treatment.
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4.2. Data Analyses and Results of Study 2
Data was analyzed as described in the Methods’ chapter.
Study 2 had a longitudinal design, which means that data across three assess-
ment points was analyzed. For Study 2 a matched group design was chosen to
control for individual differences between the subjects. Subjects of three groups
(NF1ADHD-group, NF1only-group, and ADHDonly-group) were matched for age
and SES. As far as possible, they were also matched for ADHD-subtype re-
garding the two patient groups suffering from ADHD. During the matching
procedure, sex was excluded as a matching-factor, because the patient groups
differed widely in the distribution of sex and it would have been impossible to
generate a sufficiently large number of participants in each single group.
Equality of variances was met for all dependent interval and ratio variables
of Study 2. Normality of distribution was met for all ratio variables of demo-
graphic data and all variables of intellectual performance. Regarding attention
performance, normality of distribution was not met for the Attention Perfor-
mance Index (API) of the T.O.V.A. at the first and the third assessment point
(T1 and T3) and for the difference between the API of T3 minus T1 for a part
of the patient groups (see Appendix, Table A.11). For the analyses of Study
2, the violations of normality of distribution did not have any consequences.
The variables in question served as dependent variables in bias corrected par-
tial correlation analyses, and there are no nonparametric alternatives for these
analyses.
There were only very few missing data. For the calculation of the SES, data
was missing in one participant of the NF1only-group. Data of the API of the
T.O.V.A. of T3 was also missing in one participant of the NF1only-group. There-
fore, it was not possible to calculate the difference between the API of T3 minus
T1 for this one person.
4.2.1. Choice of Covariates
For Study 2, age and sex distribution were chosen as covariates. Age was cho-
sen despite the fact that groups were matched for age and there were no sig-
nificant differences between the groups in age (ANOVA: F(2, 66) = 1.039; p =
.360; η2 = .032), because of the possibility of even little age differences being
relevant for the benefit of therapeutic interventions in the long term. So far,
79
Chapter 4. Study 2: Analysis of Attentional and Intellectual Development in NF1
it remains unknown, at what age children profit more from early interventions
regarding attention dysfunctions. Young children might be too young for a suc-
cessful attention training, while older children might have less developmental
potential (neurologically) for ameliorations through a training than younger
children do. Regarding treatment of ADHD symptoms with medication, there
is first evidence that children between 6-8 years profit more from MPH treat-
ment than children between 9-12 years concerning general intellectual function-
ing (Tsai et al., 2013). However, ADHD symptom severity was not differently
moderated by MPH treatment in different age groups in the study by Tsai et al.
(2013).
Sex distribution was treated as a covariate, because there were wide differ-
ences between the groups (χ2(1, N = 66) = 7.700, p = .026) – as mentioned
above – which might have kept the risk of biases.
4.2.2. Characteristics of the Study Population
Data analyses
Like in Study 1, demographic data was analyzed with chi-square tests for sex,
ADHD subtype, and NF1 subtype, or two-tailed ANOVAs for age and SES.
Severity of attention dysfunction was compared between the groups by two-
tailed ANOVAs with the dependent variables API of the T.O.V.A. and ADHD-
index of the Conners-3 parent evaluation at the first examination (T1).
Normality of distribution and equality of variances were met for the ratio
variables age, SES, and ADHD-index. The API of the T.O.V.A. did not meet the
criterion of normality of distribution, as mentioned before. The nominal and
ordinal variables were not tested for normality of distribution, because these
data naturally do not follow a normal distribution.
Regarding therapeutic interventions, the use of occupational therapy, psy-
chotherapy, and MPH was analyzed for group differences with chi-square tests.
All three patient groups were compared concerning occupational therapy and
psychotherapy. The frequency of the use of MPH was only compared between
the two ADHD groups, since participants of the NF1only-group were not diag-
nosed with ADHD and therefore were not treated with stimulant medication.
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Results
After the matching procedure, 22 subjects in each patient group were left. All
in all, 66 participants were included in Study 2.
In the NF1ADHD-group, 11 participants (50.0%) were female and 11 partic-
ipants (50.0%) were male. The mean age of this group was 8.754 years (SD:
1.352). Nine participants (40.9%) suffered from the familial type of NF1. Nine
participants (40.9%) had the Inattentive Type and 13 participants (59.1%) the
Combined Type of ADHD. Four participants (18.2%) were taking MPH for the
treatment of ADHD prior to the beginning of the study and during the study.
Additionally, 6 participants started taking MPH during the study, so that 10
participants (45.5%) were receiving MPH at the time of the last examination.
The SES lay in the middle range (Winkler-index: mean = 12.773, SD: 3.939).
In the ADHDonly-group, 5 participants (22.7%) were female and 17 partic-
ipants (77.3%) were male. The mean age of this group was 8.966 years (SD:
1.254). 12 participants (54.5%) fulfilled the criteria for the Inattentive Type of
ADHD and 10 participants (45.5) for the Combined Type of ADHD. One partic-
ipant (4.5%) received MPH prior to the beginning of the study and 3 additional
participants received MPH during the course of the study. The SES lay in the
middle range (Winkler-index: mean = 11.136, SD: 3.256).
In the NF1only-group, 14 female participants (63.6%) and 8 male participants
(36.4%) were enrolled. The mean age was 8.383 years (SD: 1.461). Sixteen partic-
ipants (72.7%) were suffering from a sporadic mutation of the NF1-gene, while
6 participants (27.3%) had the familial type of NF1. The SES lay in the middle
range (Winkler-index: mean = 12.857, SD: 3.953).
The distribution of sex differed significantly between the groups (χ2(2, N =
66) = 7.700, p = .026), with an even sex ratio in the NF1ADHD-group, slightly
more girls than boys in the NF1only-group, and profoundly more boys than girls
in the ADHDonly-group.
No significant differences between the groups were found for age (F(2, 66) =
1.039; p = .360; η2 = .032), SES (F(2, 65) = 1.477; p = .236; η2p = .045), ADHD
subtype (χ2(1, N = 44) = 0.820, p = .547), or NF1 subtype (χ2(1, N = 44) =
.910, p = .526). As expected, there were significant group differences regarding
the severity of attention dysfunction. Groups differed significantly on the API
of the T.O.V.A. (F(2, 66) = 5.171; p = .008; η2 = .141) and the ADHD-index
of the Conners-3 parent evaluation (F(2, 66) = 19.809; p < .001; η2 = .390) at
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the first assessment point with the NF1only-group being significantly less im-
paired on both variables than the NF1ADHD-group and the ADHDonly-group
(see Table 4.1).
Also, there were no significant differences between the three groups regard-
ing therapeutic interventions like the use of occupational therapy (χ2(2, N =
60) = .996, p = .703) or psychotherapy (χ2(2, N = 61) = 1.802, p = .768)
during the process of the study. However, the frequency of MPH therapy dif-
fered between the two ADHD groups at the end of the study (χ2(2, N = 44) =
5.350, p = .045), but not in the beginning (χ2(2, N = 44) = 2.031, p = .345).
Participants of the NF1ADHD-group were treated with MPH significantly more
frequently than participants of the ADHDonly-group.
Table 4.1 summarizes data of explorative analyses for group characteriza-
tions.
Table 4.1.
Demographic data and group characteristics for Study 2
Mean (SD), number or percent per group p
NF1ADHD ADHDonly NF1only values
Number of participants 22 22 22 -
Sex (female/male) 11/11 5/17 14/8 .026* b
Age at T1 8.754 (1.352) 8.966 (1.254) 8.383 (1.461) .360 a
SES (Winkler-Index) 12.773 (3.939) 11.136 (3.256) 12.857 (3.953) .236 a
familial/sporadic NF1 9/13 6/16 - .526 b
ADHD/ADD 9/13 12/10 - .547 b
API at T1 -1.476 (3.785) -1.445 (2.856) 1.181 (2.684) .008** a
C3 c ADHD-index at T1 63.238 (7.127) 65.455 (6.375) 54.273 (5.054) .000*** a
Occupational therapy 31.8% (7) 40.9% (9) 22.7% (5) .703 b
Psychotherapy 4.5% (1) 9.1% (2) 0% (0) .768 b
Methylphenidate at T1 18.2% (4) 4.5% (1) - .345 b
Methylphenidate at T3 45.5% (10) 13.6% (3) - .045 b
a = ANOVA
b = Pearson Chi-Square
c = Conners-3
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4.2.3. [H1] Attention is a Predictor for Intellectual
Development
Data analyses
To test the first part (a) of hypothesis 1, a repeated measures analysis of covari-
ance, as well as three separate ANCOVAs for each assessment point (3 times)
were conducted with full-scale IQ of the WISC-IV as dependent variable. Age
and sex served as covariates. The level of significance was set at p < .05 for
each separate analysis.
For hypothesis 1 (b), the two NF1 groups were combined with each other,
because the results of Study 1 showed that children with NF1 without ADHD
partly present at least subclinical attention problems. The purpose of the present
analyses was to investigate the longterm effect of all forms of attention prob-
lems on intellectual development in NF1, as well as the absence of attention
problems in NF1. Additionally, the statistical power of the analyses improves
with a bigger patient group. In a first step, the correlation between the API of
the T.O.V.A. at the first assessment point and intellectual performance at each
of the three assessment points (full-scale IQ at T1, T2, and T3) was separately
tested for the combined NF1-group and the ADHDonly-group with second-
order partial correlation analyses (Pearson’s correlation coefficient). Effects
were controlled for age and sex. In a second step, multiple linear regressions
(method: forced entry) were calculated for the combined NF1-group and for
the ADHDonly-group to predict the intellectual performance (full-scale IQ) at
the first, second and third assessment point based on SES and the attention
performance (API of the T.O.V.A.) at the first assessment point.
Results
The results of the repeated measures ANCOVA showed that the covariates had
no significant effects and there was no statistically significant effect of Time on
full-scale IQ (see Table 4.2).
The separate ANCOVAs of full-scale IQ for the first and second assessment
point showed significant differences between the groups (see Table 4.2). In both
analyses, the covariates had no significant effect. Planned pairwise compar-
isons revealed a significantly better performance of the NF1only-group com-
pared to the NF1ADHD-group at the first and second assessment point (T1:
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p = .002; T2: p = .008), while there were no significant differences between
the ADHDonly-group and any of the NF1 groups.
The ANCOVA for the third assessment point showed only a marginally sig-
nificant effect of the independent variable Group on full-scale IQ and no ef-
fect of the covariates (see Table 4.2). Again, the NF1only-group presented much
higher scores in full-scale IQ than the NF1ADHD-group. Mean values of the
WISC-IV full-scale IQ are pictured in Figure 4.1 and mean values of all WISC-IV
indices for all three assessment points are listed in Table A.12.
Table 4.2.
Results of the repeated measures analysis and the separate univariate analyses of group differences on
full-scale IQ
WISC-IV (full-scale IQ) N df F-value sig. partial η2 post hoc
comparisons
Repeated measures analysis 66 2 1.644 .202 .052 -
ANCOVA for T1 66 4 3.363 .015* .181 A<B**
ANCOVA for T2 66 4 3.027 .024* .166 A<B**
ANCOVA for T3 66 4 2.480 .053 .140 -
*** < .001, ** < .01, * < .05
A = NF1ADHD-group, B = NF1only-group, C = ADHDonly-group
“<” means “lower score/more problems” (e.g. A<B* = group A has significantly lower mean scores and more problems
than group B)
Bias corrected partial correlation analyses for calculating the relationship be-
tween attentional functioning and intellectual functioning showed that the at-
tention performance was significantly correlated with the intellectual perfor-
mance in the combined NF1-group as well as the ADHDonly-group. The com-
bined NF1-group showed significant positive correlations for attention perfor-
mance at the first assessment point and for intellectual performance at each of
the three assessment points (see Table 4.3 and Figure 4.2).
For the ADHDonly-group, the correlation between attention functions and
intellectual performance at the first assessment point was marginally not sig-
nificant, while the correlations at the second and third assessment point were
significant (for results see Table 4.3 and Figure 4.2). Mean values of all T.O.V.A.
parameters for all three assessment points are listed in Table A.13.
The multiple linear regressions for the combined NF1-group revealed sig-
nificant regression equations for all three assessment points (T1: F(2, 40) =
4.737, p = .014 with R2 = .192; T2:F(2, 40) = 7.197, p = .002 with R2 = .265;
and T3: F(2, 40) = 5.121, p = .010 with R2 = .204). The API of the T.O.V.A.
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Figure 4.1. Mean values of the WISC-IV for T1, T2 and T3 for all three patient groups. Significant
group differences emerged between the NF1only-group and the NF1ADHD-group at
T1 and T2. Error bars show the standard error (SE) of the mean.
at the first assessment point was a significant predictor for full-scale IQ at the
first, the second and the third assessment point for the combined NF1-group,
while SES was no significant predictor at any assessment point, see Table 4.4.
For the ADHDonly-group, none of the regression models could significantly
predict the outcome variable, which means: there was no model fit at any as-
sessment point (T1: F(2, 19) = 1.373, p = .277 with R2 = .126; T2:F(2, 19) =
2.547, p = .105 with R2 = .211; and T3: F(2, 19) = 2.603, p = .100 with
R2 = .215). Table 4.4 shows – in the analyses for the ADHDonly-group– that
some of the regression coefficients have a significant impact on the outcome
variable, but these significance tests are not accurate and can not be interpreted,
because the overall models did not fit.
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Table 4.3.
Results of the correlation analyses for the relationship between attention functions and intellectual func-
tioning
Correlation between Combined NF1-group ADHDonly-group
attention functions and r BCaCI p r BCaCI p
full-scale IQ at T1 .405 [ .081, .636] .008** .420 [-.001, .763] .065
full-scale IQ at T2 .464 [ .158, .689] .002** .565 [ .198, .796] .009**
full-scale IQ at T3 .392 [ .007, .646] .010* .539 [ .097, .778] .014*
*** < .001, ** < .01, * < .05
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Figure 4.2. Correlations between the API score of T1 and the full-scale IQ (FIQ) scores of T1, T2,
and T3 for the combined NF1 group (left side) and the ADHDonly-group (right side).
Significant correlations between attention performance and intellectual performance
emerged in almost every of the analyses, except for the first assessment point in the
ADHDonly-group.
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Table 4.4.
Results of multiple regression analyses about predictors for full-scale IQ at the first, second and third
assessment point
Combined NF1-group ADHDonly-group
1. assessment point 1. assessment point
b SE(b) β p b SE(b) β p
Step 1 Step 1
Constant 93.809 6.231 - .000*** Constant 94.861 8.737 - .000***
SES .117 .466 .039 .804 SES .033 .754 .010 .966
Step 2 Step 2
Constant 91.998 5.707 - .000*** Constant 95.134 8.381 - .000***
SES .278 .427 .093 .520 SES .187 .729 .055 .800
API 1.441 .470 .439 .004** API 1.377 .832 .358 .114
R2 = .002 for Step 1;4R2 = .190 for Step 2 R2 = .002 for Step 1;4R2 = .126 for Step 2
2. assessment point 2. assessment point
b SE(b) β p b SE(b) β p
Step 1 Step 1
Constant 90.414 7.058 - .000*** Constant 92.355 9.094 - .000***
SES .460 .527 .135 .389 SES .613 .851 .159 .479
Step 2 Step 2
Constant 88.057 6.218 - .000*** Constant 92.734 9.094 - .000***
SES .669 .466 .196 .159 SES .827 .792 .215 .309
API 1.874 .512 .500 .001** API 1.911 .902 .435 .048*
R2 = .018 for Step 1;4R2 = .246 for Step 2 R2 = .025 for Step 1;4R2 = .186 for Step 2
3. assessment point 3. assessment point
b SE(b) β p b SE(b) β p
Step 1 Step 1
Constant 93.195 7.638 - .000*** Constant 97.517 10.980 - .000***
SES .337 .574 .091 .561 SES .166 .948 .039 .863
Step 2 Step 2
Constant 90.922 7.007 - .000*** Constant 97.964 9.990 - .000***
SES .539 .525 .146 .310 SES .418 .869 .099 .636
API 1.808 .577 .446 .003** API 2.253 .991 .466 .035*
R2 = .008 for Step 1;4R2 = .196 for Step 2 R2 = .002 for Step 1;4R2 = .214 for Step 2
*** < .001, ** < .01, * < .05
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4.2.4. [H2] Improvement of Intellectual Functioning
Data analyses
The second hypothesis about an amelioration of intellectual functioning in de-
pendence of improved attention functions in children with NF1ADHD was tested
with a repeated measures ANCOVA. In a first step, the NF1ADHD-group was
divided into two groups: group 1 consisted of participants, who improved in
the API of the T.O.V.A. over the two-year-period. Group 2 consisted of partic-
ipants, who declined in the API over the two-year-period. In a second step,
those new groups were compared regarding their performance in intellectual
functioning at the first and the third assessment point with a repeated measures
ANCOVA. Sex and age served as covariates in these analyses.
Additionally, a second-order partial correlation analyses (Pearson’s correla-
tion coefficient) was conducted to calculate the relationship between changes
in attention functions (API of T3 minus API of T1) and changes in intellec-
tual functions (full-scale IQ of T3 minus full-scale IQ of T1) over the two-year-
period. Effects were controlled for sex and age.
To explore the hypothesis that the expected effect is specific for children with
NF1ADHD (H2b), the same analyses as described above were conducted for the
ADHDonly-group.
Hypothesis 2(c) was tested with a repeated measures ANCOVA with sex and
age as covariates. Full-scale IQs of T1 and T3 of the NF1only-group were com-
pared.
Results
Concerning the NF1ADHD-group, eleven patients were allocated to each new
group, but it was only a coincidence that the original group split up in two parts
of equal size. The repeated measures ANCOVA showed no significant effect of
Time on full-scale IQ (F(1, 22) = 1.149; p = .298; η2p = .060) and the covari-
ates sex and age had no effect. Figure 4.3 shows the mean values for full-scale
IQs for the two new subgroups API+ and API-. Figure 4.4 illustrates the bias
corrected partial correlation analysis, which yielded no significant correlation
between changes in attention functions and changes in intellectual functioning,
either (r = .191, BCaCI[−.425, .665], p = .421).
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Figure 4.3. Mean values for full-scale IQs of T1 and T3 in the subgroups API+ (improve-
ment of attention performance) and API- (decline of attention performance) for the
NF1ADHD-group and the ADHDonly-group. Error bars show the standard error (SE)
of the mean.
For the ADHDonly-group, the two new groups consisted of 16 participants,
who improved in attention functions (group 1), and 6 participants, who de-
clined in attention functions (group 2). The results of the different analyses
showed the same picture for the ADHDonly-group as for the NF1ADHD-group.
There was no significant effect of Time on full-scale IQ in the repeated mea-
sures ANCOVA (F(1, 22) = .013; p = .911; η2p = .001) and no effect of the
covariates sex and age. Figure 4.3 shows the mean values for full-scale IQs
for the two new subgroups API+ and API-. Figure 4.4 illustrates the bias cor-
rected partial correlation analysis, which did not show a significant correlation
between changes in attention functions and changes in intellectual functioning
(r = .053, BCaCI[−.331, .458], p = .825).
The repeated measures ANCOVA to compare full-scale IQs of the NF1only-
group showed no significant modification in intellectual functioning over the
two-year-period (F(1, 22) = .003; p = .955; η2p < .001) and no effects of the
covariates sex and age.
4.2.5. [H3] Treatment Effects of MPH in NF1
Data analysis
In a first step, participants of the NF1ADHD-group were allocated to two new
groups: one group that received MPH during the term of the study (MPH+
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Figure 4.4. Correlation between changes in the API (T3 minus T1) and changes in full-scale IQ
(T3 minus T1) for the NF1ADHD-group and the ADHDonly-group. Both correlation
analyses were not significant.
group) and another group that did not receive MPH (MPH- group). After-
wards, a univariate ANCOVA with sex and age as covariates was conducted
with the purpose to investigate, if treatment with MPH is superior to other
treatments/interventions regarding improvement of attention functions. The
dependent variable was the differences of the Attention Performance Index
(API) of the T.O.V.A. of T3 minus T1. To test the third hypothesis about a major
advancement of stimulant medication (MPH) on intellectual functioning com-
pared to other or no interventions, a univariate ANCOVA was conducted with
sex and age as covariates. The dependent variable for this analysis was the
difference of the intellectual performances (full-scale IQ) of T3 minus T1.
Results
The NF1ADHD-group originally consisted of 22 participants, 10 of whom re-
ceived MPH during the term of the study.
The comparison of participants receiving MPH and participants not receiv-
ing MPH did not result in significant differences in the improvement of atten-
tion functions (API of the T.O.V.A.) (F(1, 22) = .535; p = .474; η2p = .029) nor in
significant differences in the improvement of intellectual functioning (full-scale
IQ) (F(1, 22) = .434; p = .518; η2p = .024). The covariates had no effect on the
dependent variables in both analyses. Figure (4.5), however, shows small but
not significant differences between the groups.
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Figure 4.5. Mean values for changes in the full-scale IQ and the API between T1 and T3 for the
groups MPH+ and MPH-. Error bars show the standard error (SE) of the mean.
Looking at the courses of the attentional and intellectual performances of
single patients receiving MPH, no trend towards or against an improvement
over the two-year-period is evident. Reasons could be the very low number
of patients and the great heterogeneity of the duration and dose of the MPH
therapy (see Table 4.5). However, the duration of the MPH therapy seems to
correlate with IQ changes to some extent (see Figure 4.6).
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Table 4.5.
Data on full-scale IQs, API scores, and MPH duration and doses in single NF1ADHD patients receiving
MPH
NF1ADHD Full-scale IQ API score MPHa MPHa
patients T1 T3 T1 T3 duration dose
1 112 118 -1.83 2.61 2 25
2 108 105 0.86 -0.44 21 10
3 100 108 -0.09 -0.12 60 7,5
4 97 105 -6.56 0.62 41 15
5 95 101 0.51 -0.21 1 10
6 89 95 2.64 0.24 6 30
7 78 80 2.52 3.33 26 7,5
8 73 68 -0.09 -0.99 24 10
9 71 73 -6.52 -9.52 72 10
10 70 60 -14.27 -8.04 12 40
a: MPH duration in months and MPH dose in milligram at T3
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Figure 4.6. Correlation between the duration of MPH treatment and changes in full-scale IQ
between T1 and T3 for patients with NF1ADHD that were treated with MPH. The
correlation was not significant.
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4.3. Discussion of Study 2
4.3.1. Attention Performance as Predictor for Intellectual
Development
The longitudinal results of Study 2 corroborate the assumption that attention
dysfunction is related to reduced intellectual functioning in NF1. Attention
dysfunction was not only correlated with reduced intellectual functioning in
the short and long term (see Figure 4.2), but was also a significant predictor
for the short-term outcome and for the long-term development of intellectual
functioning in children with NF1. This means that there is a causal link between
the extend of attention deficit and the level of intellectual functioning in NF1.
Significant correlations between attention dysfunction and intellectual func-
tioning were also found for children with ADHDonly (see Figure 4.2), but atten-
tion dysfunction could not predict intellectual functioning in this group. The
relationship between attention deficit and intellectual functioning in ADHDonly
seems to be rather categorial than dimensional. Thus, the first hypothesis [H1]
was confirmed for both NF1 patient groups, but only partly confirmed for the
ADHDonly-group.
Regarding patients with NF1, research results on this topic are rather incon-
sistent. Our results are in line with the findings of newer studies (Potvin et al.,
2015; Lidzba et al., 2012; Pride et al., 2012). Lidzba et al. (2012) confirm the as-
sociation between attention dysfunction and intellectual difficulties in patients
with NF1. They found that NF1 patients with ADHD and ADD symptoms per-
formed significantly worse on intelligence measures than those without ADHD
or ADD. Pride et al. (2012) also found that inattention and executive dysfunc-
tion are predictive for academic achievement and significantly undermine in-
tellectual performance in NF1, even if the authors concluded from their data
that inattention and executive dysfunction are general characteristics of NF1,
which cannot be confirmed by the present data (see Study 1). An older study,
however, found no association between sustained attention problems and low-
ering of IQ in children with NF1 (Hyman et al., 2005). In this study, only SES
was a significant predictor of general intellectual functioning (Hyman et al.,
2005). In the present study, SES was not a predictor for intellectual function-
ing, neither in NF1 nor in ADHDonly, but this may be due to the fact that the
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SES lay in the middle range for every group and there were no large deviations
inbetween the groups.
For children with ADHDonly, previous research consistently provides evi-
dence for an association between ADHD and academic achievement, as well
as intellectual functioning (Biederman et al., 2009; Frazier et al., 2004), even
if symptom severity of ADHD was not found to be correlated with the ex-
tent of intellectual dysfunction (Tsai et al., 2013; Naglieri, Goldstein, Delauder,
& Schwebach, 2005). The present results for the ADHDonly-group also show
no significant correlation between attention performance (which may repre-
sent ADHD symptom severity) and intellectual performance at baseline, but
the symptom severity at baseline correlated significantly with the intellectual
performance after one and after two years. This is a finding of great clinical rel-
evance, since it indicates long-term cognitive disadvantages, which are some-
how related to the behavioral characteristics of ADHD.
4.3.2. Improvement of Intellectual Functioning
Regarding the second hypothesis [H2] of Study 2, the results are contrary to the
expectations and could not support the assumption that improvement of atten-
tion function is associated with an improvement of intellectual functioning. All
of the patient groups showed only moderate, not significant modifications of
intellectual functioning (see Figure 4.1), even if full-scale IQ increased slightly
over the two-year term of the study (NF1ADHD: + 1.5 IQ points, NF1only: +2.2
IQ points, ADHDonly: +4.4 IQ points). However, improved attention functions
had no (significant) effect on intellectual functioning and development – nei-
ther in NF1 nor in ADHDonly– as Figure 4.3 and Figure 4.4 illustrate.
In the NF1 research area, there are previous studies showing a significant im-
provement of intellectual functioning over time (Lidzba et al., 2014; Payne et al.,
2014), but these studies investigated a far longer time period than the present
study and were partially conducted with retrospective data. Additionally, the
positive progressions on intellectual functioning were not entirely and not nec-
essarily associated with changes in attention functions. A study of Lidzba et
al. (2014) investigated the long-term effect of MPH treatment in children with
NF1ADHD and found a significant positive effect of the medication (and other
therapeutic interventions) on attention performance and on intelligence test
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scores. The authors found that the relationship between improved attention
and improved intelligence was not (entirely) responsible for the amelioration
of intellectual functioning, because the improvement of intelligence test scores
stayed significant after controlling for changes in attention measures. There-
fore, the authors assumed that pharmacotherapy, specifically treatment with
MPH, has a specific positive effect on cognitive development in NF1, which is
not limited to attention improvement (Lidzba et al., 2014).
Another study on long-term development of intellectual functioning in NF1
found significant improvement in general cognitive performance over an 18-
year-period. However, the positive effect was limited to patients with discrete
T2 hyperintensities in childhood that decreased or resolved over time (Payne
et al., 2014). In this study, a relationship between T2 hyperintensities and atten-
tion function was not investigated, and something like a second order relation-
ship between an amelioration of attention function and intellectual functioning
seems rather unlikely.
Regarding the present ADHDonly-group, it was expected that there is no ef-
fect of improved attention function on intellectual functioning [H2b]. Previous
literature showed that the course of neurocognitive function is relatively in-
dependent from the course of ADHD (Biederman et al., 2009). The results of
Study 2 are in line with this previous research and show no relationship be-
tween an amelioration of ADHD symptoms and an improvement of intellec-
tual functioning in children with ADHDonly. Like in NF1, some previous stud-
ies on ADHDonly rather found a positive effect of MPH itself on intelligence
test performance than a second order relationship between improved attention
function by MPH that resulted in improved intellectual functions (Tsai et al.,
2013; Gimpel et al., 2005). Consistent with other previous research, Tsai et al.
(2013) found that children with ADHDonly perform significantly worse on in-
telligence tests than healthy controls (at an average of 9 IQ points on full-scale
IQ). Furthermore, they demonstrated that long-term MPH treatment has a pos-
itive effect on intelligence test performance (plus 2.3–3.6 full-scale IQ points
after one year of treatment). However, the improvement of IQ scores was not
correlated with a decrement of ADHD symptoms or baseline ADHD severity.
The authors assumed that MPH may possibly produce a different benefit such
as more accuracy on the test.
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4.3.3. Treatment Effects of MPH in NF1
In the present study, treatment with MPH did not have a significant positive
effect on attentional or intellectual functioning (see Figure 4.5) and MPH treat-
ment did not differ from other treatment options regarding the benefits. There-
fore, hypothesis 3 [H3] has to be rejected. However, the present data is not
comparable to the studies of Lidzba et al. (2014) or Tsai et al. (2013), because
the number of children receiving MPH in the present study was limited and
there was no possibility for a controlled, randomized allocation of the patients
to a MPH-group and a no-MPH-group. Additionally, the duration and dosage
of the medical treatment differed strongly in those patients receiving MPH,
which weakens the comparability and generates a very heterogeneous group.
Due to the small sample size and the heterogeneity of the sample, the statistical
power of the present data is limited in its ability to detect changes in intellec-
tual functioning between pre- and post-treatment. Furthermore, some patients
were even treated with MPH before the start of the study, which is why there
is no pre-treatment data in these cases. Because of these profound limitations,
the results are rather not representative for the entire NF1ADHD population and
a well-founded statement can not be made. Further research on the effect of
MPH on cognitive development and especially intellectual functioning in NF1
is urgently needed.
4.3.4. Conclusion
The results of Study 2 lead to the conclusions that firstly, attention functions
are correlated with intellectual functioning in NF1 and attention performance
can predict intellectual performance in NF1. Secondly, there are marked differ-
ences in the intellectual abilities of patients with NF1 with and without ADHD,
which stay stable over – at least – a two-year-period. Thirdly, intellectual ability
in NF1 does not seem to be modified by changes in attention functions, but in-
tellectual ability seems to increase slightly over time. Fourthly, the results of the
present study do not allow a statement about the effect of MPH on cognitive de-
velopment in NF1, because of too many limitations. Maybe, the investigation
interval of two years is too short to observe intellectual development and its
determinants in NF1. Further longitudinal studies with a prospective design
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and randomized controlled trials are required to investigate treatment effects
of MPH and other therapeutic interventions on cognitive development in NF1.
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5. General Discussion
5.1. Results of the Present Thesis
The present thesis investigated cognitive characteristics of children with NF1
with and without ADHD, as well as the influence of attention deficit on intel-
lectual development in NF1.
Study 1 presented cross-sectional data, which indicates that there exists more
than one cognitive profile in NF1. The condition NF1ADHD can be clearly dis-
tinguished from the condition NF1only at the level of neurocognitive character-
istics. In NF1only, the cognitive profile was characterized by average intellec-
tual abilities, average verbal memory skills, mostly average attention functions,
and average executive functions. Quality of life was also mostly in the nor-
mal range. The only issues of children with NF1only were mild problems with
inattention and mild deficiencies in social skills (building/maintaining friend-
ships). In contrast, the cognitive profile of NF1ADHD included a downward shift
of intellectual abilities (in the lower normal range), which has formerly been as-
signed to the whole NF1 patient group in most previous NF1 studies (North et
al., 2002; Ferner et al., 1996). Furthermore, the profile of NF1ADHD included mi-
nor general attention problems and moderate inattention, as well as moderate
executive dysfunctions (regarding working memory, impulsivity/inhibition,
initiative, planning/organizing, monitoring of task performance and self mon-
itoring). Quality of life was reduced regarding familial aspects and social skills
(building/maintaining friendships).
The heterogeneity of the incidence of certain cognitive deficiencies and of
ADHD in the NF1 population seems surprising at first glance, since NF1 is a
monogenetic disorder. Nevertheless, it is well known that NF1 is no homo-
geneous medical condition and the diversity of cognitive traits might be ex-
plained by different phenotype expressions. Other factors than the mutation
of the NF1-gene alone seem to add to the specific clinical phenotype (Kehrer-
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Sawatzki & Mautner, 2009). Evidence suggests that factors like sex, age, specific
cell type, genomic modifiers, and micro-environmental influences determine
the cognitive and behavioral phenotype triggered by the NF1 condition. Differ-
ent levels of Ras and dopamine activity in specific combinations are proposed
to contribute to diverse cognitive profiles in NF1: High levels of Ras activity
plus slightly reduced levels of dopamine may lead to severe spatial learning
and memory deficits, while high levels of Ras activity plus heavily reduced
levels of dopamine may result in severe attention problems and mild learning
deficits (Diggs-Andrews & Gutmann, 2013). However, to elucidate the role of
Ras, dopamine or other neurotransmitters on learning, memory, and attention
deficits in NF1, further research is needed.
Study 2 presented longitudinal data on the cognitive development of chil-
dren with NF1. The results of Study 2 showed that the differences in intellectual
abilities between children with NF1only and children with NF1ADHD stayed sta-
ble over time, although both NF1 patient groups seemed to slightly improve in
their intellectual abilities over the two-year-interval of the study, which might
be explained by maturation processes. Further research will have to take care
of this concern and exclude mere maturation processes in intellectual develop-
ment in NF1. Regarding attention functions, the results of Study 2 indicated
that the relationship between attention and intellectual ability in NF1 is dimen-
sional as well as causal. The level of attentional functioning was not only corre-
lated to the level of intellectual functioning, but also predictive for future intel-
lectual performances. However, intellectual abilities could not be modified by
changes in attention functions in the present study, which might be due to the
limited duration of the present research project. Furthermore, the investigation
of an expected positive effect of MPH treatment on attention and intellectual
development in NF1 was not successful, because of too many methodological
limitations. Therefore, Study 2 can not contribute to answer the open questions
about the effect of MPH on cognitive functions in NF1.
Concerning a differentiation of NF1ADHD from ADHDonly, the results of the
present thesis indicate that certain deficits in the attention domain are specific
for NF1ADHD and are rather associated with the NF1 condition than merely the
result of comorbid ADHD in NF1. Study 1 showed that children with NF1ADHD
were especially affected regarding inattention, while children with ADHDonly
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had more serious problems with response times. Additionally, Study 2 showed
that attention deficits were dimensionally and causally linked to intellectual
deficiencies in NF1, while the relationship between attention deficit and intel-
lectual functioning in ADHDonly was rather categorial and not causal.
5.2. Limitations
There are some limitations to consider when interpreting the results of this the-
sis, which ask for a critical discussion. At first, limitations associated with sam-
ple characteristics are reflected and in the following, limitations associated with
methodology and study design are discussed.
First of all, participants recruited for the NF1ADHD-group and the ADHDonly-
group of this project partly had an indication for clinical neuropsychological di-
agnostics because of developmental, behavioral, or academic problems. There-
fore, we can not totally rule out that the intellectual and attention performance
of these participants might be worse than that of others with NF1ADHD or
ADHDonly. Additionally, participants for the two NF1 groups were recruited
from all over Germany and were highly motivated to participate despite long
traveling times and the fact that we could not reward them in any way. In
contrast, participants for the ADHD control group were all recruited from the
local area around Tübingen and dropped out from the study more often than
the NF1 patients. The greater availability of specific diagnostics for patients
with ADHDonly and the lower rate of complications might be one reason for
the lower motivation in the ADHDonly-group to participate and to stay until
the end of the present study project. All in all, the ADHDonly-group was rather
small considering the prevalence of ADHDonly and, additionally, the number
of participants taking medication for the treatment of ADHD was unusually
small, which might limit the representativeness of the sample for the entire
ADHD population.
Second, both studies presented in this thesis are missing a comparison group
of healthy children. Such a group would have provided additional information
about the differentness of the neurocognitive profile of children with NF1only,
NF1ADHD, or ADHDonly from those of healthy children and could have given
rise to meaningful treatment implications. Ideally, further studies should inves-
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tigate siblings in a comparison group to control for genetic or environmental
factors.
Third, the three patient groups investigated in Study 1 were of very differ-
ent group sizes, which might limit the statistical power of the analyses and
affect type II error rates. Furthermore, the sample size in Study 2 was relatively
small, which leads to several limitations: (a) Results of studies with small sam-
ple sizes are restricted in their generalizability, because the statistical power to
detect group differences is reduced. (b) Outliers and hidden covariates might
have a strong influence or interfere with real effects. We met these concerns by
matching the groups for age and SES, and controlling most of the analyses for
the covariates age and sex. Additionally, we assessed possible covariates and
found no differences between groups for NF1 subtype or ADHD subtype, and
for the frequency of therapeutic interventions.
Fourth, an influence of sex on the results could not be ruled out. In Study 1
as well as in Study 2, sex distribution was uneven in all three patient groups.
The majority of participants of the ADHDonly-group was male, while it was
reversed in the NF1only-group. In the NF1ADHD-group, the sex distribution
was 3:2 boys to girls in Study 1. Even though we controlled for sex in most of
the analyses, qualitative differences between boys and girls regarding ADHD
symptomatology and cognitive dysfunction could still have influenced the re-
sults. Research in the NF1 area shows that male gender seems to be a specific
risk factor for cognitive dysfunction in NF1. In an animal design that investi-
gated the role of sex as a modifier of neuronal dysfunction in NF1, only male
mice were found to be impaired in learning and memory, which was associ-
ated with reduced hippocampal dopamine levels and increased hippocampal
Ras activation (Diggs-Andrews et al., 2014). Regarding learning and memory
deficits in humans, male NF1 patients were found to be seven times more likely
to exhibit specific learning deficits than females (Hyman et al., 2005). In the
present work, the results of Study 1 show significant effects of sex. On the one
hand, boys performed worse on Processing Speed (WISC-IV) than girls in both
ADHD groups. Since the majority of the NF1ADHD-group were boys and the
majority of the NF1only-group were girls, it is conceivable that the significant
difference in intellectual functioning between the two NF1 groups is partly due
to the effect of sex. On the other hand, however, girls performed worse on
Omission Errors (T.O.V.A.) than boys in all three patient groups. Regarding
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ADHD in general, these results would match the fact that the inattentive sub-
type is more common in girls than the combined or hyperactive subtype – at
least in the general population (Spencer, Biederman, & Mick, 2007). However,
in the present ADHDonly-group, the inattentive subtype was equally common
as the combined subtype in girls and in the NF1ADHD-group, girls even pre-
sented the combined subtype slightly more often than the inattentive subtype.
One explanation for the incongruence of the ADHD subtypes with the perfor-
mances in the test measures could be that the ADHD subtypes of our patients
might rather match functional ratings of ADHD symptoms than neuropsycho-
logical test performances. Nonetheless, future studies must obviously control
for sex and ADHD subtype effects.
Fifth, a further limitation is the absence of differentiation between the inat-
tentive and the combined subtype of ADHD in the analyses, which was due
to the relatively small sample size of the ADHD control group. Even though
the distribution of subtypes did not differ significantly between the NF1ADHD-
group and the ADHDonly-group, we can not guarantee that there was no effect
of slight differences in the frequency of the subtypes on the results. Addition-
ally, we can not contribute to the open questions on the distribution and conse-
quences of ADHD subtypes in NF1.
Sixth, we assessed attention functions only with one continuous performance
test and one attention questionnaire. Although the T.O.V.A. is very useful in
predicting ADHD in individuals, it might not measure single attention func-
tions in a sufficiently differentiated way to distinguish between NF1ADHD and
ADHDonly. For further studies on this topic, the use of more elaborate test bat-
teries is recommended to address different domains of attention and also exec-
utive functions and to gain a more detailed picture of the profiles of NF1ADHD
compared to ADHDonly.
Seventh, external assessments of ADHD symptoms, attention functions, ex-
ecutive functions, and QoL were conducted via parent and teacher question-
naires, which does not meet the so-called gold standard for the assessment of
behavioral symptoms. A clinical observation of a child’s behavior in differ-
ent situations of daily living would be preferable to questionnaires, because a
rating by parents and teachers might be influenced by social expectations or
negative/positive experiences with the child. A clinical observation would be
desirable for future studies investigating behavioral symptoms in NF1, but it is
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probably only rarely possible in the context of most research projects for logis-
tical reasons.
Eighth, no randomized controlled trial was conducted for Study 2 of the
present thesis. In designing the study, we had determined that a randomization
of medication across groups for a long-term study would be ethically inappro-
priate . Therefore, it was not possible to control the decision for or against a
treatment with MPH. Parents or caregivers decided to start with medication
after medical advice, but the decision was not based on a clinical evaluation.
Since many influencing factors affect the treatment decision of parents or care-
givers, this is a very ambiguous variable, which is difficult to control.
Ninth, in the clinical practice other treatments were often conducted (e.g.
occupational therapy, cognitive behavior therapy) in combination with MPH
treatment or even exclusively, but an interference of the medication effect with
a possible effect of other treatments or the effect of other treatments themselves
on intellectual functioning were not investigated in the present study. Future
studies will have to meet this concern.
Tenth, Study 2 was designed to investigate long-term effects regarding the
cognitive development of children with NF1, because we assumed that such
a basic deficit like attention dysfunction has a cumulative, negative effect on
intellectual functioning. Additionally, we hypothesized that an improvement
of cognitive functions as a result of an intervention with medication would also
rather be a long-term development. Therefore, the design of Study 2 contained
follow-up assessments over a time period of two years. However, it seems that
the study duration was still too short to observe major changes in the cognitive
development of children with NF1, irrespective of whether or not it concerns
a negative influence of attention dysfunction, the possible positive effect of a
MPH treatment, or plain maturation processes in intellectual functioning.
5.3. Conclusion and Implications
The present thesis contains a cross-sectional neurocognitive investigation as
well as longitudinal analyses of the intellectual development of children with
NF1. While cross-sectional studies have already been conducted several times
in NF1 research, the present work is the first to prospectively investigate long-
term effects of attention deficit on intellectual development in children with
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NF1. Also, it is the first attempt to examine treatment effects of MPH on intel-
lectual development in NF1 in a prospective design. Despite some drawbacks
associated with methodological issues and study design, the present work gives
first evidence for diverse cognitive characteristics and different developmental
courses in-between the NF1 population. The present findings support the as-
sumption that there are – at least – two distinct cognitive profiles of NF1 with
one group being far more affected than the other. Attention deficit is a spe-
cific risk factor for intellectual dysfunction in NF1 and the condition NF1ADHD
entails an additional cognitive burden. Moreover, ADHD is not a mere comor-
bidity in NF1, but certain attention deficits seem to be associated with the NF1
condition.
Also, the longitudinal results lead to some important conclusions, despite
the unsuccessful outcome of the attempts to find an effect of changes in atten-
tion functions on intellectual functioning and to elucidate the effect of MPH on
intellectual development in NF1. Attention deficit in NF1 is causally linked to
intellectual functioning in the short and long term and leads to decreased intel-
lectual functioning, which stays stable over time. We assume from the results
of previous research that MPH might help to improve intellectual functioning
in patients with NF1ADHD, but it was impossible to appropriately investigate
this issue in the present research project.
However, the results of the present thesis emphasize how important it is to
record ADHD and attention deficit as a factor in future neurocognitive inves-
tigations and may give rise to further investigations on neurobiological causes
of cognitive dysfunction in NF1. Building subgroups of patients on the basis of
neurocognitive characteristics could also be a good practice for other neurolog-
ical diseases to gain valuable information.
Furthermore, the findings of the present thesis entail implications for po-
tential treatment options for children with NF1ADHD and might encourage re-
search on the development of cognitive training, which is specifically adapted
to the neuropsychological profile and the requirements of children with NF1ADHD.
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A. Appendix
A.1. Supplemental Data for Study 1
A.1.1. Equality of Variances and Normality of Distribution
Table A.1.
Equality of variances via Levene’s test and normality of distribution via Shapiro-Wilk-test for all depen-
dent variables of the neuropsychological assessments of Study 1
Dependent variable equality of
variances
(sig.)
normality of distribution
(sig.)
NF1ADHD NF1only ADHDonly
W
IS
C
-I
V
full-scale IQ .089 .221 .562 .137
Verbal Comprehension .917 .107 .040* .983
Perceptual Reasoning .022* .071 .142 .997
Working Memory .123 .052 .176 .019
Processing Speed .436 .095 .521 .946
V
LM
T Immediate Recall .837 .017* .071 .006**
Delayed Recall .320 .038* .057 .033*
Recognition .524 .034* .242 .064
T.
O
.V
.A
. API .983 .000*** .168 .015*
Variability of RT .573 .040* .018 * .010*
Response Time .416 .465 .003** .015*
Commission Errors .946 .026* .000*** .595
Omission Errors .466 .000*** .000*** .000***
*** < .001, ** < .01, * < .05
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Table A.2.
Equality of variances via Levene’s test and normality of distribution via Shapiro-Wilk-test for the depen-
dent variables of the Conners-3 parent and teacher evaluation
Dependent variable equality of
variances (sig.)
normality of distribution
(sig.)
NF1ADHD NF1only ADHDonly
parent evaluation
Inattention .996 .014* .259 .000***
Hyperactivity/Impul-
sivity
.269 .092 .802 .026*
teacher evaluation
Inattention .744 .001** .448 .000***
Hyperactivity/Impul-
sivity
.180 .014* .532 .171
*** < .001, ** < .01, * < .05
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Table A.3.
Equality of variances via Levene’s test and normality of distribution via Shapiro-Wilk-test for the depen-
dent variables of the BRIEF parent and teacher evaluation
Dependent variable equality of
variances
(sig.)
normality of distribution
(sig.)
NF1ADHD NF1only ADHDonly
parent evaluation
Global Executive Composite .021* .316 .682 .263
Behavioral Regulation Index .010* .007** .111 .048*
Metacognition Index .007** .219 .139 .092
Inhibit .003** .016* .001** .075
Shift .095 .013* .023* .650
Emotional Control .044 .006** .205 .349
Initiate .692 .027* .241 .153
Working Memory .046* .150 .101 .056
Plan/Organize .008* .669 .039* .027*
Organization of Materials .065 .090 .210 .001**
Monitor .064 .116 .660 .379
Monitoring of Task Perform. .113 .118 .127 .259
Self Monitoring .318 .109 .010* .092
teacher evaluation
Global Executive Composite .131 .641 .028* .665
Behavioral Regulation Index .004** .570 .013* .019*
Metacognition Index .188 .669 .012* .583
Inhibit .005** .670 .115 .035*
Shift .993 .575 .001** .015*
Emotional Control .365 .007** .002** .003**
Initiate .643 .695 .020* .209
Working Memory .976 .064 .008** .521
Plan/Organize .587 .197 .012* .409
Organization of Materials .160 .000*** .000*** .012*
Monitor .866 .282 .113 .422
Monitoring of Task Perform. .543 .127 .013* .066
Self Monitoring .844 .221 .026* .063
*** < .001, ** < .01, * < .05
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Table A.4.
Equality of variances via Levene’s test and normality of distribution via Shapiro-Wilk-test for the depen-
dent variables of the Kiddo-Kindl
Dependent variable equality of
variances (sig.)
normality of distribution
(sig.)
NF1ADHD NF1only ADHDonly
Total Score .280 .178 .631 .135
Physical well-being .196 .001** .004** .168
Mental well-being .270 .000*** .005** .061
Self-Esteem .022* .423 .056 .788
Family .016* .002** .209 .113
Friends .484 .010* .177 .075
School .588 .030* .048* .037*
Chronic Disease .297 .002** .009** .005**
*** < .001, ** < .01, * < .05
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A.1.2. Mean Values and Standard Errors
Table A.5.
Mean values and standard errors of the mean (SE) for all dependent variables of the neuropsychological
assessments of Study 1
Dependent variable NF1ADHD NF1only ADHDonly
W
IS
C
-I
V
Full-scale IQ Mean 89.409 101.055 95.159SE 1.390 1.954 1.867
Verbal Comprehension Mean 95.545 103.831 99.028SE 1.422 1.998 1.910
Perceptual Reasoning Mean 91.964 100.879 95.110SE 1.601 2.250 2.150
Working Memory Mean 87.650 97.215 95.117SE 1.569 2.205 2.107
Processing Speed Mean 91.399 101.590 95.212SE 1.771 2.489 2.379
V
LM
T
Immediate Recall Mean 46.292 45.326 45.324SE 1.285 1.810 1.639
Delayed Recall Mean 51.831 53.313 54.368SE 1.265 1.781 1.613
Recognition Mean 47.881 50.110 45.736SE 1.428 2.011 1.821
T.
O
.V
.A
.
API Mean -0.888 0.349 -1.652SE 0.417 0.593 0.536
Variability Mean 84.294 93.225 80.837SE 2.560 3.644 3.289
Response Time Mean 91.270 94.442 84.277SE 2.559 3.643 3.289
Commission Errors Mean 95.450 98.935 95.566SE 2.583 3.677 3.319
Omission Errors Mean 72.569 82.234 81.809SE 3.252 4.629 4.179
Mean values for the WISC-IV and the T.O.V.A. in standard scores: mean = 100, SD = 15;
Mean values for the VLMT in T-scores: mean = 50, SD = 10
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Table A.6.
Mean values and standard errors of the mean (SE) for all variables of the Conners-3 parent and teacher
evaluation
Dependent variable NF1ADHD NF1only ADHDonly
parent evaluation
Inattention Mean 65.036 54.868 68.119SE 0.882 1.280 1.109
Hyperactivity/Impulsivity Mean 59.910 49.031 61.061SE 1.306 1.895 1.642
Learning Problems Mean 65.300 50.961 62.600SE 1.749 1.665 1.197
Executive Functioning Mean 64.580 49.115 65.600SE 1.389 1.326 1.446
Defiance/Aggression Mean 56.462 48.769 57.300SE 1.414 1.057 1.678
Peer Relations Mean 60.865 52.500 59.700SE 1.468 1.741 2.051
ADHD Index Mean 62.431 53.615 65.533SE 0.907 0.959 1.126
Global Index Mean 60.255 50.154 64.500SE 1.139 1.433 1.528
teacher evaluation
Inattention Mean 66.739 53.677 65.325SE 1.710 2.378 1.977
Hyperactivity/Impulsivity Mean 61.844 50.212 59.508SE 1.540 2.142 1.781
Learning Problems Mean 65.050 54.864 61.778SE 1.448 1.596 1.616
Executive Functioning Mean 63.275 50.646 63.889SE 1.600 1.436 1.732
Defiance/Aggression Mean 50.231 50.000 49.519SE 1.329 0.431 0.422
Peer Relations Mean 63.488 60.818 65.481SE 1.465 1.518 1.444
ADHD Index Mean 65.073 55.091 64.704SE 1.508 1.660 1.827
Global Index Mean 62.805 54.182 63.852SE 1.559 1.634 1.723
Mean values in T-scores: mean = 50, SD = 10
112
A.1. Supplemental Data for Study 1
Table A.7.
Mean values and standard errors of the mean (SE) for the dependent variables of the BRIEF parent
evaluation
Dependent variable NF1ADHD NF1only ADHDonly
Global Executive Composite Mean 62.582 47.655 64.562SE 1.808 2.381 1.828
Behavioral Regulation Index Mean 57.657 47.836 60.515SE 2.134 2.811 2.158
Metacognition Index Mean 64.909 48.262 66.390SE 1.826 2.405 1.846
Inhibit Mean 62.241 49.304 62.406SE 2.217 2.920 2.242
Shift Mean 54.441 47.801 57.958SE 2.127 2.802 2.150
Emotional Control Mean 52.231 47.351 56.118SE 2.016 2.655 2.038
Initiate Mean 60.013 50.290 62.849SE 1.896 2.497 1.916
Working Memory Mean 64.146 49.016 68.652SE 1.684 2.217 1.702
Plan/Organize Mean 62.208 48.220 65.171SE 1.848 2.434 1.868
Organization of Materials Mean 57.336 46.837 56.089SE 2.123 2.796 2.146
Monitor Mean 63.332 48.147 62.677SE 1.691 2.227 1.709
Monitoring of Task
Performance
Mean 61.654 50.067 61.924
SE 1.860 2.450 1.880
Self Monitoring Mean 61.476 47.421 60.917SE 1.867 2.459 1.887
Mean values in T-scores: mean = 50, SD = 10
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Table A.8.
Mean values and standard errors of the mean (SE) for the dependent variables of the BRIEF teacher
evaluation
Dependent variable NF1ADHD NF1only ADHDonly
Global Executive Composite Mean 63.246 46.048 62.210SE 2.228 3.132 2.149
Behavioral Regulation Index Mean 57.447 46.582 57.732SE 2.146 3.017 2.070
Metacognition Index Mean 64.315 46.367 62.865SE 2.152 3.026 2.076
Inhibit Mean 60.046 45.498 58.991SE 2.143 3.013 2.067
Shift Mean 57.571 50.792 55.981SE 2.389 3.359 2.304
Emotional Control Mean 54.872 49.650 55.346SE 2.292 3.223 2.211
Initiate Mean 65.145 48.131 62.231SE 2.203 3.097 2.125
Working Memory Mean 65.032 50.910 63.348SE 2.372 3.335 2.288
Plan/Organize Mean 63.239 47.620 61.032SE 2.269 3.190 2.189
Organization of Materials Mean 56.806 46.539 58.211SE 2.671 3.756 2.577
Monitor Mean 62.743 49.297 61.621SE 2.267 3.187 2.187
Monitoring of Task
Performance
Mean 62.620 48.497 62.085
SE 2.330 3.276 2.248
Self Monitoring Mean 60.846 50.630 58.790SE 2.267 3.187 2.187
Mean values in T-scores: mean = 50, SD = 10
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Table A.9.
Mean values and standard errors of the mean (SE) for the dependent variables of the Kiddo-Kindl
Dependent variable NF1ADHD NF1only ADHDonly
Physical well-being Mean 0.190 0.359 0.179SE 0.207 0.305 0.245
Mental well-being Mean -0.181 0.297 -0.424SE 0.205 0.303 0.243
Self-Esteem Mean 0.087 0.340 0.029SE 0.102 0.151 0.121
Family Mean -0.632 0.012 -0.703SE 0.198 0.292 0.234
Friends Mean -1.171 -0.245 -1.054SE 0.228 0.335 0.269
School Mean -0.177 0.887 -0.293SE 0.184 0.270 0.217
Cronic Disease Mean 1.461 1.319 1.459SE 0.165 0.243 0.195
Mean values in z-scores: mean = 0, SD = 1
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Table A.10.
Mean values and standard errors of the mean (SE) for all variables of the CBCL
Dependent variable NF1ADHD NF1only ADHDonly
Total Score Mean 63.882 54.5 62.767SE 1.269 1.777 1.654
Externalizing Mean 59.824 50.962 61.467SE 1.355 1.898 1.767
Internalizing Mean 58.412 54.923 60.467SE 1.475 2.066 1.923
Anxious/Depressed Mean 58.647 54.5 60.8SE 1.103 1.544 1.438
Withdrawn/Depressed Mean 58.020 56.308 59.3SE 1.090 1.527 1.422
Somatic Complaints Mean 60.275 59.231 58.767SE 1.255 1.757 1.636
Social Problems Mean 69.510 56.808 64.033SE 1.475 2.066 1.923
Thought Problems Mean 57.510 55.731 55.433SE 1.243 1.741 1.621
Attention Problems Mean 68.667 56.038 67.333SE 1.222 1.711 1.593
Rule-Breaking Behavior Mean 58.980 52.269 58.367SE 1.001 1.402 1.305
Aggressive Behavior Mean 61.882 53.577 62.833SE 1.217 1.704 1.586
Mean values in T-scores: mean = 50, SD = 10
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A.2. Supplemental Data for Study 2
A.2.1. Equality of Variances and Normality of Distribution
Table A.11.
Equality of variances via Levene’s test and normality of distribution via Shapiro-Wilk-test for the depen-
dent variables of Study 2
Dependent variable equality of
variances (sig.)
normality of distribution
(sig.)
NF1ADHD NF1only ADHDonly
Demographic data
Age .393 .096 .266 .413
SES .575 .820 .642 .991
WISC-IV
full-scale IQ T1 .101 .669 .824 .142
full-scale IQ T2 .609 .358 .072 .494
full-scale IQ T3 .772 .764 .848 .745
IQ difference T3-T1 .608 .033* .251 .515
T.O.V.A.
API T1 .621 .001** .022* .175
API T3 .095 .027* .286 .157
API difference T3-T1 .920 .066 .039* .000***
*** < .001, ** < .01, * < .05
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A.2.2. Mean Values and Standard Errors
Table A.12.
Mean values and standard errors of the mean (SE) for the dependent variables of the WISC-IV at T1,
T2, and T3
Dependent Variable NF1ADHD NF1only ADHDonly
T1
W
IS
C
-I
V
FIQ Mean 89.703 101.457 95.113SE 2.258 2.318 2.343
Verbal Comprehension Mean 95.190 105.095 99.079SE 2.134 2.191 2.215
Perceptual Reasoning Mean 92.385 101.530 94.675SE 2.556 2.624 2.653
Working Memory Mean 88.792 96.732 94.703SE 2.388 2.452 2.478
Processing Speed Mean 90.671 100.635 95.830SE 3.010 3.091 3.124
T2
W
IS
C
-I
V
FIQ Mean 90.346 102.029 99.170SE 2.607 2.677 2.706
Verbal Comprehension Mean 98.536 107.105 104.187SE 2.633 2.837 2.733
Perceptual Reasoning Mean 92.432 99.877 103.407SE 2.758 2.972 2.863
Working Memory Mean 86.985 96.179 96.626SE 2.525 2.721 2.621
Processing Speed Mean 89.263 102.358 91.503SE 2.866 3.088 2.975
T3
W
IS
C
-I
V
FIQ Mean 91.234 103.648 99.528SE 2.866 2.943 2.975
Verbal Comprehension Mean 99.230 107.318 104.906SE 2.608 2.678 2.707
Perceptual Reasoning Mean 93.725 100.450 101.325SE 3.043 3.125 3.158
Working Memory Mean 85.985 98.353 96.117SE 2.755 2.829 2.860
Processing Speed Mean 91.306 104.397 93.297SE 2.852 2.928 2.960
Mean values in standard scores: mean = 100, SD = 15
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Table A.13.
Mean values and standard errors of the mean (SE) for the dependent variables of the T.O.V.A. at T1, T2,
and T3
Dependent Variable NF1ADHD NF1only ADHDonly
T1
T.
O
.V
.A
.
API Mean -0.878 0.470 -1.331SE 0.669 0.688 0.660
Variability Mean 83.933 94.191 81.649SE 3.991 4.109 3.941
Response Time Mean 89.420 93.539 86.495SE 3.973 4.090 3.923
Commission Errors Mean 101.378 100.043 94.443SE 3.830 3.944 3.782
Omission Errors Mean 73.687 84.955 81.903SE 4.960 5.106 4.897
T2
T.
O
.V
.A
.
API Mean -0.441 0.369 -0.856SE 0.665 0.721 0.657
Variability Mean 85.938 92.906 85.238SE 4.545 4.931 4.490
Response Time Mean 92.117 93.971 87.410SE 3.752 4.071 3.707
Commission Errors Mean 95.039 106.905 101.274SE 4.197 4.554 4.147
Omission Errors Mean 77.380 85.437 86.769SE 4.416 4.791 4.363
T3
T.
O
.V
.A
.
API Mean -0.576 1.042 -0.499SE 0.658 0.690 0.650
Variability Mean 83.631 95.276 85.651SE 4.145 4.343 4.095
Response Time Mean 90.674 98.691 92.803SE 3.226 3.380 3.187
Commission Errors Mean 104.659 104.720 101.881SE 3.252 3.408 3.213
Omission Errors Mean 77.496 89.625 84.090SE 4.915 5.150 4.856
Mean values in standard scores: mean = 100, SD = 15
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